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ABSTRACT 
 
Identification and Characterization of Novel Sir3/MeCP2-Chromatin Interactions 
 
By Nicholas L. Adkins 
 
 The eukaryotic genome is packaged into chromosomes that are made up of a highly 
organized and heavily regulated structure called chromatin. The proteins involved in the 
compaction of DNA into this condensed state are mostly understood at the level of the structure 
of the nucleosome. The higher order arrangement of chromatin and how it effects gene 
regulation is only partially understood and characterized. The compaction of nucleosomal arrays 
into 30-nm and higher structures are partially the responsibility of architectural, or structural, 
chromatin associated proteins. The following dissertation analyzes the individual chromatin 
contributions of two well studied architectural proteins, the yeast silencing protein Silent 
Information Regulator 3 (Sir3) and the human transcriptional regulator methyl CpG binding 
protein 2 (MeCP2). Silencing in yeast is the responsibility of the SIR family of proteins. 
Classically, the Sir3 protein has been characterized as associating with chromatin through the 
hypo-acetylated N-termini of the core histones H3 and H4. The Sir3 protein has recently been 
found to contain a DNA-binding element, my studies characterized Sir3-nucleic acid interactions 
and showed that Sir3 can bind to chromatin independently of histone N-termini. In contrast, the 
MeCP2 protein has classically been characterized as a methylated DNA dependent 
transcriptional repressor, but recent genome-wide analysis reveals MeCP2 distribution can occur 
on promoters of active genes. Recent in vitro work with MeCP2 and nucleosomal arrays showed 
a highly ordered, compacted chromatin structure even in the absence of DNA methylation. 
MeCP2 is of particular biological interest due to the observed link with the neurodevelopmental 
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disorder Rett Syndrome (RTT). My studies demonstrated that MeCP2 can bind in vitro to the N-
termini of core histones H2A, H3, and H4. Additionally, the removal of these tails impacted 
MeCP2-chromatin interactions, and resulted in a reduced level of nucleosomal array 
condensation. Importantly, the two RTT mutants analyzed here, R133C and R168X, exhibited 
differential binding to histone N-termini. These results add to the understanding of chromatin 
organization and arrangement by demonstrating and characterizing additional chromatin contacts 
for these two chromatin associated proteins.  
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CHAPTER ONE: BACKGROUND AND SIGNIFIGANCE 
INTRODUCTION 
 
Recent advances in research on the mechanisms of gene expression and silencing in 
eukaryotic organisms have revealed an incredible level of complexity.  In addition to regulatory 
DNA sequences, chromatin structure has been shown to be intimately linked to the control of 
gene expression with coordinated rearrangement of multiple molecules being required for DNA 
accessibility.  In contrast to the general dogma that an open, accessible chromatin structure 
facilitates gene activation, silencing requires the compaction of chromatin over areas of the 
genome where genes are repressed. These transitions from unfolded to compacted chromatin 
must also occur in a reversible manner, suggesting coordinated regulatory events. Unintended 
alterations in structure can often lead to disease through anomalous gene expression. Aberrant 
changes in structure can occur through several different mechanisms including altered patterns of 
DNA-methylation, improper post-translational modifications (PTMs) of DNA-associated 
proteins such as histones, or genetic mutations that result in changes for regulatory factors 
binding affinity. Treatment of diseases linked to these changes is critically dependent on 
understanding all of the protein-protein or DNA-protein interactions that influence chromatin 
dynamics and/or any signals that result in structural changes. The study of chromatin associated 
proteins (CAPs) and their interactions with chromatin is therefore essential, and is one of the 
fundamental first steps towards understanding the pathological mechanisms of certain diseases.  
CAPs’ functions are regulated by similar protein-protein interaction domains, catalytic 
subunits, and DNA-binding motifs. In addition, CAPs share similar characteristics in a given 
organism and across species. An important subset of CAPs is the silent information regulator 
(Sir) group. These proteins are involved in the silencing of genes in Saccharomyces cerevisiae 
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that is more commonly known as bakers or budding yeast. Saccharomyces cerevisiae, one of the 
most widely used model systems,  is an essential research tool for the understanding of both 
genetic and epigenetic events (regulatory events important for regulation of gene expression that 
do not involve changes in DNA sequences). One of the Sir family members, Sir3, is an 
architectural CAP that was initially characterized as a histone-tail binding protein. However, it 
was recently demonstrated to also have a DNA-binding ability (Georgel et al., 2001). Another 
CAP family known to be involved in eukaryotic silencing is the methyl-DNA-binding protein 
(MDB) group. Amongst this family of CAPs, the methyl-DNA binding protein 2 (MeCP2) is of 
particular importance because of its links with the Rett syndrome (RTT) disorder (Amir et al., 
1999). RTT is a progressive childhood neurodevelopmental disorder that is one of the most 
common causes of mental disabilities in white Caucasian female patients with an incidence rate 
of 1 in 15,000 (Hagberg, 1985). Mutations in MeCP2 have been directly linked with the majority 
of patients classified with RTT (Amir et al., 1999). This CAP was initially described as a methyl-
DNA binding global transcriptional repressor, but was recently demonstrated to also associate 
with transcriptionally active promoters (Nan et al., 1997, Yasui et al. 2007; Chahrour et al. 
2008). Mutations linked to RTT have also been found outside of the methyl-DNA binding 
domain (MBD), indicating additional domains are necessary for proper MeCP2 developmental or 
regulatory functioning (Amir et al., 1999). In addition to its methyl DNA binding role, MeCP2 
has been described as a chromatin associated protein (Wade and Wolffe). A systematic in vitro 
characterization of MeCP2’s role in chromatin dynamics described its ability to promote the 
adoption of novel secondary structures suggesting that the function of MeCP2 in silencing gene 
expression may be related to its ability to induce large-scale chromatin reorganization (Georgel 
et al., 2003).   These two CAPs appear to affect chromatin through multiple types of interactions, 
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and a more thorough investigation is required to more fully understand the mode of action of 
these architectural CAPs.  
The focus of this study was to characterize the chromatin binding determinants of the 
CAPs Sir3 and MeCP2 and to clarify their role in chromatin architecture.  Multiple studies have 
characterized the CAP interaction with chromatin through a single determinant, however the 
additional  and  related  functions of these  proteins have  yet  to be fully  explained. Emerging 
evidence seems to link multiple CAPs with more than one activity or target (Georgel et al. 2001; 
Nielsen et al., 2001; Vakoc et al., 2005; Kanno et al., 1995; Jacobs et al., 1999; Molofsky et al., 
2003). The studies described herein are aimed at understanding the DNA-binding component of 
Sir3, identifying and analyzing the preferences in binding to DNA features. These DNA 
interactions will provide a better understanding of the complex role of Sir3 in silencing gene 
expression. Similarly, we also report that MeCP2, in addition to recognizing methylated CpGs, 
influences chromatin folding through histone N-Termini (or tails) interactions. Importantly, 
MeCP2 mutants linked to the onset of RTT have the ability to differentially recognize and bind 
specific histone tails. By further understanding the complex interplay between CAPs and 
chromatin, and their impacts on gene expression, we may be able to manipulate these regulatory 
events in order to treat genetic-linked diseases.  
CHROMATIN COMPOSITION AND ORGANIZATION 
 
In eukaryotic nuclei, DNA is packaged into a nucleo-protein complex referred to as 
chromatin. This structure is highly complex and yet organized in a manner that still allows 
sufficient DNA accessibility for such processes as transcription, replication, and DNA repair to 
take place. The packaging of eukaryotic DNA requires increasingly complex levels of chromatin 
condensation. The open structure, called euchromatin, is found in more highly transcribed 
4 
 
regions of the genome, while highly condensed regions, called heterochromatin, is found in 
telomeres, centromeres, and non-coding sequences. Access to DNA regulatory elements is 
achieved by the alteration of DNA-histone contacts that allows mobilization of nucleosomes 
revealing the target sequences of DNA that are required to interact with transcription factors.  
The structure of DNA was solved over 50 years ago, yet alterations in chromatin structure, 
composition, and function directed by regulatory CAP- interactions remain to be fully elucidated. 
The first level of DNA compaction results from its formation of a complex with an 
octamer of DNA-binding proteins called core histones that form a nucleosome. The nucleosome 
core particle (NCP) is the basic unit of chromatin and consists of 146 base pairs (bp) of DNA 
wrapped in a left-handed manner around a histone core octamer comprised of two copies of each 
core histone; H2A, H2B, H3, and H4 (Figure 1.1). Under physiological ion concentrations, DNA 
is a helical structure that makes a complete turn every 3.4 nm (10.5 bp/turn). Nucleosomal DNA 
is wrapped around the histone core octamer through 1.75 helical turns with a 10.2 bp/turn 
average (Wolffe 1998). The curvature and shape of the DNA around the histone core octamer is 
not uniform. Two regions of 10.0 bp/turn of DNA are known to flank the dyad axis of 
nucleosomal DNA.  The dyad axis region has a periodicity of 10.7 bp/turn.  Severe DNA 
distortion is found at the junction of these regions leading to a change in the average bp/turn 
within nucleosomal DNA (Wolffe 1998). These distortions in the natural linear B-DNA type 
structure have the potential to be recognized as a particular substrate or binding site, and 
influence the recruitment of various DNA associated proteins and enzymes. For instance, the 
preference of HIV integrase activity for nucleosomal DNA is due to the particular DNA structure 
adopted while incorporated around core histones and is a useful example of how DNA structure 
within chromatin can affect a biological process (Pruss et al., 1994). Nucleosome assembly has 
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been shown to be sequential, starting with the recruitment of a tetramer of histones H3 and H4, 
followed by the addition of two H2A-H2B dimers.  Each core histone has a structured domain 
referred to as a histone fold that is comprised of three alpha helices (one long helix flanked by 
two shorter helices) which allow histone-histone interactions (the alpha helices of each core 
histone structure and interactions can be seen in the NCP crystal structure (Figure 1.1). The 
unstructured N-terminal sections of core histones (N-terminal tail) are known to be structural 
modulators of chromatin architecture, and serve as targets for PTMs. These histone N-terminal 
tail PTMs can play a role in chromatin architectural changes, and influence CAP recruitment. 
The DNA residing between two adjacent nucleosomes is referred to as linker DNA, and is a 
short stretch of linear DNA that is minimally hindered sterically by the nucleosomal structure. A 
collection of nucleosomes on a stretch of DNA is referred to as an array of nucleosomes, or 
nucleosomal arrays (NA) (Wolffe 1998). An extended nucleosomal array has a diameter of 10-
nm, often referred to as beads-on a-string, and has recently been termed as the “primary” 
structure of chromatin in a nomenclature analogous to that which describes levels of protein 
folding (Woodcock and Dimitrov, 2001). 
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Figure 1.1: X-ray Crystal Structure of the Nucleosome Core Particle (NCP) * 
 
*Modified from Luger et al, 1997 
 
The secondary structure of chromatin results from condensation of the 10-nm primary 
structure into a higher order 30-nm chromatin fiber. Despite extensive studies, there are still 
large gaps in understanding this chromatin folding process, and the exact structure of the 30-nm 
fiber is presently being debated. There are two proposed models of the 30-nm chromatin 
structure;  the solenoid chromatin model (Figure 1.2, A) (Finch and Klug, 1976; Thomas et al., 
1979; Felsenfeld & McGhee, 1986) in which a one-start helical stack of nucleosomes has bent 
linker DNA between adjacent nucleosomes and the zigzag two-start helix model (Figure 1.2, B 
and C) which proposes a relatively straight segment of linker DNA that connects two helical 
stacks of nucleosomes (Figure 1.2; linker DNA highlighted in yellow to allow orientation within 
the chromatin fiber) (reviewed in Wu et al., 2007). Within the zigzag model there have been two 
possible structures proposed with different linker DNA conformations. The helical/twisted-
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ribbon model (Figure 1.2, B) has the linker DNA orientated at angles ranging from 0° to 50° 
(Worcel et al, 1981; Woodcock et al, 1984) and the crossed-linker model that has the linker DNA 
perpendicular to the chromatin fiber axis (Williams et al, 1986; Smith et al, 1990). Recent 
evidence seems to favor the zigzag two-start helix over the one-start solenoid model, but more 
studies must be done to fully understand the condensation of nucleosomal arrays into the 30-nm 
fiber (Dorigo et al, 2004; Kruithof et al, 2009). Studies involving in vitro reconstituted arrays 
from purified components have demonstrated that the core histone octamer itself and the N-
terminal tails play a critical role in the folding of NA into the 30-nm structure (Fletcher and 
Hansen 1995; Luger et al, 1997; Dorigo et al, 2004; Zheng et al., 2005; Kan et al., 2007; Kan et 
al., 2009). Another set of DNA-binding proteins, linker histones H1/H5, are of particular interest 
because they are found in nearly stochiometric abundance to nucleosomes and are known to 
stabilize the intrinsic 30-nm secondary structure adopted by nucleosomal arrays under 
physiological conditions (reviewed in Lugar and Hansen 2005). Another chromatin-associated 
protein, heterochromatin protein 1 (HP1), was shown to associate and remodel chromatin 
secondary structure through a series of in vitro biophysical studies and in vivo fluorescence 
recovery after photobleaching (FRAP) analysis (Fan et al, 2004; Cheutin et al, 2003).  After the 
nucleosome, the 30-nm secondary chromatin structure has been the most intensively studied 
structure in the field of chromatin biology, and yet the structural mechanics and interacting 
architectural proteins are just now starting to come into focus. 
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Figure 1.2: Models of the 30-nm Chromatin Fiber * 
(A) Solenoid model. (B) Helical/Twisted-ribbon model. (C) Crossed-linker model. 
 
* Modified from Wu et al. (2007) 
There is currently very little known about the structure-function relationship of chromatin 
compaction beyond the 30-nm diameter chromatin fiber. It is known that, due to the size of the 
nucleus, nucleosomal arrays have to be folded into compact, higher order secondary and tertiary 
structures. This intensive chromatin folding is achieved through the contribution of both histone 
proteins and non-histone architectural proteins (Woodcock and Dimitrov, 2001; Luger and 
Hansen, 2005).  Supporting evidence comes from in vitro studies using reconstituted NA 
showing that certain specific CAPs such as Myeloid and Erythroid Nuclear Termination stage-
specific protein (MENT), polycomb group protein complex (PcG), MeCP2, and Sir3 can 
strongly influence chromatin compaction (Springhetti et al., 2003; Georgel et al., 2001; Georgel 
et al., 2003 Francis et al., 2004). The exact structure and function of the higher order chromatin 
architecture above the 30-nm fiber is currently mostly unknown, but this field of research is 
critical considering that the level and orderly modulation of chromatin folding is intricately 
linked to transcriptional control and developmental regulation (Wolffe, 1998).  
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EPIGENETIC MODIFICATIONS 
 
The term epigenetics was first used in the late 1930s by Dr. Conrad Hal Waddington in 
reference to what he described as the epigenetic landscape, a concept he proposed to explain how 
the external manifestation of genetic activity influenced the cells fate (tissue types). Historically, 
this arrived at a time when the individual components of the nuclei were still thought to be 
unimportant, and only after the discovery of DNA as heritable information was his research was 
revisited and seriously considered. In the 1970s, studies began to demonstrate that not only was 
the sequence of DNA influencing phenotypes, but another layer of control was dictating genetic 
events (Holliday and Pugh, 1975; Weintraub and Groudine, 1976; Gottesfeld and Butler, 1977; 
Lohr et al., 1977). The regulation of gene expression through steric hindrance of transcription 
factor recruitment on promoter regions by both DNA methylation and nucleosome location 
ushered in an age of what is now known as epigenetic research. Subsequent studies have 
demonstrated additional epigenetic effects associated with certain RNA molecules (non-coding 
RNA), histone PTMs, and CAPs (Figure 1.3).  
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Figure 1.3: Different Mechanisms of Epigenetic Regulation * 
 
* Modified from Probst et al. (2009) 
DNA-METHYLATION 
 
Methylation of DNA was first suggested as an important epigenetic mechanism that 
could control gene activity in higher organisms by Drs. Holliday and Pugh in 1975 (Holliday and 
Pugh, 1975). Today, DNA methylation is known to be present in a wide range of organisms, both 
prokaryotic and eukaryotic, and operates by two vastly different mechanisms. In prokaryotes, 
DNA methylation occurs on both adenine and cytosine bases and this modification is used as a 
mechanism of defense in which the host restriction system can differentiate itself from foreign 
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sources of DNA. This ensures that foreign DNA (un-methylated) can be degraded without any 
deleterious effects to the bacterial DNA. In mammals, DNA methylation has only been reported 
on cytosine bases, mainly in the context of CG dinucleotides or CNG trinucleotides. The 
methylation of the eukaryotic genome has been linked to gene repression and found to co-
localize with condensed chromatin structures (Bird and Wolffe, 1999). Cytosine methylation 
occurs on the carbon-5 position of a cytosine base through the transfer of a methyl group from S-
adenosylmethionine (SAM) by DNA methyltransferases (DNMT) (Figure 1.4). This epigenetic 
modification is vital for proper eukaryotic development as evidenced by the lethality of the 
DNMT-null mutation in mice (Li et al.., 1992; Okano et al., 1999). Recently, the nucleotide 5-
hydroxymethylcytosine has been discovered and described to be located in relatively high 
abundance in the brain (Kriaucionis and Heintz 2009). This altered form of DNA methylation 
has been proposed to participate in the regulation of neuronal genes, but the epigenetic 
mechanism of this DNA modification is currently unknown.   
 
Figure 1.4: Mechanism of DNA Methylation * 
SAM= S-Adenosyl Methionine; DNMT= DNA methyltransferase 
 
* Modified from Expert Reviews in Molecular Medicine © Cambridge University Press (2002) 
 
It is estimated that 80% of CpGs are methylated in the DNA of somatic cells, and the 
majority of unmethylated CpGs reside in specific areas called CpG islands. This pattern of 
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genomic DNA methylation and subsequent gene inhibition is inherited by replicating daughter 
cells, allowing tissue specific gene methylation and repression. In contrast housekeeping genes 
with CpG islands located in their promoter regions are expressed ubiquitously across cell types 
(Figure 1.5, A). The density and location of methyl-CpGs in the promoter of genes are known to 
be critical for gene expression levels (Boyes and Bird 1992; Hsieh 1994).  
 
 
 
Figure 1.5: DNA Methylation * 
HDAC= histone deacetylase; MBD= methyl-DNA binding domain 
 
* Modified from Bergman and Cedar (2004) 
DNA-methylation inhibits gene expression through one of three mechanisms in 
eukaryotes: 1) direct inhibition of transcription factors/DNA interactions modulated by 
methylation of specific regions of promoters (Bell and Felsenfeld 2000; Hark et al, 2000; Szabo 
et al, 2000; Holmgren et al, 2001), 2) recognition of methylated DNA sequences by 
transcriptional repressors associated with the recruitment of co-repressors (Jones et al, 1998; Nan 
et al, 1998; Zhang et al, 1999), or 3) association of methylated-DNA binding proteins with 
nucleosomes leading to chromatin compaction (Georgel et al, 2003).  The first mechanism of 
DNA-methylation inhibition physically blocks transcription factors’ recognition of their cognate 
DNA sequences, whereas the second and third mechanisms rely on recognition of the 
methylated-DNA or specific chromatin feature(s) as binding sites for methylated DNA binding 
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proteins (MBDs). Gene repression from the second mechanism operates through MBPs coverage 
of methylated loci hindering transcription factors access to DNA sequences or elements. These 
MBPs can also recruit additional co-repressors to areas of DNA methylation (Figure 1.5, B), and 
can further the repression of genes through enzymatically modifying local chromatin (Nan et al., 
1998). Through the third mechanism, other methylated-DNA binding CAPs can directly 
condense nucleosomes into a higher order chromatin structure known to be repressive to 
transcriptional machinery. These three silencing mechanisms may be further modulated, through 
a currently undetermined mechanism, by the newly discovered 5-hydroxymethylcytosine 
discussed previously (Kriaucionis and Heintz 2009). This DNA modification’s function in gene 
regulation is currently unknown, but it is likely that the change in structure of the methyl group 
by the addition of a hydroxyl group could affect all three of these methylation-binding linked 
mechanisms.   
 
HISTONE POST-TRANSLATIONAL MODIFICATIONS 
 
The unstructured N-terminal regions of core histones are known to be subjected to 
various PTMs that can affect chromatin structure and function. These chromatin changes can 
occur through mechanisms that alter nucleosome stability and subsequent access to nucleosomal 
DNA or by signaling for CAPs recruitment. The CAPs themselves can affect chromatin stability 
and/or structure (Luger and Hansen, 2005).  Of these histone PTMs, acetylation and methylation 
are the most thoroughly studied and are found to be intricately involved in the regulation of gene 
activity (Table 1.1). In addition to these two PTMs, histone phosphorylation, ubiquitination, 
ADP ribosylation, deimination, isomerization, and SUMOylation have been described. These N-
terminal tail PTMs can serve as recognition and binding sites for a variety of CAPs mediated by 
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interactions with specific domains. The discovery of these signals has lead researchers to propose 
a “histone code” or “chromatin language” that pertains to regulation of transcription associated 
with specific PTMs (Allis, 2001; Berger, 2007). In addition to signaling, the PTMs of histone 
tails and core regions can interfere with DNA-histone contacts by altering residue charges, 
exposing sequences or elements of DNA that would otherwise be sterically blocked.  
 
Table 1.1: Post-Translational Modifications Effects on Transcription * 
 
* Modified from Berger (2007) 
Acetylation and methylation of lysines are the most studied and best characterized of all 
the nucleosomal PTMs. Acetylation of core histones is mainly associated with regions of actively 
transcribed genes and a more open chromatin structure. Lysine acetylation is carried out by the 
enzyme family of histone acetyltransferases (HATs) and is directed at the N-terminal tails of all 
four core histones and on a few sites within the core globular domain. In contrast, histone 
deacetylases (HDACs) are enzymes that remove this PTM, and are recruited to silent or 
repressed loci. Acetylation of histones is known to influence chromatin through two separate 
means: recruitment of CAPs by specialized domains that recognize acetylated lysines, called 
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bromodomains, and physical disruption of the histone-DNA electrostatic interaction by the 
reduction of positively charged residues that interact with the negatively charged phosphate 
backbone of the DNA.  Whereas lysine acetylation is linked to active transcription, lysine 
methylation can be involved in either activation or repression of genes depending upon the 
residues modified (Table 1.1).  The arginine and lysine residues of histones can exist in one of 
three states of methylation: monomethylation, dimethylation, or trimethyalation. These three 
forms of histone methylation can be selectively recognized by CAPs and therefore be involved in 
differential signaling. Histone methylation was once believed to be a nonreversible reaction but 
recent studies have identified the first histone demethylase enzyme, LSD1 (Shi et al., 2004). 
Since then at least ten additional enzymes have subsequently been characterized as histone 
demethylases (reviewed in Anand and Marmorstein, 2007). The effect of histone methylation on 
chromatin structure is “enforced” through the recruitment of chromodomain-containing CAPs. 
Chromodomains are motifs that can specifically recognize methylated lysines within histone 
tails. These chromodomains are found in proteins that are known to either directly remodel 
chromatin, or be incorporated into macromolecular chromatin structures. For example, di- or tri- 
methylation of histone H3 lysine 9 (H3K9me) is a well-characterized repression signal that is 
frequently referred to as a hallmark of heterochromatin. The role of H3K9me in repression was 
confirmed by immunofluorescence localization with high enrichment found in heterochromatin 
regions (Rice et al., 2003). The protein HP1, a CAP mentioned previously, is a known 
chromodomain protein that specifically recognizes H3K9 di-methylation and is found to co-
localize with this PTM (Lachner et al., 2001; James et al., 1989; Nakayama et al., 2001).  HP1 
was initially characterized as a heterochromatin associated transcriptional repressor (reviewed in 
Kwon and Workman 2008), but has since been observed in euchromatic areas of the genome 
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where it can complex with either silenced genes (Nielsen et al., 2001) or actively transcribed loci 
(Vakoc et al., 2005). This association with actively transcribed genes is evidence for either a 
separate role for HP1 in gene regulation or an example of chromatin higher order structure 
playing a role in gene transcription. There is currently little information on the recognition of 
arginine methylation by CAPs. Arginine methylation has only been linked to transcriptional 
activation because of evidence that the modification localizes on nucleosomes in active genes 
(Boisvert et al., 2005). One recent study has shown the methylation of arginine 2 on histone 3 
(H3R2me) hinders CAP binding to H3 tails (Iberg et al., 2008). This study combined with the 
lack of identified proteins with methylated arginine specific domains indicates a possible role for 
this PTM in signaling through CAP binding impediment. Histone methylation is increasingly 
found to be one of the more complex PTMs whose exact role in epigenetic regulation is still 
under investigation.  
Histone phosphorylation (Table 1.1) is a histone PTM that has been linked to a wide 
range of nuclear functions. This PTM is known to be involved in the DNA repair pathway, 
transcriptional regulation, and the mitotic chromatin condensation process. The mechanism of 
phosphorylation in gene activation is not fully understood. It is believed that this PTM hinders 
histone tail-DNA contact by the conjugation of a phosphate group which adds negative charges 
to serine or theronine residues. This reduction in the basic charge of histone tails is believed to 
reduce its affinity to the negatively charged phosphate backbone of DNA. In addition to altering 
histone-DNA contacts, the presence of phosphorylation on histone H3 serine 10 (H3S10) 
stimulates HAT activity on the histone tail and is believed to increase transcription through this 
histone-modification crosstalk (Cheung et al., 2000; Lo et al., 2000; Clayton et al., 2000). 
Phosphorylation of histones is also found on nucleosomes at sites of double-stranded DNA break 
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occurrences, and is believed to be a key signal in the DNA repair pathways (Madigan et al., 
2002; Nakamura et al., 2004; Fernandez-Capetillo et al., 2004). Furthermore, histone H3 
phosphorylation is known to play a role in heterochromatin formation during the chromatin 
condensation that occurs in mitotic division (Guo et al., 1995; Ajiro et al., 1996). In addition to 
core histone modification, the phosphorylation of linker histones is a key regulatory event of 
gene expression. This PTM stimulates the release of the linker histone by altering electrostatic 
interactions between residues and DNA. The release of linker histones destabilizes the higher 
order structure of condensed chromatin (Kaplan et al., 1984; Lin et al., 1991). Protein 
phosphorylation has long been known to be a regulatory PTM signal and now is known to play 
multiple roles in nuclear processes through nucleosome alteration and CAP signaling.   
The other core histones PTMs are not as well characterized. The role of lysine 
ubiquitination of histones H2A and H2B remains ill-defined, but may be involved in 
transcription initiation, silencing, and DNA repair (Wang et al., 2004; Ikura et al., 2007; Zhou et 
al., 2008; Nakagawa et al., 2008; Zhao et al., 2008). Ubiquitination is similar to phosphorylation 
in its proposed involvement in gene activation and DNA repair. These two PTM also have a 
large number of both transferases (>500 protein kinases and >600 ubiquitin ligases) that can 
catalyze these modifications, and hydrolases (>150 protein phosphatases and >100 
deubiquitinating enzymes) that reverse them (Hunter, 2007).  ADP ribosylation has been 
identified as a modification to each core histone, but its function/s is currently unclear (Burzio et 
al., 1979). A few studies have shown that this PTM is involved in the DNA repair process and 
cell proliferation (Kreimeyer et al., 1984; Boulikas, 1989; Boulikas, 1990). Early architectural 
studies using ADP-ribosylated chromatin as a substrate demonstrated a possible role in 
chromatin folding. ADP-ribosylated templates display a fairly open configuration, with the 
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removal of ADP-ribose resulting in a more condensed state (Frechette et al., 1985; de Murcia et 
al., 1986). Some researchers have even hypothesized that the ADP ribosylation of histones could 
be involved in crosstalk with NAD(+)-dependent pathways and might be a direct link between 
the regulation of bioenergetics and gene transcription (reviewed in Hassa et al., 2006). Histone 
SUMOylation occurs through the conjugation of SUMO, a small ubiquitin-like protein, to lysine 
residues in all four core histones (Nathan et al., 2006). SUMOylation of histones has been 
demonstrated to antagonize histone acetylation linking this PTM with gene repression (Nathan et 
al., 2006). The PTM isomerization refers to the two conformational states peptidyl proline can 
adopt and is a non-covalent histone PTM. The difference between these two conformational 
states is the dihedral angle of the peptide bond between the proline and the preceding residue that 
differs by 180o, dramatically altering the polypeptides secondary structure. This PTM is involved 
in both repression and activation of transcription through the mechanism of these two 
conformational states acting as a differential signal for additional histone modifying enzymes 
(Nelson et al., 2006). Deimination as a PTM is the process of converting an arginine into a 
citrulline residue, an amino acid that is not directly coded for by DNA. This histone deimination 
is known to antagonize arginine methylation based transcriptional induction (Cuthbert et al., 
2004).  
HISTONE VARIANTS 
 
In addition to the canonical core histones, variant histones have been discovered which 
have specialized functions relating to DNA repair, replication, and transcription (Table 1.2).  
These variants can be incorporated into the histone core octamer, replacing one of the four core 
histones. This change in NCP composition introduces an additional level of complexity when 
examining the relationship of chromatin with gene regulation and nuclear events.  Histone 
19 
 
variants alter chromatin dynamics by having distinct N-terminal tails comprised of an altered 
amino acid sequence that allow them to obtain cell regulatory PTMs which are not compatible 
with the four common core histones (reviewed in Bernstein and Hake, 2006). In addition to these 
altered N-terminal signaling capabilities, some of these histone variants display variations in 
their globular domain that can cause structural and functional alterations in nucleosome and 
chromatin structure. These structural changes can be recognized by specific CAPs. One recent 
study showed that the CAP, HP1, was more effective at modulating chromatin if the histone 
variant H2A.Z was incorporated into an array of nucleosomes (Fan et al, 2004). This example of 
a histone variant regulating CAP interactions was the first evidence linking a histone variant 
incorporation to a chromatin architectural protein’s function (reviewed in Luger and Hansen, 
2005). H2A.Z, often associated with boundary regions of heterochromatin in Saccharomyces 
cerevisiae, is believed to block the spread of heterochromatic domains, but the exact mode of 
action is still under investigation (Meneghini et al., 2003; Xu et al., 2005). The PTMs of histone 
variants can also be critical in the regulation of nuclear events in a cell. Phosphorylation of the 
histone H2A variant, H2A.X, is one of the most well characterized modifications of histones and 
is a key signal in the repair pathway of DNA double-stranded breaks (Rogakou et al., 1998; 
Arkady et al., 2003). There are numerous histone variants with a wide range of biological 
functions (Table 1.1) that have been identified across species, but are beyond the scope of this 
thesis. The interactions between histones, histone variants, and CAPs are now known to be a 
critical component in the epigenetic regulation of cellular activity.   
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Table 1.2: Function and Location of Variant Histones * 
TS= Tissue Specific; RD= Replication Dependent; RI= Replication Independent; ND= Not Determined; TG= Throughout 
Genome; a= DNA Damaged Induced; b= Found at Borders of Heterochromatin/Euchromatin in Saccharomyces cerevisiae, 
excluded from mammalian Xi; Xi= Inactive X Chromosome 
 
* Modified from Bernstein and Hake (2006) 
CHROMATIN-ASSOCIATED PROTEINS 
 
The packaging and maintenance of DNA within the chromatin environment is performed 
by a broad range of proteins termed chromatin-associated proteins (CAPs). One of the least 
understood aspects of cellular functioning is how DNA is packaged into the tight confines of the 
nucleus. This compaction is highly dynamic as certain genomic loci remain accessible and 
functionally active, while other areas are repressively compacted. These CAPs are typically 
divided into functional or structural groups based on enzymatic activity, histone-like 
structure/properties, architectural contribution, or transcriptional regulatory activity. Amongst 
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the most studied and best characterized groups of CAPs are those who display an enzymatic 
activity. These enzymes are generally involved in modifying both histone and non-histone 
components of chromatin. Histone modifying enzymes, such as histone acetyltransferases, 
methyltransferases, and phosphokinases have been previously defined in this dissertation (see 
page 13). In addition to these types of histone modifying enzymes another important group of 
enzymatic CAPs are key components of the ATP-dependent chromatin remodeling factors. 
These ATP-based complexes have also been shown to modulate nucleosome positioning and/or 
composition directly affecting chromatin structure. This ATPase-based chromatin remodeling 
facilitates rapid chromatin rearrangement inside the nucleus that occurs in response to outside 
stimuli or developmental signals. Additional CAPs that do not contain an enzymatic function but 
play a role in chromatin architecture have been identified. These architectural CAPs are involved 
in the condensation of DNA and nucleosomal arrays into higher order chromatin structures. The 
involvement of binding sites, enzymatic activities, and chromatin modulation capabilities of 
CAPs has been shown to be critical components in gene expression regulation and genome 
maintenance. Disruptions of these CAP’s functions have been linked to a wide range of diseases 
including cancer and neurodevelopmental disorders. The identification of these associations has 
led to an increased effort in the research  community to characterize the regulation, activity, and 
interacting partners of CAPs. 
The two best characterized ATP-dependent chromatin remodeling families are the 
SWI/SNF and ISWI-containing complexes (reviewed in Racki and Narlikar, 2008). These two 
families are classified based on the structure of their catalytic subunit. Both of these ATPase 
families use the energy of ATP hydrolysis to translocate DNA from and around histone 
octamers, but they are known to operate by different mechanisms. The SWI/SNF complexes 
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hydrolyze ATP to remove or slide nucleosomes, alter histone octamer composition by exchange 
of dimers, or create nucleosomes with DNA loops (Phelan et al., 2000; Yang et al., 2007; Bazett-
Jones et al., 1999). In contrast, the ISWI complex has only been shown to slide nucleosomes, 
altering their positioning but not removing or exchanging core histones (Corona et al., 1999). 
Initially the SWI/SNF complex was labeled a transcriptional activator due its enzymatic activity 
leading to an increase in DNA accessibility (Hirschhorn et al., 1992; Peterson and Herskowitz 
1992). The resulting “free” DNA was believed to become a better target for transcription factor 
recruitment to DNA regulatory elements, promoting transcription (Imbalzano et al., 1994; Kwon 
et al., 1994). These findings led to the subsequent classification of chromatin remodelers as 
transcriptional activators. It has since been demonstrated that ATP-dependent chromatin 
remodelers can affect both activation and repression of gene transcription through alterations of 
chromatin structure (Trouche et al., 1997; Zhang et al., 1998; Murphy et al., 1999). The functions 
and regulation of ATP-dependent chromatin remodelers is the current focus of ongoing research 
at numerous laboratories.  
The architectural function of CAPs is mostly characterized at the histone-DNA level of 
interaction. This primary level of chromatin compaction has been studied extensively over the 
past 30 to 40 years and was addressed in an earlier section of this dissertation (see page 4), but 
far less is known about the higher-order arrangement of chromatin. Recent biochemical and 
biophysical studies with non-histone CAPs have demonstrated mechanisms leading to re-
arrangements of NA secondary and tertiary structures (reviewed in Lugar and Hansen, 2005). 
Non-histone architectural CAPs such as MENT, PcG proteins, HP1α, and MeCP2 have been the 
focus of some recent in vitro chromatin folding studies. These studies have provided a few 
insights into higher order structure (Springhetti et al., 2003; Francis et al., 2004; Nielson et al., 
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2001; Georgel et al., 2003).  Out of these architectural CAPs, MeCP2’s effect on chromatin 
condensation has been characterized at the highest structural resolution (Georgel et al., 2003). 
MeCP2 structure and function will be more fully described in a later section of this dissertation.  
The MENT protein was initially identified as a major component of chicken granulocyte 
heterochromatin (Grigoryev and Woodcock 1998). It has since been further characterized for its 
role in condensing chromatin into unique secondary and tertiary chromatin structures 
(Springhetti et al., 2003). One of the regions identified as responsible for this chromatin 
condensation is MENTs M-loop domain. This region is known to contain a nuclear localization 
signal, an AT-hook motif, and a DNA-binding domain first identified in the high mobility group 
(HMG) proteins. This in vitro study also established the serpin (serine protease inhibitor) domain 
or reactive center loop (RCL) to promote MENTs self-oligomerization. This RCL region had 
previously been shown in vivo to be involved in MENT’s chromatin interactions (Irving et al., 
2002). Through RCL deletion mutants, this oligomerization ability of MENT was demonstrated 
to be responsible for the majority its intra-chromatin fiber interaction activity (Springhetti et al., 
2003). This finding led researchers to propose that MENT condenses chromatin through two 
separate mechanisms. The first is the condensation of nucleosomes within a chromatin fiber 
through its M-loop domain, and the second operating through the formation of protein “bridges” 
between chromatin fibers.  
The PcG proteins were first identified in Drosophila melanogaster and were believed to 
repress gene transcription by creating condensed heterochromatic structures (Denell 1973; 
Messmer et al., 1992). In Drosophila, PcG proteins are known to repress the HOX genes whose 
silencing is necessary to preserve the body patterning of developing flies (Lewis, 1978; Struhl, 
1981; Simon et al., 1992). In mammals, PcG proteins have been characterized to be involved in 
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cell cycle regulation, cancer genesis, and stem cell self-renewal (Kanno et al., 1995; Jacobs et al., 
1999; Molofsky et al., 2003). This CAP has recently been shown by electron microscopy (EM) 
to condense model chromatin fibers into compact secondary chromatin structures (Francis et al., 
2004). This compaction into higher order chromatin structures is theorized to be part of the 
mechanism of gene silencing that occurs in vivo. This chromatin compaction induced by PcG 
proteins was demonstrated to operate through interactions with nucleosomes. Tailless arrays 
were also analyzed and the N-termini tails of histones were not found to be involved in PcG 
mediated chromatin condensation (Francis et al., 2004).  
The heterochromatin protein, HP1, was also first identified in Drosophila melanogaster, 
and was found to be a dose-dependent transcriptional repressor associated with the position 
effect variegation (PEV) silencing effect of heterochromatic regions (James and Elgin, 1986; 
Eissenberg et al., 1990). It is probably the best characterized of all the known non-histone CAPs. 
HP1 has long been described as one of the critical CAPs responsible for the creation and 
maintenance of heterochromatic regions in a wide range of eukaryotic organisms. The one 
notable exception is Saccharomyces cerevisiae, or budding yeast, which uses the Sir proteins for 
PEV silencing. The Sir proteins will be discussed in more detail in a following section. HP1 has 
been found to specifically recognize, bind, and co-localize with the methylated histone H3K9 
and H3K27 heterochromatic marks (Bannister et al., 2001; Lachner et al., 2001). HP1 transcripts 
are differentially spliced and exist as three different isoforms, HP1α, HP1β, and HP1γ, in mice, 
humans, and Drosophila. These isoforms have a similar amino acid sequence and domain 
organization, but differences reside in their cellular localization and interacting partners (Minc et 
al., 1999). HP1 contains two characterized domains: a chromodomain (CHD) at the N-terminus 
that is responsible for its heterochromatin binding, and a chromoshadow domain (CSD) at the C-
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terminus that is involved in HP1 dimerization and in other protein interactions. These two 
domains are separated by a flexible hinge region that is highly variable in amino acid sequence 
between isoforms and organisms and contains multiple sites for PTMs (Badugu et al., 2005; 
Koike et al., 2000). The majority of HP1 structural data has been obtained through biophysical 
examination of condensed model chromatin fibers (Fan et al., 2004). This HP1α in vitro 
structural data (analytical ultracentrifugation sedimentation velocity) demonstrated a requirement 
for the histone H4 N-termini to allow compaction of chromatin fibers.  
Another well-characterized family of CAPs is the HMG proteins.  This protein super-
family is comprised of 3 HMG sub-groups: HMGA, HMGB, and HMGN. Each of the HMG 
family members contains different chromatin binding motifs, but are all known to modulate 
chromatin fiber properties (reviewed in Gerlitz et al., 2009). HMGA proteins, formerly known as 
HMG-I/Y/C, are ubiquitously found in mammalian nuclei, and their function has been linked 
with gene regulation, cell differentiation, and carcinogenesis (Landsman and Bustin, 1991; 
Berlingieri et al., 1995; Chiappetta et al., 1995; Liberati et al., 1998).  The characteristic feature 
of these CAPs is an AT-hook domain involved in chromatin interactions (Reeves and Nissen, 
1990). HMGA is known to be a highly disordered protein with little to no secondary structure, 
but it can undergo disorder-to-order structural changes upon binding to DNA and/or other 
proteins (Reeves and Wolffe, 1996; Huth et al., 1997). The HMGB protein family, formerly 
called HMG-1/2, is characterized by its HMG-Box domains. HMGB contains two HMG-box 
domains, HMG-box A and HMG-box B, which are this CAP family’s major DNA/chromatin 
interaction sites. In addition to these two domains, HMGB’s C-terminal tail is acidic and 
mediates additional DNA interactions (Lee and Thomas, 2000; Watson et al., 2007). The HMGB 
protein family has been found to play a role in both transcription and replication, but can also act 
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as an extracellular signaling molecule (Landsman and Bustin, 1991; Pil and Lippard, 1992; 
Agresti et al., 2005; Topalova et al., 2008). The last family, HMGN, previously referred to as 
HMG-14/-17, is the only HMG family known to directly bind to nucleosomes, and the 
nucleosomal binding domain (NBD) of HMBN is its characteristic feature (Crippa et al., 1992). 
In addition to the NBD domain, the C-terminal region of HMGN contributes to its chromatin 
binding, as truncated mutants display a significant decrease in binding affinity (Ueda et al., 
2004).  HMGN proteins have been shown to affect chromatin higher order structure and 
influence the expression of a subset of genes (Lim et al., 2005; Zhu and Hansen, 2007; Belova et 
al., 2008). 
EUKARYOTIC GENE SILENCING 
 
 Silencing in eukaryotic organisms is generally associated with transcriptionally 
repressive, compact heterochromatic regions of the genome. In the budding yeast, 
Saccharomyces cerevisiae, silenced regions are found in three genomic areas; the silent mating 
type loci, the repetitive ribosomal DNA (rDNA) genes, and the telomeres. While the components 
and composition of heterochromatin in Saccharomyces cerevisiae varies from other eukaryotes, 
many of the molecular mechanisms of heterochromatin silencing are conserved. In higher 
eukaryotes, heterochromatin is found at telomeres and centromeres, and is known to be involved 
in the proper segregation of chromosomes during replication. Similar to yeast, the increased level 
of chromatin compaction found in the heterochromatin of higher eukaryotes is refractory to 
transcription and replication. In Drosophila melanogaster, heterochromatin is known to 
contribute to the position effect variegation that influences the transcription of genes depending 
on their location and proximity. In mammals, heterochromatin is additionally associated with the 
X-chromosome inactivation found in females. One significant difference amongst organism’s 
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genomes is the level of DNA methylation present. DNA methylation of promoters in higher 
eukaryotes plays a significant role in regulating gene transcription. Abnormal gene silencing can 
lead to a host of complications for an organism, with cancer in humans being a key example. 
Understanding the components and molecular mechanism of eukaryotic gene silencing is 
therefore essential to developing treatments and cures for a wide range of diseases. 
SIR FAMILY OF PROTEINS 
 
Silencing in Saccharomyces cerevisiae is heavily dependent on the Sir family of proteins. 
The functions and structures of the Sir proteins vary widely. However, they all contribute to the 
establishment and/or maintenance of silent chromatin in yeast. The Sir1 protein is not considered 
critical for silencing, but it does aid in the assembly of other Sir proteins, which enhances the 
establishment of heterochromatin (Pillus and Rine 2006). The Sir2 protein belongs to another 
larger family of proteins that have been found to be NAD+-dependent deacetylases (Smith et al., 
2000, Imai et al., 2000).  This histone deacetylase function of Sir2 is not required for the 
initiation of silencing, but it is important to note that hypoacetylated histones were described to 
preferentially recruit Sir3, leading to an increase in silencing (Suka et al., 2001; Carmen et al., 
2002). Recent evidence also indicates a structural role for the product of Sir2’s enzymatic 
reaction, O-ADP-ribose, in Sir-mediated heterochromatin formation (Martino et al., 2009). The 
family member Sir4 has no known enzymatic activity, but is believed to be responsible for 
protein-protein interactions that are involved in the recruitment and association of Sir2, and to a 
lesser extent Sir3, to silenced areas (reviewed in Rusche et al., 2003).   
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SILENCING INFORMATION REGULATOR 3 (SIR3) 
 
The silencing protein Sir3 is known to be a critical architectural protein required for the 
spreading and maintenance of silencing in Saccharomyces cerevisiae (Renauld et al., 1993, 
Carmen et al., 2002). Silencing of genes due to the genomic proximity to telomeric and silent 
mating type loci is well established in current literature (Laurenson and Rine 1992; Sandell and 
Zakian 1992; Renauld et al., 1993; Barton and Kaback 2006). The increase in distance of a gene 
from a telomere also leads to a direct decrease in the frequency of silencing of a telomere-
adjacent gene (Renauld et al., 1993). Sir3 has been characterized as the only limiting protein for 
the propagation of telomeric silencing and this spread of heterochromatic silencing has been 
linked to Sir3 dosage indicating the importance of this silencing protein in transcriptional control 
(Renauld et al., 1993). Additional studies using sir 3 null mutant yeast have confirmed Sir3 as 
critical in the position-effect of silent loci (Carmen et al., 2002). Genes that exhibit telomere 
position effect have increased transcription levels with removal of the adjacent telomere, and 
similar results were found in sir3-null mutants, further galvanizing Sir3’s role in the spread of 
telomeric silencing (Barton and Kaback, 2006). The previously proposed model of spreading of 
telomeric silencing has been described to be initiated with the DNA-sequence specific binding of 
repressor activator protein 1 (Rap1), causing recruitment of the Sir3 and Sir4 proteins to the 
telomeric regions (reviewed in Rusche et al., 2003). This heterochromatin complex formation 
was further described as the result of multiple weak interactions that take place between the Sir 
proteins and the N-termini-tails of histone H3 and H4 (Hecht et al., 1995). Though Sir3 has long 
been described as interacting with/and silencing chromatin solely through these histone tail-
interactions, the DNA binding ability of Sir3 has been demonstrated in vitro (Georgel et al., 
2001). This newly discovered Sir3 property has been proposed to be important for the spreading 
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of silencing at specific loci, leading to at least a partial re-evaluation of the actual role of Sir3 
and possibly Sir4 in the establishment and maintenance of silent chromatin domains.  
 
Figure 1.6: Sir3 Domain and Partner Interaction Location * 
 
* Modified from Stone and Pillus (1998) 
The identification of Sir3’s functional domains has increased the understanding of its role 
in regulating nuclear events. Sir3 is known to interact with an array of nuclear proteins that are 
involved in different functions ranging from DNA repair (Rad7) to transcriptional silencing 
(Rap1, Histones H3 and H4) (Shore et al., 1984; Palladino et al., 1984; Moretti et al., 1994; 
Hecht et al., 1995). Sir3’s C-terminal region has been the focus of numerous studies related to its 
role in heterochromatin formation. The interaction of Sir3 with the histone tails of H3 and H4 
was linked to residues residing at Sir3’s C-terminus end (Bell et al., 1995).  These interactions 
have classically been described to be the primary mechanism for Sir3-recruitment and 
heterochromatin formation.   
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The ability of Sir3 to oligomerize has also been linked to the C-terminal region and 
recently two separate oligomerization domains within this area have been identified (Liaw et al., 
2006; King et al., 2006). This ability of Sir3 has now been further characterized through 
analytical ultracentrifugation studies (McBryant et al., 2006). The ability to self-associate has 
been proposed to affect chromatin through a nucleosome “bridging” mechanism that promotes 
interactions with both nearby nucleosomes and more widely spaced nucleosomes (reviewed in 
McBryant et al., 2006).  The C-terminal region of Sir3 has also been linked to DNA repair 
through its interactions with Rad7 (Paetkau et al., 1994) and Rad52 (Park et al., 1999). The C-
terminal structured area consists of the binding sites for Rap1, Rad7, and the N-termini of 
histones H3 and H4.  The Sir3 protein also contains an AAA domain that in other members of 
the AAA domain family couples the hydrolysis of ATP to conformational changes that aid in 
protein complex assembly/disassembly (recently reviewed in Erzberger and Berger 2006). In 
Sir3, the AAA domain lacks the critical residues that are known to be responsible for ATP 
binding. It had been theorized that the Sir3 AAA domain could bind to 2’-O-acetyl-ADP ribose 
which is a product of the Sir2 deacetylation reaction. Recent in vitro evidence supports this 
theory by demonstrating O-acetyl-ADP ribose promotes the formation of Sir3 mediated 
heterochromatic complexes (Martino et al., 2009). 
The N-terminal region of Sir3 has been the focus of many studies due to this region 
seeming to have multiple functions. The amino acids 1-214 on the N-terminal end of Sir3 show 
50% identity to the largest subunit of the origin of recognition complex, Orc1, in a domain 
suspected to be responsible for its transcriptional silencing function (Bell et al., 1995). The 
bromo-adjacent homology (BAH) domain of Sir3 is located in the first 214 residues, and is 
sufficient to silence in the absence of a full-length protein but only with over-expression of Sir1 
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(Connelly et al., 2006).  The function of the BAH domain has been predominantly characterized 
by its role in Orc1 mediated transcriptional silencing (Bell et al., 1995), and has been implicated 
in the protein-protein interactions of Orc1 and Sir1 (Hou et al., 2005). It is believed that Sir3’s 
BAH domain may interact with Sir1 and this protein-protein contact may be involved in Sir3’s 
recruitment. The BAH domain of Sir3 has also recently been described as a nucleosome/histone 
tail binding domain that interacts with the H4 N-terminal tail and H3 globular domain (Onishi et 
al., 2007). Deletion of the first 235 AA of N-terminal region of Sir3 abated its ability to function 
in mating-type repression in vivo, demonstrating the importance of this domain in Sir3 
localization (Bell et al., 1995).  The N-terminal region of Sir3 (1-503 AA), alone, when over-
expressed was sufficient to increase the frequency and area of telomere-proximal silencing, a 
phenotype similar to that obtained with full length Sir3 over-expression (Gotta et al., 1998).  It is 
not known if this phenotype results from the increased interaction with components of the 
silencing machinery, or if this truncated mutant is releasing full-length Sir3 from the complexes 
increasing the pool of available fully functioning protein.  The Sir3 BAH domain structure has 
recently been determined to a 1.9 A resolution (Connelly et al., 2006). The crystallized Sir3 
BAH domain formed mostly a β-sheet with a helical H domain. The H domain of Orc1 is known 
to interact with the Sir1 C-terminal domain. Through circular dichroism (CD), one third of Sir3 
has been shown to be disordered with the majority residing in a 300-amino acid stretch between 
the structured N and C terminals (McBryant et al., 2006). The structured N-terminal region of 
Sir3 corresponds with the BAH domain.  
While Sir3 does not possess a classic DNA-binding motif, it does contain patches of 
positively charged residues that may be responsible for Sir3’s interaction with the DNA through 
the negatively charged phosphate backbone. While regions of Sir3 have been studied and shown 
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to be important for silencing, the individual contributions of the different functions of Sir3 in 
particular the role of Sir3’s DNA binding interaction on heterochromatin formation are not yet 
fully understood. 
POST-TRANSLATIONAL MODIFICATIONS OF SIR3 
 
There are a number of studies indicating the phosphorylation of Sir3 can influence its 
silencing function.  Initial experiments demonstrated Sir3 became hyperphosphorylated under 
heat shock and starvation, and in response to mating pheromone (Stone and Pillus 1996). This 
Sir3 hyperphosphorylation was linked with an increase in transcriptional silencing at telomeric 
regions. Another study demonstrated through inhibiting Sir3 phosphorylation, that the PTM 
status of Sir3 affected its subtelomeric silencing  More recent studies have identified the 
phosphorylation of the serine residue 275 (S275) of Sir3 by the Slt2p MAP kinase pathway (Ray 
et al., 2003). This S275 phosphorylation was also shown to redistribute Sir3 silencing, and 
decrease the yeast’s lifespan upon commitment to cell growth. The phosphorylation of Sir3 is 
believed to be a possible post-translational event that could serve as a trigger mechanism for 
changes in Sir3-mediated silencing.    
METHYLATED-DNA BINDING PROTEIN FAMILY 
 
 Because links between gene silencing and DNA methylation have been demonstrated, the 
cellular mechanism of methylated DNA recognition by methyl-DNA binding domain proteins 
(MBD) has emerged as an important research focus in gene regulation. The MeCP2 protein was 
the first MBD protein discovered to selectively recognize and bind methylated DNA sequences 
(Lewis et al., 1992; Meehan et al., 1992). Since the discovery of MeCP2, four additional 
members of the MBD family (MBD1, MBD2, MBD3, and MBD4) have been identified through 
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polypeptide sequence bioinformatic analysis of the methylated-DNA binding domain (MBD) 
shared by these proteins (Figure 1.7) (Hendrich and Bird 1998). In addition to the common MBD 
motif, MBD1, MBD2, and MeCP2 contain a similar C-terminal transcription repression domain 
(TRD). This TRD has been identified as the region involved in the gene repression activity 
associated with these CAPs (Nan et al., 1997). The most recently identified methyl-DNA binding 
protein (MBP), Kaiso, lacks the characteristic MBD found in other MBPs (Table 1-N) 
(Prokhortchouk et al., 2001). This MBP is atypical in its method of methylated-DNA binding by 
utilizing a zinc finger (ZF) domain for DNA methylation recognition. Instead of a TRD, Kaiso 
has a poxvirus and zinc finger/Bric-a-brac, Tramtrack, Broad-complex (POZ/BTB) domain that 
is responsible for its transcriptional repression function. 
 
  
Figure 1.7: The Known Members of the Mammalian methyl-CpG-binding Protein Family * 
POZ= poxvirus and zinc finger domain; BTB= Bric-a-brac, Tramtrack, Broad-complex domain; MBD= methyl-binding domain; 
ZF= zinc-finger domain; CxxC= zinc-binding domains; TRD= transcriptional repression domain; GR= 11 repeat stretch of 
glycine/arginine residues 
 
* Modified from Klose and Bird (2006) 
The mechanism of MBD silencing was previously discussed in the DNA methylation 
section of this dissertation. Briefly, the MBD family of proteins is believed to recognize and 
selectively bind to methylated regions of the genome. Through this selective binding, these 
34 
 
MBPs have classically been described as repressors of transcription through steric masking of 
DNA elements and/or recruitment of chromatin remodeling co-repressor complexes to DNA 
methylated loci. Out of all the MBD proteins, MeCP2 has been the most thoroughly studied due 
to its link with the neurodevelopmental disorder RTT, which will be discussed more thoroughly 
in a later section.  
Additional functions of the MBD family outside of MeCP2 have recently been 
elucidated. For instance, the MBD1 protein has been found to form a stable complex with a H3 
lysine 9 (H3K9) methyltransferase (SETB1) (Sarraf et al., 2004). This complex interacts with the 
replication machinery during the S phase of the cell cycle and was observed to facilitate H3K9 
methylation during replication-dependent chromatin assembly.   Also, the MBD2 protein has 
been linked to genetic silencing through methylation specific binding over gene promoters 
(Hendrich et al., 2003). MBD2 is the methyl-DNA-binding component of the methyl-CpG-
binding protein 1 (MeCP1) transcriptional repressor complex (Ng et al., 1999). Prior to MeCP2’s 
discovery, the MeCP1 complex was characterized to bind to methylated DNA regions, but its 
individual peptide composition and their contribution to the complexes function was unclear at 
the time (Meehan et al., 1989). The MeCP1 complex has since been characterized in vitro to 
preferentially bind methylated nucleosomes, deacetylate histone N-termini, and remodel 
nucleosome positioning (Feng and Zhang, 2001). The MBD2 protein has also been shown to be 
critical for tumorigenesis in mouse intestinal cancer, indicating a possible role for this MBD in 
the regulation of cell proliferation (Sansom et al., 2003).  
The MBD3 protein is associated with the MBP family based on the MBD sequence 
homology, but it lacks key residues in the MBD motif responsible for methylated DNA 
interaction (Hendrich and Bird 1998). Recently, MBD3 has been identified as a component of 
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the nucleosome remodeling and deacetylation (NuRD) co-repressor complex, a well 
characterized transcriptional repressor involved with genetic silencing in a range of organisms 
(Wade et al., 1999; Denslow and Wade 2007). The MBD3 protein is not capable of selectively 
recognizing DNA methylation, but is required for proper NuRD formation/stabilization (Kaji et 
al., 2006).  MBD3 is also important for development as an Mbd3 null mutation was found to be 
embryonically lethal in mice (Hendrich et al., 2001). The MBD4 protein has been mostly 
characterized for its role in DNA repair (Hendrich et al., 1999; Millar et al., 2002; Wong et al., 
2002), but has also recently been implicated in transcriptional silencing (Kondo et al., 2005). The 
C-terminal glycosylase domain of MBD4 is not found in any other MBD proteins, and is 
essential for its DNA repair function (Hendrich et al., 1999).  
The Kaiso protein represses transcription of methylated genes in Xenopus laevis through 
its association with the nuclear receptor co-repressor (N-CoR) complex which possesses a 
histone deacetylase activity (Yoon et al., 2003). Kaiso null-mutations in Xenopus laevis clearly 
show up-regulation of genes with methylated promoters (Ruzov et al., 2004), but this phenotype 
was not apparent in similar mouse studies (Prokhortchouk et al., 2006). The depletion of this 
MBP in mice resulted in a resistance to intestinal tumorigenesis similar to that described in 
MBD2-null experiments (Prokhortchouk et al., 2006), but additional studies are needed to further 
characterize Kaiso’s role in mammals.  
METHYL-CpG-BINDING PROTEIN 2 (MeCP2) 
 
 As previously stated, MeCP2 was the first of the MBD family of proteins to be identified 
(Lewis et al., 1992; Meehan et al., 1992). The MBD motif characterized in the MeCP2 protein 
was used to ascertain the other MBD family members (including the MBD2 protein, a sub-unit 
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of the MeCP1 complex); consequently MeCP2 has been termed the “founding member” of the 
MBD (or MBP) protein family. MeCP2 was also the first MBP found to interact with HDAC-
containing complexes, linking two epigenetic repression mechanisms: DNA methylation and 
histone deacetylation (Nan et al., 1998). Biological interest in MeCP2 rose exponentially with 
the discovery of a genetic link between MeCP2 and the neurodevelopmental disorder RTT (Amir 
et al., 1999). The vast majority of patients with RTT have been found to harbor alterations in 
either MeCP2 or protein sequence, leading researchers to propose this protein’s function to be 
critical for normal neurodevelopment. In support of this theory, additional mutations of the 
mecp2 gene have recently been linked with other neurodevelopmental disorders such as autism 
and Angelman-like syndrome (Watson et al., 2001; Hammer et al., 2002; Shibayama et al., 2003; 
Carney et al., 2003). 
 MeCP2 PATHOLOGY (RTT AND CANCER) 
 
 The Rett Syndrome (RTT) was originally described by Andreas Rett in a German article 
in 1966, but this work was not extensively distributed across the world’s medical community. 
The RTT disorder was more widely known after an English publication by Dr. Hagberg in 1983 
(Hagberg et al., 1983). This childhood neurodevelopmental disease’s pathology is characterized 
by normal development for up to 6-18 months followed by a period of slowed development 
occurring towards the end of this period.  This period of slowed progress in development is 
followed by regression that affects mostly the patient’s speech and hand coordination. Later, 
RTT characteristics manifest in more advanced, stereotypical hand gestures, such as hand 
wringing. In addition, patients may develop an abnormal gait, autistic behavior, and a reduction 
in growth. The severity of RTT disability in patients can vary widely, with the type of Mecp2 
mutation somewhat influencing the disease’s course and development. RTT was initially 
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described to affect mostly Caucasian females with an incidence of 1 in 15,000 births (Hagberg 
1985). The understanding of its molecular mechanism was advanced enormously when the RTT-
associated locus was mapped to the region of the X-chromosome that contained the Mecp2 gene 
(Amir et al., 1999). The majority of RTT patients are now known to have mutations in the Mecp2 
gene, however patient diagnosis is currently based on clinical observations and not by genetic 
testing. Clinical studies have now demonstrated that this syndrome can also affect male patients, 
but at a much lower rate due to the X chromosome link (Meloni et al., 2000; Orrico et al., 2000; 
Van Esch et al., 2005). Although when RTT is found in male patients, its severity is much 
greater, since all of the male’s cells have only one copy of the gene which would be the mutant 
form (Meloni et al., 2000; Couvert et al., 2001). The molecular mechanism of RTT is only 
partially understood, and there is currently no known cure or treatment.  
An additional role for MeCP2 during cancer genesis has recently been described. The 
hypermethylation of tumor suppressor gene promoters is a well characterized event in cancer 
genesis (Merlo et al., 1995; Gonzalez-Zulueta et al., 1995). The initial evidence of MeCP2 
involvement with cancer arose when it was found that the methylation of the breast cancer 1 
gene (BRCA1) promoter in the presence of MeCP2 resulted in repression. Hypermethylation of 
additional tumor-suppressor genes in cancer have also been shown to be associated with MeCP2 
and other MBDs (Wischnewski et al., 2007; Ballestar et al. 2003; Bakker et al. 2002; Magdinier 
et al., 2001). Studies involving prostate cells demonstrated MeCP2 to be critical in both normal 
and cancerous cell growth (Bernard et al., 2006). This study, through the ectopic expression of 
MeCP2, showed that in androgen-dependent prostate cancer cells, MeCP2 promotes growth 
without androgen stimulation. These prostate cancer cells were also able to sustain tumorigenic 
properties during androgen depletion indicating a role for MeCP2 in repressing tumor 
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suppressing genes.  Interestingly, individual mouse knock outs for MBD1, MBD2, or MeCP2 did 
not affect tumor formation, suggesting an overlapping function for these MBDs in tumor 
suppression (Hendrich et al., 2001; Zhao et al., 2003). Further characterization of MeCP2s role 
in cancer genesis is needed to elucidate its individual function in tumor suppression. 
ISOFORMS OF MeCP2 
 
 There are two alternatively spliced isoforms of Mecp2 transcripts (Kriaucioniz and Bird, 
2004; Mnatzakanian et al., 2004). These isoforms, MeCP2e1 and MeCP2e2, differ only in their 
N-terminal regions (Figure 1.6). The spliced variant MeCP2e1 has a 21 residue section with an 
acidic pI of 4.25, whereas the e2 isoform of MeCP2 has only 9 residues over the same section 
that possesses a basic pI of 9.5 (Mnatzakanian et al., 2004). It is interesting to note that the 
MeCP2e2 isoform was the first identified variant of MeCP2 and therefore most characterized, 
but the MeCP2e1 isoform is more abundant in the brains of both mice and humans 
(Mnatzakanian et al., 2004).  These two isoforms have further been characterized to have 
differential distribution in developing postnatal mouse brains between the dorsal thalamus and 
hypothalamus (Dragich et al., 2007). However, recent studies have shown both of these isoforms 
to co-localize to heterochromatic regions in murine fibroblast cells (Kumar et al., 2009). Though 
differences in structure and distribution have been demonstrated, there are currently no known 
functional differences described between these two MeCP2 isoforms. 
FUNCTION AND STRUCTURE OF MeCP2 
 
MeCP2 has classically been described and mostly characterized as a global 
transcriptional repressor (Nan et al., 1997). After the identification of the methyl-DNA binding 
MeCP1 complex from crude nuclear extract, MeCP2 was characterized as the second 
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nucleoprotein that could bind methylated-CpGs (Lewis et al., 1992). This MeCP2 protein, unlike 
the MeCP1 complex, could bind to DNA that contained only a single methylated CpG (Lewis et 
al., 1992). The ability of MeCP2 to bind to methylated DNA combined with its localization to 
murine pericentromeric heterochromatin initially led researchers to propose this protein to be a 
methyl-DNA binding transcriptional repressor (Lewis et al., 1992). Since this discovery, the 
majority of studies on MeCP2’s function have attempted to elucidate its role in this repression 
mechanism. Another early study on MeCP2 revealed that it was over 100 times more abundant 
than MeCP1 in the nucleus, and it could bind to either methylated or unmethylated DNA to 
repress transcription (Meehan et al., 1992). In contrast to earlier experiments, additional in vitro 
gene expression studies indicated that MeCP2 only repressed promoters that contained CG 
methylation, and slightly enhanced transcription levels were reported when MeCP2 was bound to 
unmethylated promoters (Nan et al., 1997). This study also described MeCP2 to contain not only 
a MBD, but also a TRD that alone can repress the transcription of genes (Nan et al., 1997). 
Regions responsible for non-specific DNA interaction within MeCP2 have been identified in 
both the MBD and TRD (McBryant et al., 2007), although full-length MeCP2 has been found in 
vitro to preferentially bind methylated over unmethylated DNA templates (Ballestar et al., 2000). 
In addition to these two repression-linked domains, MeCP2 is known to further inhibit gene 
activity through interactions with histone modifying enzymes. MeCP2 was characterized early 
on to form a complex with Sin3 and HDAC (Nan et al., 1998). This association is theorized to 
further repress transcription at the MeCP2 recognized methylated loci through the HDAC histone 
deacetylase activity. MeCP2 has also been shown to interact with an unidentified histone 
methyltransferase through immuno-precipitation experiments (Fuks et al., 2003).  This study 
showed an increased localization of MeCP2 correlated to an increase in the amount of H3K9 
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methylation at the observed loci. In vitro chromatin binding studies using chromatin as template 
and purified human MeCP2 protein demonstrated this CAP to possess, in addition to its other 
functions, a chromatin condensation ability (Georgel et al., 2003). This chromatin condensation 
was accompanied by the formation of higher order oligomeric structures at increased MeCP2 
molar ratios. The MeCP2-mediated higher order structures were observed to contain intra-
chromatin fiber interactions in addition to inter-chromatin condensation. This study also 
demonstrated, by using unmethylated chromatin, that this MeCP2-mediated chromatin 
compaction function was separate from its methyl-DNA binding preference. In mice, MeCP2 
null-mutations displayed a loss of long-range chromatin interactions, providing further 
indications that MeCP2 regulates chromatin structure in vivo (Horike et al., 2005). The recent 
discovery of an architectural role for MeCP2 in higher order chromatin structures is not fully 
characterized, and is a major focus in this dissertation. 
Recently, researchers have unexpectedly discovered MeCP2 to have additional functions 
related to RNA processing (Young et al., 2005) and active transcription (Yasui et al., 2007; 
Chahrour et al., 2008). The association with RNA splicing was indicated initially through a Co-
IP mass spectrophotometric identification of an interaction between MeCP2 and an RNA binding 
protein: the Y-box binding protein 1(YB-1) (Young et al., 2005). The same study demonstrated 
that MeCP2 itself can bind to RNA and regulate splicing in vivo. In addition to its RNA splicing 
activity, MeCP2 has also been found to associate with actively transcribed genes (Yasui et al., 
2007; Chahrour et al., 2008). Through the use of chromatin immunoprecipitation-microarray 
chip technology (ChIP-chip assays), MeCP2-binding sites on 26.3 megabases of imprinted and 
non-imprinted neuronal cells were analyzed (Yasui et al., 2007).  This study found 59% of 
MeCP2 binding sites resided outside of known genes, and unexpectedly, 63% of the MeCP2-
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bound promoters were transcriptionally active. Additional mouse studies using hypothalamus 
that either lacked or overexpressed MeCP2 demonstrated that ~85% of affected genes were 
activated when higher MeCP2 levels were detected (Chahrour et al., 2008). This MeCP2-induced 
activation finding was confirmed by the identification of MeCP2 on the promoters of six selected 
activated genes. In addition, MeCP2 was also found to associate with the cAMP responsible 
element binding protein 1 (CREB1) transcriptional activator on an active, but not a repressed 
form of the same gene. These studies demonstrate that the cellular role of MeCP2 is more 
complex than simply repressing transcription through its methyl-DNA binding ability and 
association with co-repressors.  
Structural studies of MeCP2 have yielded few insights into its cellular functions. 
Classically, only two domains have been associated with MeCP2 function. The one structural 
domain that has been solved is the MBD (Figure 1.8) (Wakefield et al., 1999), which is the same 
domain that was used to define this family of CAPs (Hendrich and Bird 1998).  This MBD of 
MeCP2 is 63 residues in length and consists of four anti-parallel beta sheets that generate a 
wedge shaped structure. On one side of the beta sheet wedge, the two longer beta sheets are 
believed to interact with the major groove of the DNA where the methylation specificity would 
take place. The TRD has been characterized through truncated MeCP2/Gal4 DNA binding 
domain fusion products (Nan et al., 1997).  The area between amino acid 205 through 310 was 
found to be sufficient to repress transcription of target genes. The mechanism of TRD repression 
is currently unknown. The C-terminal end of MeCP2, beyond the TRD, has also been implicated 
as an important contributor in RTT as indicated by the number of identified truncated mutants in 
diagnosed patients (Amir et al., 1999). This C-terminal region has recently been described as 
containing a WW binding domain important for MeCP2s interactions with splicing factors 
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(Buschdorf and Strätling 2004).  WW binding domains are known to recognize proline residues 
of interacting ligands. WW domains are characterized by the signature presence of two 
tryptophan residues (W) that are separated by 20-22 amino acids. In addition to these three 
characterized regions, biophysical and protease digestion experiments have identified 6 distinct 
domains (Adams et al., 2007). Two domains identified corresponded with the previously 
described locations of the MBD and TRD domains. The HMGD1 and HMGD2 domains of 
MeCP2 share sequence similarities with the previously mentioned high mobility group AT-hook 
2 (HMGA2) protein. Furthermore, the trypsin digestion analysis of MeCP2 sub-divided the CTD 
into a CTD α and a CTD β. The CTD β domain contains the WW binding domain which is 
involved in splicing factor interactions and also contains a stretch of 7 consecutive histidines 
between residues 366 and 372. There is currently no function attributed to the CTD α domain.  
 
Figure 1.8: The Described Domains of the Methyl-CpG-binding Protein 2 (MeCP2) * 
HMGD1= HMG (High Mobility Group protein)-like domain 1; MBD= methyl-binding domain; HMGD2= HMG (High Mobility 
Group protein)-like domain 2; TRD= transcriptional repression domain; CTDα= C-terminal Domain alpha; CTDβ= C-terminal 
Domain beta 
 
* Modified from Georgel et al. (2003) and Hite et al. (2009) 
 The tertiary structure of MeCP2 has been characterized to be atypical for nucleoproteins, 
as it contains a large amount of intrinsic disorder. The calculated mass of a MeCP2 monomer 
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based on amino acid composition is 53 kDa, but gel filtration experiments yield a molecular 
mass of 500 kDa, and SDS-PAGE migration yields an apparent size of 75-80 kDa (Klose and 
Bird 2004). To date, there is no NMR or X-ray crystal structure of the full length MeCP2 protein. 
Biophysical and biochemical methods have been used to study its unusual tertiary structure.  CD 
analysis of full-length MeCP2 demonstrated almost 60% of the protein to be unstructured 
(Adams et al., 2007).  Of the structured portions, ~35% were β-strand/turns and ~5% were α-
helices. Through analytical ultracentrifugation, MeCP2 has been shown to exist as a monomer 
across a wide range of ionic conditions and molar concentrations (Adams et al., 2007). MeCP2 
also displayed an unusually low sedimentation coefficient of 2.2 S and a correspondingly high 
frictional coefficient ratio (f/fo = 2.4). The results of the CD and analytical ultracentrifuge 
experiments suggest MeCP2 has a coil-like tertiary structure that is similar to a partially 
denatured protein. Though some progress has been made, full elucidation of the influence of 
MeCP2 structure on function is critical for understanding the molecular link between mutations 
and the development of RTT. 
POST-TRANSLATIONAL MODIFICATION OF MeCP2 
 
The post-translational modification status of MeCP2 has recently been found to modulate 
its gene regulatory activities (Zhou et al., 2006; Tao et al., 2009). Phosphorylation of the serine 
421 (S421) residue was the first PTM of MeCP2 to be described, and was found to be induced 
during increased neuronal activity associated with influx of calcium ions. This phosphorylation 
event was therefore proposed to be triggered by a CaMKII (Ca2+/calmodulin-dependent protein 
kinase II)-reliant mechanism. Out of twelve tissue types tested, this PTM was found only on the 
MeCP2 protein from brain tissue, suggesting phosphorylation of S421 to be solely a neuronal 
event (Zhou et al., 2006). The phosphorylation of S421 was further characterized in these studies 
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to be involved in alleviating the MeCP2-regulated transcriptional repression of the Bdnf (brain-
derived neurotrophic factor) gene. These findings were the first to demonstrate a direct 
correlation between a PTM of MeCP2 and its gene regulatory activities. Further studies have 
identified additional MeCP2 phosphorylation sites from the brain samples of multiple species 
(Tao et al., 2009).   The MeCP2 serine 80 (S80) was one of these residues characterized as 
phosphorylated through immunoblotting experiments. MeCP2 S80 phosphorylation was found to 
be dependent on the neuronal calcium influx, similar to what was demonstrated for S421. 
Although in contrast to the previous S421 characterization, the S80 phosphorylation was 
negatively regulated by neuronal activity, suggesting alternative signaling between these residues 
in resting or depolarized neurons. The phosphorylation of both S421 and S80 was found to 
decrease the association of MeCP2 at specific loci. Interestingly, MeCP2 binding to gene 
promoters was not always indicative of gene repression, supporting the alternative role for 
MeCP2 as a co-activator. An additional four MeCP2 phosphorylation sites have been identified 
(Tao et al., 2009), but the occurrence and function of these PTMs and any cumulative effect 
remains to be characterized. The potential effect of phosphorylation on MeCP2s secondary or 
tertiary structures has not yet been investigated.  
MeCP2 RTT MUTATIONS 
 
 Genetic analysis has identified 218 mutations linked to patients diagnosed with RTT 
(Miltenberger-Miltenyi and Lacone, 2003). Mutations have been found in all six MeCP2-
characterized domains, indicating that each individual domain contributes to proper function. 
These mutations are usually single point mutations in the coding sequences that result in a 
missense or nonsense mutant, altering a single amino acid or causing a truncated form of the 
protein. Almost all the cases reported to date have been sporadic mutations to the Mecp2 gene 
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with limited familial exceptions.  Eight of these Mecp2 mutations have been most commonly 
found in RTT patients and have been termed mutational “hot spots” (Figure 1.9) (Kriaucionis 
and Bird, 2003). Interestingly, the majority of these mutations occur at arginine residues. The 
MeCP2 mutations linked with RTT have been the focus of numerous studies aiming at 
discovering the molecular mechanism of this neurodevelopmental disease. While MeCP2s 
function has mainly been attributed to its methylation specificity, two of the more common RTT 
mutations the T158M and the R168X mutants do not affect the MBD function. The T158M point 
mutant resides within the MBD, but has been demonstrated to have only a modest twofold 
decrease in affinity for methylated DNA as opposed to the more drastic reduction in other RTT 
MBD mutants (Ballestar et al., 2000). In addition the R168X truncated mutant has an intact, fully 
functional MBD. These two common mutations, as well as the additional truncated and non-
MBD point mutants identified, indicate MeCP2 functions other than methyl-CpG DNA binding 
is critical for normal neurodevelopment. After the chromatin condensation ability of MeCP2 was 
demonstrated, the effect of the RTT R133C and R168X mutations on chromatin interactions was 
examined (Georgel et al., 2003). The MeCP2 R133C mutant had previously been shown to lose 
its DNA methylation binding specificity (Ballestar et al., 2000), and was further characterized in  
an additional study to have no significant difference in its ability to interact with chromatin 
(Georgel et al., 2003). However, the R168X mutant lost the ability to form higher order 
chromatin oligomeric structures.  Further characterization of the functional differences between 
wild type MeCP2 and RTT mutants is needed and is a focus of this dissertation. Identifying the 
structural role of MeCP2 in the dynamic chromatin folding process will contribute to the 
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elucidation of the molecular mechanism of RTT syndrome. 
 
Figure 1.9: Location and Frequency of MeCP2 “Hotspot” Mutations in RTT Patients * 
R106W= Arginine to Tryptophan Point Mutation at Residue 106; R133C = Arginine to Cysteine Point Mutation at Residue 133; 
T158M= Threonine to Methionine Point mutation at Residue 158; R168X= Arginine to Stop Codon at Residue 168; R255X= 
Arginine to Stop Codon at Residue 255; R294X= Arginine to Stop Codon at Residue 294; R306C= Arginine to Cysteine Point 
Mutation at Residue 306 
 
* Modified from Zlatanova (2005) and Hite et al. (2009) 
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ABSTRACT 
 Recent studies of the mechanisms involved in the regulation of gene expression in 
eukaryotic organisms depict a highly complex process requiring a coordinated rearrangement of 
numerous molecules to mediate DNA accessibility. Silencing in Saccharomyces cerevisiae 
involves the Sir family of proteins. Sir3p, originally described as repressing key areas of the 
yeast genome through interactions with the tails of histones H3 and H4, appears to have 
additional roles in that process, including involvement with a DNA binding component. Our in 
vitro studies focused on the characterization of Sir3p-nucleic acid interactions and their 
biological functions in Sir3p-mediated silencing using binding assays, EM imaging, and 
theoretical modeling. Our results suggest that the initial Sir3p recruitment is partially DNA-
driven, highly cooperative, and dependent on nucleosomal features other than histone tails. The 
initial step appears to be rapidly followed by the spreading of silencing using linker DNA as a 
track.  
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INTRODUCTION 
 
The regulation of gene expression in eukaryotes is dependent on several sets of proteins 
that regulate DNA accessibility. In this context, the level of chromatin compaction plays a 
central role in the transition from a transcriptionally active to a repressed state. In yeast, gene 
silencing requires the establishment of a specific chromatin configuration that displays a high 
level of similarity to the heterochromatin conformation observed in higher eukaryotes. 
Saccharomyces cerevisiae possesses a set of specialized proteins called Silent Information 
Repressors (Sir 1-4) (Rine and Herskowitz, 1987) that, in combination with ORC1 and RAP1, 
promote nucleation and spreading of silencing at specific loci (Loo and Rine, 1994). Sir 2 is a  
NAD-dependent histone deacetylase (Rine and Herskowitz, 1987), and Sir3p and Sir4p are 
structural chromatin-associated proteins initially described as N-terminus binding partners for 
histones H3 and H4 (Loo and Rine, 1994; Hecht et al., 1995; Hecht et al., 1996; Moazed et al., 
1997; Moretii and Shore, 2001). The mechanism of Sir-mediated silencing is intimately linked 
with structural modifications of chromatin (Hecht et al., 1995; Hecht et al., 1996; Georgel et al., 
2001). The recruitment of Sir3 and Sir4 has initially been described as a process mediated by 
their binding to the histone tails of H3 and H4 (Hecht et al., 1995; Hecht et al., 1996), although 
biochemical data indicate that the tails are not needed for binding to chromatin in vitro (Luger et 
al., 1997; McBryant et al., 2008). Recent publications have also indicated a potential role for 
double-stranded DNA (dsDNA) in the establishment of silencing theorizing that the DNA itself 
may provide a means for establishment and/or spreading of silencing (Georgel et al., 2001; Liaw 
and Lustig, 2006). Our initial experiments suggested that Sir3p would bind more readily to the 
linker DNA in chromatin than to DNA wrapped around a histone octamer, but in a different 
manner than that of linker histone (Georgel et al., 2001). In addition, the Sir3p concentration was 
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shown to affect chromatin fiber-fiber interactions, resulting in potential large-scale chromatin re-
organization (Georgel et al., 2001).   
 The goal of this study is to provide a better delineation of the role of nucleic acids in the 
Sir3p-mediated recruitment and formation of supra-molecular structures in vitro. To this end, we 
have carried out experiments using normal and tailless nucleosome arrays as controls, as well as 
nucleic acid fragments of various compositions, lengths, and conformations. The study also 
includes analysis of Sir3p binding as a function of Sir3p and DNA concentrations, to mimic 
possible changes in local concentrations within the nucleus.  
 To determine the effect of DNA conformation on Sir3p recruitment, we used several 
short linear DNA fragments with various intrinsic bendabilities. Our results indicate that Sir3p 
does not significantly differentiate between linear, curved, or bent DNA. However, a synthetic 
four-way-junction (FWJ) designed to mimic the nucleosomal entry-exit DNA region (Georgel et 
al., 1997) is a poorer substrate for DNA binding.  Using a binding assay employing DNA 
fragments of decreasing sizes, we determined that Sir3p binding occurs over templates as small 
as 12 bp. Finally, we investigate the influence of Sir3p molarity on inter-molecular DNA 
bridging using either DNA, nucleosomal arrays (NA), or trypsinized or tailless NAs as binding 
templates, and find that an increased local concentration promotes DNA bundling. Electron 
microscopy images are consistent with our electrophoretic mobility shift assay (EMSA) results 
and demonstrate the presence of Sir3p-induced layered DNA fragments. In combination with our 
observations that Sir3p can efficiently form complexes with tailless NA (Georgel et al., 2001; 
McBryant et al., 2008), we conclude that the mechanism by which Sir3p induces gene silencing 
is not only associated with histone tails, but is in part  DNA-driven.  
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EXPERIMENTAL PROCEDURES 
 
Sir3p purification- The protein was purified from SF9 cells infected with a recombinant 
bacculovirus containing a recombinant Sir3p sequence fused to six C-terminal histidines 
(Georgel et al., 2001, Bell et al., 1995). After 40 hours, nuclear extracts prepared from infected 
cells were purified through a Ni affinity chromatography column followed by Q-Sepharose (Bell 
et al., 1995). After purification, Sir3p was dialyzed against H5EGN (5 mM HEPES, 0.1 mM 
EDTA, 5% glycerol, 10 mM KCL, 0.1% NP-40). The concentration was determined by 
spectroscopy based on the extinction coefficient, and confirmed by comparison to BSA standards 
after SDS-PAGE as described in Georgel et al. (Mumberg et al., 1995). Alternatively, Sir3p was 
over-expressed and purified from a bacterial system as follows. Sir3p was expressed from pJC52 
(Georgel et al., 2001) in BL21 cells (Stratagene).  Expression was induced by addition of IPTG 
to a final concentration of 1 mM for 5 hours in the presence of 3% ethanol. Sir3p was purified 
using TALON Metal Affinity Resin (Clontech) according to the manufacturer’s specifications. 
 The protein was subsequently dialyzed against H5EGN, and the concentration was calculated by 
comparing Coomassie blue staining against that of purified BSA, and confirmed by spectroscopy 
based on the extinction coefficient. Note that both forms of Sir3p displayed indistinguishable 
nucleic acid and chromatin binding properties when used for titration experiments.  
DNA and nucleosomal arrays-  The 208-7 and 208-12 DNA templates containing repeats 
of the 5S rDNA from Lytechinus variegatus were purified from plasmids pPol I 208-7 and pPol I 
208-12 (Georgel et al., 1993), after digestion with Hha1, followed by gel-filtration purification, 
as described in Hansen et al. (Hansen et al., 1989). Histone octamers were purified from chicken 
erythrocytes (Georgel et al., 2001), and tailless histones were prepared by limited trypsin 
digestion as described by Fletcher and Hansen (Fletcher and Hansen, 1995). Nucleosome arrays 
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(normal or tailless) were reconstituted by salt dialysis at a ratio of 1.1 mole octamer: 1 mole 208-
bp of DNA (Hansen and Lohr, 1993). The efficiency of reconstitution was analyzed by 
ultracentrifugation and Quantitative Agarose Gel Electrophoresis (QAGE), as described by 
Fletcher et al. (Fletcher et al., 1994).  
PCR fragments and oligomers used for gel electrophoresis analysis- The linear DNA 
fragment referred to as “Straight” was prepared by PCR amplification using the plasmid pdHSP 
XA 0.5 (Becker and Wu, 1992) as the template, and primers p1 and p2 encompassing positions -
185 to -165 (p1: 5’TCG AGA AAT TTC TCT GGC CG3’) and +18 to +36 (p2: 5’TTC GCG 
ATG TGT TCA CCT3’) from the Drosophila hsp70 gene. The 199 bp “Bent” fragment 
encompassing the Acanthamoeba histolitica RNA polymerase 1 binding site was generated from 
the plasmid pPol I 208-12 (Georgel et al., 1993) using primers p3 (5’CGC TCG TTT TAC AAC 
GTC3’) and p4 (5’CCG CAC AGA TGC GTA AGG3’).   
The 208-1 5S rDNA was used as a source of material for the “Curved” fragment. It was 
prepared by Ava1 digestion of the 208-12 DNA fragment (10 units/µg of DNA for 60 minutes at 
37oC) and gel-purified after electrophoresis in a 1% agarose gel. The 100 bp fragment was 
prepared by PCR amplification (primers). The 50 bp fragment was also PCR-amplified using 
primers p5 (5’TCG ACG AAG CGC CTC T3’) and p6 (5’AGG CGC GCT CTC TCT C3’) and 
the plasmid pdHSPXA 0.5 as template (Becker and Wu, 1992). 
The 32 bp fragment was generated by annealing primers p7 (5’TTC AGG CGC GCG 
CTA GCG AAG CAA CAG AG3’) and p8 (5’CTC TGT TGC TTC GCT AGC GCC CGC CTG 
AA3’). The 12 bp fragment was generated similarly by annealing the primers p9 (5’TCA CTT 
ATT TGT3’) and p10 (5’ACA AAT AAG TGA3’).  
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Evaluation of DNA curvature- The “Straight”, “Bent”, and “Curved” DNA conformations 
were assessed by QAGE, the DNA fragments were electrophoresed in multigel as described in 
Fletcher et al. (Hansen and Lohr, 1993). The effective radii (Re) were determined using the 
following equation: 
µ/µ'o= (1 - Re/Pe) 2 
where µ represents the mobility of the fragments, µ 'o is the surface-charge density, Re is the 
effective radius, and Pe is the pore size of the agarose gels [500 ng of DNA plus 500 ng of T3 
phage (used as an internal marker)]. After 4 hours of electrophoresis at 1.33 V/cm in TAE buffer, 
the multigels were stained with SYBR green for 30 minutes. The distances of migration of all 
samples were measured and Pe was calculated from the information obtained from the 
concomitant electrophoresis of the T3 phage internal marker, whose known size allows 
calibration (Fletcher et al., 1994). The DNA conformations and overall curvatures were then 
estimated based on their respective sizes and Re values. The theoretical calculations to determine 
the conformation of the DNA fragments were performed using the Trifonov algorithm, as 
described in Georgel and Robert (Georgel and Robert, 2002). 
Reconstitution of a four-way-junction- The four-way-junction template was assembled 
from four separate oligonucleotides by sequentially annealing equimolar amounts of two sub-sets 
of single-stranded oligos at 65oC  
(FWJ1: GATCCTAGGCCTCACGTATTATATCGATGCATGCG, 
 FWJ2:  AATTCGACGATCGAAGCTGAATACGTGAGGCCTAGG, 
 FWJ3:  ACCATGCTCGAGATTACGAGCAGCTTCGATCGTCG, and 
 FWJ4:  TTCGCATGCATGCATCGATATCTCGTAATCTCGAGCATGG). 
54 
 
First, oligonucleotides FWJ2 and FWJ3 were incubated in standard TE buffer (10 mM Tris HCl 
and 1 mM EDTA) at 65oC for 10 minutes, then slow-cooled (~ 1-2 degrees per minute) to 10oC 
to allow the formation of DNA duplexes.  Oligonucleotides FWJ1 and FWJ4 were treated 
similarly.  The two intermediate DNA products (duplexes) were mixed together, re-heated to 
65oC and again slowly brought down to 10oC.  The formation of the four-way junction structure 
was monitored and confirmed by electrophoresis in a 10% non-denaturing acrylamide gel by 
comparing the respective electrophoretic mobility of the single-stranded oligonucleotides, the 
intermediate duplexes  (FWJ2-FWJ3 and FWJ1-FWJ4), and the completed four-way junction, as 
described by Panyutin et al. (Panyutin and Hsieh, 1993). Based on the measured intensity of 
SYBR green staining, we estimated that 90% of the single-stranded oligonucleotides were 
incorporated into four-way junctions (data not shown). 
Sir3p-nucleic acid Electrophoretic Mobility Shift Assays (EMSA)-  Sir3p titrations of 
DNA templates were performed using Electrophoretic Mobility Shift Assays. A given quantity 
of Sir3 protein was mixed with the DNA template and equilibrated at 25oC for 30 minutes. The 
EMSA were performed using DNA at either 5 ng/µl or 10 ng/µl. The experiments were 
compared using the same values of Sir3p molar ratios (rSir3, corresponding to moles of Sir3 to 
moles of 208 bp of DNA, as defined in Georgel et al. (Georgel et al., 2001)). Aliquots (10 µl for 
normal EMSA or 20 µl in competition assays) of the equilibrated solutions containing different 
amounts of Sir3p were loaded onto 1% agarose gels (longer fragments: ~200 bp and above) or 
6% acrylamide (shorter DNA fragments: 12-100 bp and single-stranded DNA) for quantification 
of the free-DNA template band by integration of the Southern blot signal intensities (using NIH 
ImageJ). In each quantified gel, control lanes containing DNA with no added Sir3 were loaded 
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and co-electrophoresed in order to provide internal calibration standards, which also provided an 
estimate of the standard deviation of measured free-DNA values. 
Electron microscopy-   Samples were prepared for transmission electron microscopy 
essentially as described (Nikitina et al., 2007).  Briefly, DNA and Sir3p were mixed at the 
desired concentrations in HEN buffer (10 mM Hepes, 0.25 mM EDTA, and 2.5 mM NaCl), held 
at room temperature for 30 minutes, and then fixed with 0.1% glutaraldehyde for 4 hours at 4oC 
before overnight dialysis into HEN.  Samples were diluted, applied to glow-discharged carbon 
coated grids, and positively stained with 1% aqueous uranyl acetate followed by extensive 
washing.  Grids were examined in a Tecnai 12 TEM operated at 100 KV in the tilted darkfield 
mode, and digital images were recorded using a TVIPS 2024x2024 CCD camera.  
Analysis of binding curves- Binding analyses typically refer to measurements of the 
amount of bound complex formed as a function of increasing concentration of ligand. However, 
for a variety of reasons, protein-DNA complexes often cannot be unequivocally identified and 
quantified directly from gel retention assays. The free template concentration, m, is more easily 
estimated and is directly related to the chemical potential of the DNA template in the equilibrium 
solution (Georgel and Robert, 2002). A classical approach to the formulation of multiple binding 
equilibria is through the binding polynomial or binding partition function, P, which is a function 
of all relevant protein-binding reactions to the template (Wyman and Gill, 1990; Robert et al., 
1988). For a non-aggregating system, the chemical potential, µM, is related to the binding 
polynomial by the relation 
µM = µMo- RT ln P(x)       (1), 
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in which µMo is the chemical potential under reference-state conditions (here defined in the 
absence of ligand), and x is the Sir3p ligand concentration. The concentration of free-DNA 
template, m, relative to the total concentration, mtot, is obtained by 
 
  m/mtot = 1/P(x)      (2). 
 
For a system in which concentrations are low enough for activity coefficient effects to be 
neglected, P(x) is simply a sum of terms, each representing the concentration of a DNA species 
(bound by zero or more Sir3p ligands) relative to the unbound DNA template concentration. 
(The simplest example is a single-site binding model, or P = ([M] + [MX])/[M] = 1 + k x, where 
k is the affinity constant in M-1.) Several binding polynomials (P) representing different binding 
models were formulated following standard procedures (e.g., Robert et al., 1988; Teif, 2007) and 
tested against the gel-retention assay data. 
 
Independent sites: P1 = (1 + k x)n     (3a), 
Sites interacting in pairs: P2 = (1 + 2 k x + delta k2 x2)n/2  (3b), 
Perfectly cooperative model: Pn = 1 + kn xn    (3c), 
Nearest-neighbor model: Pnn = (1,1) An (1, 0)'   (3d). 
 
In these equations k represents the intrinsic site affinity (units M-1), the dimensionless 
parameter delta gives the multiplicative increase in affinity due to cooperative interaction with 
another bound site, n represents the number of Sir3p binding sites on the template, and A is a 2x2 
transfer matrix with the top row (1, 1) and the bottom row (k x, delta k x). 
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Given xtot and mtot, the total concentrations of Sir3p and DNA template, respectively, the 
free concentration of Sir3 in the equilibrium solution was obtained by solving the mass-balance 
equation: the total Sir3 concentration is written as the sum of the free and bound Sir3, the latter 
being expressed in general form by a logarithmic derivative of the binding polynomial (Teif, 
2007), giving 
 
xtot = x + (d ln P(x)/ d ln x) mtot                   (4). 
 
Eq. (4) implicitly defines the free Sir3p concentration, x, as a function of the total Sir3p 
and DNA concentrations and the other binding parameters contained in P(x). A bisection 
algorithm was used to obtain x at each total Sir3p concentration. Binding parameters were 
determined by fitting the free DNA template fraction (eq. 2) versus total Sir3p concentration 
using the Marquardt algorithm for the different models for P(x) given in eq. 3. 
 
RESULTS 
 
We have recently demonstrated that Sir3p can interact directly with long dsDNA (~2500 
bp) and that the DNA component(s) of chromatin contributes to its recruitment (Georgel et al., 
2001; McBryant et al., 2008). As previous studies have strongly suggested that Sir3p does not 
display any significant DNA sequence specificity (Shore and Nasmyth, 1987; Buchman et al., 
1988; Johnson et al., 1990), we focused our attention on binding as a function of DNA 
conformation and size. To further characterize the contribution of the DNA component of 
chromatin, we performed numerous EMSA and Electron Microscopy (EM) imaging experiments 
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to precisely assess the effect of DNA length and conformation, as well as Sir3p molarity on 
binding and formation of higher-order complexes.  
Binding ability of Sir3p to DNA and NAs.  
As controls, the binding of Sir3p to 208-12 normal and tailless nucleosomal arrays (NA) 
and parent 208-12 DNA was confirmed by EMSA under previously described conditions 
(Georgel et al., 2001). The results indicated that Sir3p appears to bind cooperatively to the DNA 
template (Figure 2.1). We also noted that the lack of histone tails does not appear to impede 
Sir3p binding to nucleosomal arrays (compare Figure 2.1, panels B and C, lanes 11-14 and lanes 
18-21).  As the molar ratio of Sir3p was increased, we observed the formation of very large 
DNA-Sir3p complexes, represented by material that did not migrate very far from the wells (see 
white arrowhead in Figure 2.1, panel A, lane 7). Under this set of experimental conditions (50 ng 
of DNA in a final volume of 10 µl), the phenomenon was observed only with the 208-12 DNA 
template. This observation confirms the formation of the previously described Sir3p-associated 
supra-molecular complexes (Georgel et al., 2001). 
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Figure 2.1: Sir3p binding efficiency to DNA is similar to that of tailless NA 
Panel A. Binding of Sir3p to 208-12 DNA. Lane 1 contains the 1kb+ DNA marker. Lane 2 corresponds to 208-12 DNA alone. 
Lanes 3 to 7 are binding of Sir3p to 208-12 DNA at increasing rSir3 ratios (from 1 to 16 Sir3 per 208 bp of DNA). The white 
arrowhead (lane 7) indicates the position of supra-molecular complexes. Panel B. Binding of Sir3p to 208-12 NA. As described 
above lane 8 contains the 1 kb+ DNA marker and lane 9 is NA alone. Lanes 10-14 correspond to NA in presence of increasing 
rSir3 ratios. Panel C. Binding of Sir3p to 208-12 tailless NA. Trypsinized arrays were used as templates. Lane 15: 1 kb+ DNA 
marker. Lane 16: NA tailless alone. Lanes 17-21 correspond to NA in presence of increasing rSir3 ratios. All EMSA were 
performed under high DNA concentration (10 ng/µl). 
Length-dependence: Sir3p binds differently to DNA fragments shorter than 208 bp. 
To test Sir3p binding as a function of DNA length in a context relevant to chromatin, we 
first monitored Sir3 binding activity to fragments that could accommodate one, seven and twelve 
nucleosomes. As we increased the size of the DNA from 208 bp using single unit or tandemly-
repeated copies of the 208 bp 5S rDNA from Lytechinus variegatus (Georgel et al., 1993) 
(Figure 2.2, A, panel A) to 1456 bp (seven repeats of 208 bp DNA, Figure 2.2, A, panel B) and 
2496 bp (twelve repeats of 208 bp DNA, Figure 2.2, A, panel C), we did not observe any 
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significant difference in binding behavior. Sir3p molar ratios (rSir3, normalized to 208 bp) from 1 
to 16 were tested. At rSir3 from 4 to 16, the Sir3p-DNA complexes that forms are heterogeneous 
as seen by the presence of a smear (see Figure 2.2, A panels A-C lanes 4-6). Based on the 
determination of free-DNA half-depletion for each DNA length, no significant difference was 
observed as a function of the DNA size, suggesting that the actual number of 5S rDNA repeats 
does not play a critical role in Sir3p binding. Interestingly, as the molar ratio is increased, the 
Sir3p-DNA complexes become too large to migrate significantly in the 1% agarose gels (as seen 
by accumulation of material in the wells). In conclusion, the Sir3p affinity for DNA fragments in 
the size range from 208 to 2496 bp did not appear to vary significantly.  
 
Figure 2.2, A: Binding of Sir3p as a function of DNA length. 
Panel A: Binding of Sir3p to 208-1 DNA. Lane 1 corresponds to 208-1 DNA alone. Lanes 2-6 correspond to 208-1 DNA in 
presence of increasing rSir3 ratios (from 1 to 16 Sir3p per 208 bp of DNA). Location of DNA marker fragments indicated on the 
left side of each panel. Panel B: Binding of Sir3p to 208-7 DNA. Lane 1: 208-7 DNA fragment alone. Lanes 2 to 6, similarly to 
Panel A, are 208-7 DNA in presence of increasing rSir3 ratios (from 1 to 16). Panel C: Binding of Sir3p to 208-12 DNA. Lane 1: 
208-12 DNA alone. Lanes 2-6: 208-7 DNA in presence of increasing rSir3 ratios (from 1 to 16). 
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Our initial results indicated that Sir3p binding to NAs leaves the linker DNA highly 
accessible for restriction enzyme cleavage (Georgel et al., 2001), although more recent studies 
have suggested a possible role for linker DNA in Sir3p binding (McBryant et al., 2008). To 
further investigate this issue and to determine the minimal length requirement for Sir3p binding, 
we performed additional EMSA experiments with DNA fragments ranging from 12 to 100 bp 
(Figure 2.2, B). Note that agarose gels did not give a sufficient resolution and that we switched to 
an acrylamide system to investigate the formation of Sir3p-DNA complexes. Sir3p was added to 
the DNA at rSir3 ranging from 1 to 8. In all cases, Sir3p binding was very efficient, even at rSir3 of 
1 to 2 (Figure 2.2, B, lanes 3 and 4 for each panel). Higher molecular weight complexes were 
observed (as indicated by accumulation of material close to the wells, see open triangles in 
Figure 2.2, B) for all DNA templates. Well-defined complexes were observed with DNA 
fragments of 32 bp and 12 bp at rSir3 of 1 to 4. When the rSir3 was increased to 8, additional bands 
(Figure 2.2, B, black triangles) corresponding to higher molecular weights were present, 
suggesting oligomerization of the initial Sir3p-DNA complexes. Combining this observation 
with earlier results using 208-12 DNA or NA (Georgel et al., 2001) leads to a model describing 
large supra-molecular complexes involving trans- interactions between individual DNA or NA 
molecules. These observations are consistent with a role for short linear stretches of linker DNA 
in Sir3p-chromatin fiber interactions.  
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Figure 2.2, B: Binding of Sir3p to short DNA fragments. 
Side by side comparison of Sir3p binding ability to DNA of size ranging from 100 bp down to 12 bp. The DNA and Sir3p-DNA 
complexes were separated using a native 6% acrylamide gel. Lane 1 in each panel contains the 1 kb+ DNA marker. Lanes 2 
correspond to DNA alone. Lanes 3-6 contain DNA in presence of increasing rSir3 ratios (from 1 to 8). The white arrowhead 
indicates the location of supramolecular complexes (close to the well). The black arrowheads indicate the formation of an 
intermediate size complex (32-bp DNA and 12-bp DNA panels). The sizes of relevant DNA bands are indicated on the left of 
each panel. 
 
DNA sequence/conformation dependence on Sir3p binding.    
Our experiments indicate that both nucleosomal and DNA components may be involved 
in Sir3p-chromatin interactions (McBryant et al., 2006; see above). We were therefore interested 
in whether Sir3p showed a preference for DNAs with different conformations. Specifically, 
linker DNA may have a more linear conformation, where nucleosomal DNA would display a 
more curved or bent conformation. Based on the nucleosome core particle structure (Luger et al., 
1997), nucleosomal DNA is distorted at positions 45 and 100 (positions nearly opposite the 
nucleosomal dyad axis), showing a more pronounced bending. The rest of the nucleosomal DNA 
is more gently curved around the histone octamer. To mimic all possible DNA conformations 
described for the nucleosome core particle, we tested three different DNA fragments that would 
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represent 1) the linker DNA as a linear/straight fragment (221 bp covering position -185 to +36 
from the hsp70 Drosophila melanogaster promoter region, which displays a nearly straight 
conformation), hereafter referred to as “Straight”, 2) the more pronounced bends described over 
the nucleosomal DNA at positions 45 and 100 were mimicked using a template containing a 
sharper bend (a 199 bp fragment covering the binding site for RNA polymerase 1 from 
Acanthamoeba histolitica (Georgel and Robert, 2002), referred to as “Bent”, and 3) the more 
evenly curved nucleosomal DNA, using the known 5S rDNA positioning sequence that contains 
two curves (Georgel et al., 2001, Georgel and Robert, 2002), referred to as “Curved”. The actual 
conformation of all three fragments was modeled using an algorithm developed by Trifonov 
(Trifonov, 1991) (http://hydra.icgeb.trieste.it/~kristian/dna/, Figure 2.3, A). In Figure 2.3, A, all 
fragments are represented in an orientation that reflects the maximum predicted curvature.  To 
confirm the predicted DNA conformation differences, we performed QAGE analysis (in 
triplicate) of the various fragments to determine their electrophoretic effective radii. If the 
conformation of all fragments was assumed to be linear, then based on size only, the order of Re 
would have been: “Straight”, “Curved”, followed by “Bent”. However, our results (see Table 
2.1) indicate a conformational component that confirms the predictions from the Trifonov 
modeling algorithm for the various DNA fragments. The smallest Re was that of the “Curved” 
fragment (9.7 +/-0.3 nm), and the largest was that of the “Straight” DNA (11.18 +/- 0.6 nm). The 
“Bent” DNA fragment had a value between those of the other two fragments (10. 37 +/- 0.46 
nm).  All three fragments were subjected to EMSA analysis under the lower concentration (5 
ng/µl) conditions described for Figures 2.1 and 2.2. EMSA experiments employed a fixed mass 
of DNA (50 ng) that was incubated in the presence of increasing rSir3. Comparison of half-
depletion of free DNA in each panel (Figure 2.3, B, panels A-C, lanes 7 and 8; rSir3 of 8 to 16, 
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Figure 2.3, C) showed the “Straight” fragment to be the template with highest Sir3p binding 
efficiency and the “Curved” fragment (5S rDNA 208-1) to have the lowest binding efficiency. 
The difference in binding EMSA shifts between the three fragments was very small. To confirm 
this result, we performed a competition assay mixing all three fragments in equimolar amounts 
with increasing rSir3. The order of shifting as seen by EMSA matched the expected binding 
ability seen when using individual fragments (data not shown). 
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Figure 2.3, A and B: Predicted curvature and EMSA analysis of Sir3p binding to various 
DNA conformations 
(A) The DNA sequences of all three fragments (p29-p58), PX199 and 208-1 were analyzed and visualized using the Trifonov 
algorithm (http:hydra.icgeb.trieste.it/~kristian/dna/). The presented orientations were selected to display the maximum curvature. 
The locations of the bends and curves are indicated by the white arrows. (B) Panel A: Sir3p-mediated DNA depletion analysis 
using the “Straight” DNA template. Lane 1 contains the 1kb+ DNA marker. Lane 2 contains the DNA template alone. Lanes 3 to 
8 are the DNA templates in presence of increasing rSir3 (from 1 to 16). Lanes 8 to 11 contain a serial dilution of “Straight” DNA 
used for calibration in the depletion analysis. Panel B: Similar experiment using the “Bent” DNA as template. Panel C: Similar 
experiment using the “Curved “ DNA as template. The sizes of relevant DNA bands are indicated on the left of each panel. 
 
The binding of Sir3p to short DNA stretches left open the possibility that the protein 
could interact with the nucleosomal entry-exit DNA. A four-way-junction (FWJ) DNA template, 
commonly used as a substitute for the nucleosomal DNA entry-exit region, was assembled and 
used as a template (Panyutin and Hsieh, 1993). The binding affinity of Sir3p for the FWJ, based 
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on half-depletion of free DNA, was significantly lower than that of any of the tested linear 
fragments (compare Figure 2.3, B, panel D, lanes 6 and 7 to Figure 2.3, B, panels A-C, lanes 6 
and 7). This result suggests that Sir3p’s ability to bind to the nucleosome entry-exit region is 
low. It is important to note that, depending on Mg+2 and EDTA concentrations, FWJ can adopt a 
partially flattened conformation that may interfere with Sir3p binding (Lilley, 2000; Declais et 
al., 2003). This potential conformational change may have affected Sir3p binding resulting in the 
observed low affinity. All three linear DNA fragments' binding properties were tested by EMSA 
and modeled, the results are summarized in Table 2.1.  
Sir3p binding to DNA is highly cooperative.  
The analysis of Sir3p-DNA binding indicates that it is strongly cooperative. To determine 
the mode of interaction over a wide range of rSir3, the 208-1 monomeric unit of the tandemly-
repeated 208-7 and 208-12 DNA was selected to establish a cooperative binding baseline for 
Sir3p. It was mixed in the presence of increasing rSir3, and free DNA depletion was then 
determined from gels as a function of the total Sir3p concentration (expressed in µM) and 
analyzed using eq. 2. The data, run in triplicate, provided a measure of the intrinsic run-to-run 
variability of 0.1-0.15 in units of fractional template concentration. The tendency of the free 
DNA to disappear completely after a few steps of the titration with Sir3p was clearly seen in 
each experiment. 
In order to determine how cooperatively Sir3 was binding, we tested several different 
binding models using free-DNA depletion data for the 208-1 template and for the “Straight” and 
“Bent” DNA templates. We first applied a non-cooperative independent-sites model (eq. 3a) with 
a single class of binding sites. The results of this binding model were very poor: the standard 
error of a point of the best fit varied from 0.20 to 0.27 depending on the template, and the non-
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cooperative model was clearly unable to account for the steepness of the free-template depletion 
curve. It bears pointing out that inclusion of additional classes of independent binding sites 
would have exacerbated the poor fit, leading to apparent anti-cooperativity and consequently an 
even less-steep curve (Wyman and Gill, 1990). Adding a cooperative interaction for pairs of 
interacting Sir3 binding sites (eq. 3b) improved the fit somewhat, but the standard error of a 
point of the resulting best-fit (0.14 - 0.23) was still far larger than the intrinsic errors associated 
with the data. 
We found that models best representing the free-DNA depletion data involved a high 
degree of cooperativity in Sir3p binding to the template. The high cooperativity was first 
modeled as a phenomenological "all-or-nothing", or perfectly cooperative, association (eq. 3c). 
This simple model accounted well for the steepness of the template depletion curves and 
provided standard errors of 0.1 - 0.15, well within in the range of the intrinsic run-to-run 
variability of the data. Another cooperative model that has the additional benefit of being 
immediately applicable to template DNA of any length is the nearest-neighbor model (eq. 3d). 
This model described the data with the same standard error of a point as the perfect cooperativity 
model. Although gel data are not of sufficiently high precision to distinguish between details of 
the cooperative model chosen to represent the Sir3p interaction, the binding results clearly 
suggest a high degree of cooperativity in their binding to the naked DNA template. The fits to the 
data are shown in Figure 2.3, C. Intrinsic association constants obtained for Sir3p binding to the 
different templates (“Straight”, Bent”, and “Curved”) using this model are shown in Table 2.1. 
All templates show a similar number of binding sites for Sir3. Binding to the straight DNA is 
favored by a factor of 10 over the curved template, although the cooperative interaction is 
highest for the curved DNA. 
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Figure 2.3, C: Fraction of free DNA for increasing concentrations of Sir3 protein 
Left: "Straight" template (Hsp), Middle: "Bent" template (Pol1), right: "Curved" template (208-1). Estimated total Sir3 
concentrations at 1/2 DNA depletion are 0.24, 0.28, 0.40 µM, respectively. 
 
We also used EMSA to examine Sir3 binding to DNA templates containing 7 or 12 
repeats of the 208 bp sequence. The free-DNA depletion data for the 208-1, 208-7, and 208-12 
templates are shown in Figure 2.4. As with the 208-1 data alone, the 208-7 and 208-12 template 
data are clearly consistent with cooperative Sir3p binding: a non-cooperative binding model 
again resulted in a very poor fit. In order to analyze this data obtained for templates of 
significantly different lengths, the nearest-neighbor interaction model was used (eq 3d).  This 
formulation is more physical than the perfect-cooperativity approach and models the 
cooperativity as arising from stabilizing interactions between Sir3p molecules bound at 
neighboring sites on the DNA template. This model also described the cooperative Sir3p binding 
quite well: the curves shown in Figure 2.4 correspond to the best fit of this model to all datasets 
simultaneously, in which the total number of sites was defined to be 1, 7, or 12 times the 208-1 
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template value. Fitted parameters are given in the legend of the figure.  To illustrate the positive 
cooperativity in Sir3p binding, the first line of Table 2.1 shows the intrinsic binding constants, 
presented as dissociation constants. These constants, with values on the order of 100 µM, refer to 
binding of a Sir3 protein to a site on the DNA when no Sir3 is bound to adjacent sites. For 
contrast, the third line of Table 2.1 shows the effective binding constant for Sir3p at a site 
neighboring a bound Sir3 protein. These values are on the order of 0.1 µM. The affinity increase, 
given by the parameter delta, is a few hundred to a thousand-folds for all 208-bp repeat 
templates. 
 
 
Figure 2.4: Sir3p binds cooperatively to DNA. 
Fraction free/total DNA template plotted as a function of the logarithm of the total Sir3p concentration for the 208-1 (open 
circles), 208-7 (filled circles), and 208-12 (white squares) templates. Corresponding lines (solid, broken, and dotted, respectively) 
indicate the best-fit of the nearest-neighbor model (eq. 3d, best-fit SEP 0.10) with binding site size of 28±2 bp (calculated by 
template length in bp / n), intrinsic binding constant log(k/1µM-1)=-1.88±0.03 for the 208-1 template and -2.09±0.02 for the 7 
and 12-mers, and nearest-neighbor interaction term log(delta)=2.47±0.04, 2.66±0.03, and 3.22±0.08 for the 208-1, -7, and -12 
templates, respectively. 
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The formation of 208-12 DNA-Sir3 complexes and cooperativity were further 
investigated by EM imaging (Figure 2.5, panel D) to evaluate stoichiometry and conformation. 
Cooperative binding seemed to be favored under the high DNA and high Sir3p concentration 
conditions, suggesting a Sir3p-Sir3p interaction component driven by high local concentration. 
The different complexes observed by EMSA were imaged at various rSir3. At low rSir3 and low 
DNA concentration, cooperative binding is evidenced by the co-existence in the same sample of 
free DNA fragments (Figure 2.5D, panel A) and Sir3p clusters on the DNA (panels C, D). As the 
rSir3 is increased to 8 and 16 and under high DNA concentration conditions, the DNA becomes 
coated with Sir3 clusters (Figure 2.5, panels E and F) and eventually forms self-associating 
DNA-Sir3p complexes (Figure 2.5, panels G and H). Once again the cooperative nature of the 
event is evidenced by the presence of Sir3-free DNA molecules adjacent to Sir3p-associated 
DNA complexes (Figure 2.5, panels D and G). 
 
Table 2.1: Characterization of mobility and Sir3 binding of the DNA fragments 
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Figure 2.5: EM imaging of Sir3p-DNA complexes at Low and High DNA concentrations. 
208-12 DNA at a concentration of 5 ng/µl and rSir3=4 (panels A-C). Small (black arrow) and large oligomers of Sir3p (grey 
arrow) can be observed in the background in the presence of free DNA (panel A). The population also includes complexes with 
large Sir3p clusters bound DNA (white arrow) and resulting in loops (panels B and C). The bar in Panel C corresponds to 20 nm. 
At higher rSir3 of 8 and high DNA concentration (panels D-F), free DNA can still be observed (panel D), in addition to molecules 
that are almost entirely cover by Si3p (panels E and F). Free Sir3p can still be observed (black arrows). At even higher rSir3=16, 
the Sir3p-coated DNA complexes appear to associate to form very large supra-molecular assemblages (white arrows, panels G 
and H). The co-existence of free DNA alongside the large assemblages (panel G) strongly supports the cooperative model.  
Sir3p saturation affects complex formation. 
Based on our observation linking the formation of higher order Sir3p-DNA complexes 
with the actual DNA concentration, we decided to systematically evaluate its effect on the initial 
Sir3p binding, as well as on the formation of supra-molecular complexes. EMSA experiments 
were performed using the same three previously described DNA, NA and tailless NA templates 
under higher DNA concentrations over the same range of Sir3p molar ratios.  The relative 
binding affinity observed under 5 ng/µl DNA concentration conditions reflected the initial results 
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obtained and described in Figures 2.1, C and 4, A-C. The connection between the formation of 
supra-molecular complexes through DNA and Sir3p interactions was investigated using 10 ng/µl 
DNA (Figure 2.6 A, lanes 13-14, see white arrowhead). No large complexes (running close to 
wells in agarose gels) were observed under 10 ng/µl DNA conditions with either the NA or 
tailless NA (Figure 2.6A, B, and C, lanes 6-7 and 13-14). Further, we observed the formation of 
a well-defined complex and the depletion of free template at a lower rSir3p under 10 ng/µl DNA 
experimental conditions for NA, tailless NA, and naked DNA (Figures 2.6, A, B, and C: 
compare lanes 6 and 7 to lanes 13 and 14). The later depletion of free material and the early 
formation of complexes of intermediate size between Sir3p and tailless NA suggest a role for the 
histone N-termini, possibly through electrostatic interactions resulting in a partial masking of the 
DNA. The results indicated a strong connection between local Sir3p concentration and DNA 
binding efficiency. This suggests that the local Sir3p concentration may contribute to the 
formation of complexes involved in silencing in a DNA-dependent manner.    
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Figure 2.6: Effect of DNA concentration on Sir3p binding. 
(A) Effect of DNA concentration alone on Sir3p binding. Side by side comparison of Sir3p binding ability at 5 ng/µl (left panel) 
and at 10 ng/µl (right panel). Lanes 1 and 8 contain the 1 kb+ DNA marker. Lanes 2 and 9 correspond to DNA alone. Lanes 3-7 
and 10-14 contain 208-12 DNA in presence of increasing rSir3 ratios (from 1 to 16). The white arrowhead indicates the location of 
supramolecular complexes (7). (B) Effect of DNA concentration on Sir3p binding to nucleosomal arrays. The same experiment 
was repeated using NA instead of DNA. The gel set-up is identical to that described in Figure 2.6 A. (C) Effect of DNA 
concentration on Sir3p binding to tailless nucleosomal arrays. The same experiment was repeated using tailless NA instead of 
DNA. The gel set-up is identical to that described in Figure 2.6 A. 
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Sir3p interaction with single-stranded DNA 
 After observing that Sir3p can bind to short dsDNA fragments, we investigated whether it 
can also complex with single-stranded DNA (ssDNA). The primer p7 (32mer) was used as 
template for Sir3p EMSA analysis (Figure 2.7). The 32mer ssDNA complexed with Sir3p even 
at a ratio of one Sir3p molecule per DNA molecule, and was nearly entirely depleted at a rSir3 of 
4 (Figure 2.7, lane 5). Multiple complexes of higher molecular weight were formed as the rSir3 
was increased, indicating either multiple binding sites or the formation of Sir3-DNA oligomers. 
At rSir3 of 4 and 8 (Figure 2.7, lanes 5 and 6), the complexes generated were too large to be 
resolved in the gel, and some of the material remained trapped next to the well area.  
 
Figure 2.7: Sir3p binds to ssDNA. 
EMSA experiments were performed using 32mer ssDNA (primer p7, see sequence in material and methods), under similar DNA 
concentration and rSir3 conditions to that shown in Figure 2.2 B. Based on DNA depletion, Sir3p appears to bind short ssDNA as 
efficiently as short dsDNA forming complexes of various sizes (white arrows). Lane 1 contains 1 kb+ DNA marker. Lane 2 
contains ssDNA alone. Lanes 3 to 6 are ssDNA in presence of increasing rSir3 (1 to 8). 
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DISCUSSION 
 
The ability of Sir3 to contribute to the general silencing mechanism is well-established 
(Loo and Rine, 1994; Hecht et al., 1995; Hecht et al., 1996). The development of silenced 
regions over the HM loci and telomeres has been linked to Sir3p interactions with hypoacetylated 
histone H3 and H4 N-termini (Rine and Herskowitz, 1987; Loo and Rine, 1994; Hecht et al., 
1995), but despite initial studies (Moazed et al., 1997; Liaw and Lustig, 2006) the mechanism of 
spreading along chromatin fibers remains poorly explained. We have shown that the Sir3p 
interacts with both DNA and the non-tail nucleosomal components of chromatin while 
establishing condensed chromatin architecture. Our results presented here, as well as previously 
published work strongly suggest that the DNA component may be important in the establishment 
of silenced regions. Sir3p-DNA interactions have previously been mentioned in the literature 
(Georgel et al., 2001; McBryant et al., 2008), but no thorough analysis had been performed to 
investigate their actual contribution to silencing. The description of the DNA binding properties 
of Sir3p as cooperative, size-, conformation-, and DNA concentration-dependent opens the door 
for a more a thorough understanding of the  how Sir3p functions in the initiation and spreading 
of silencing.  
Importance of nucleosomal DNA features for Sir3p binding.   
Our Sir3p binding analysis indicates high affinity for naked DNA, cooperative binding at 
higher rSir3p, and importantly, the influence of local Sir3p concentration, all of which support a 
model where initial Sir3p recruitment and spreading would consist of three separate steps. The 
initial recruitment of Sir3p to a chromatin or DNA template in vivo has been shown to involve 
Sir4p (Hecht et al., 1995) and histone tail deacetylation by Sir2p (Tanny et al., 1999), brought 
together through interactions with the H3 and H4 N-termini. The level of acetylation of histone 
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H3 appears to be intricately linked to the regulation of the efficiency of the initial Sir3p 
mobilization and may contribute to its ability to spread (Kristjuhan et al., 2003). However, 
Hoppe and co-workers (Hoppe et al., 2002) recently presented evidence for an alternative mode 
of action that would involve Sir3p in spreading silencing in the absence of Sir2-Sir4 complexes 
(see also Hecht et al., 1996; Renauld et al., 1993; Strahl-Bolsinger et al., 1997). Following this 
line of evidence, one can envision a significant role for DNA in spreading of silencing that may 
not be dependent on histones H3 and H4.   
Our observation that the binding of Sir3p to 208-12 5S rDNA displays a similar affinity 
to that of the same DNA reconstituted into nucleosomal arrays using tailless histones confirms 
that Sir3p plays a role in spreading silencing through DNA interactions (Georgel et al., 2001, 
Figure 2.1). Our analysis of DNA size dependence seems to indicate that DNA larger than 208 
bp is a less efficient target than shorter fragments (down to 12 bp). This may include association 
with short linker DNA, if available for binding. This observation, combined with the ability of 
Sir3p to spread silencing in the absence of Sir4p and Sir2p, suggests a spreading mechanism 
involving short stretches of nucleosomal or linker DNA that would require minimal Sir3p 
interactions with core histones. Our analysis of DNA conformation indicates a Sir3p binding 
preference for short straight DNA fragments. At equal molar ratio, potential interactions between 
Sir3p and nucleosomal DNA could be mediated through recognition of short stretches of straight 
DNA. As was described by Luger et al. (Luger et al., 1997), the last 10-bp segment at the edge of 
the nucleosome structure (close to the entry-exit location) is mostly straight and has limited 
interactions with the histone octamers, and thus could provide Sir3 with a preferred DNA 
binding site. Another physical feature of the nucleosome core particle may also be of importance 
for Sir3p binding to DNA. The periodicity of histone tails passing through the DNA double helix 
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at 20 bp intervals (Luger et al., 1997) may delineate structural domains that could be preferred 
targets for Sir3p binding. The 20 bp interval is of the same order of magnitude as the minimal 
observed size that allows Sir3p binding (12 bp, as described in our size-dependence binding 
analyses, Figure 2.2, B). The observed differences in binding efficiency to linear DNA of ~ 200 
bp in length are also consistent with such a mode of interaction. The mostly straight DNA was a 
slightly better substrate for Sir3p binding, whereas the DNA with highest curvature interacted 
less efficiently. In the context of nucleosomal DNA, the highest curvature is observed at super-
helical (SHL) positions 1.5 (15 bp from the DNA entry site) and 3.5 and 4 about 15 bp from 
straighter DNA (around SHL position 5.5) having fewer histone contacts (Luger et al., 1997; 
Pryciak and Varmus, 1992; Muthurajan et al., 2003). The DNA fragments we tested (Figure 2.3, 
panels A-C) reflect such differences in intrinsic or induced curvature. Our results suggest that 
Sir3p binding may be more efficient over straighter portions of the nucleosomal DNA. Since 
other proteins such as MENT (Grigoryev and Woodcock, 1998) have been described as cross-
linking nucleosomal DNA at the entry-exit region, we investigated Sir3p binding to a synthetic 
FWJ designed to mimic the nucleosomal linker entry-exit site. The poor binding of Sir3p to such 
templates does not support a binding mechanism similar to that of MENT or even linker histones 
(Figure 2.3, panel D; Grigoryev and Woodcock, 1998; Thomas et al., 2002), but instead favors a 
model involving association with nucleosomal and/or linker DNA.  
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Figure 2.8: Model for DNA-mediated Sir3p binding component. 
The model represents only the DNA portion of a chromatin fiber (the linker DNA is highlighted in red and the histone N-termini 
in green). The blue ovals represent Sir3p. The initial Sir3p recruiting step is mediated by nucleosomal domain(s) interactions. As 
the local concentration increases (indicated by the blue triangle), additional Sir3p-DNA interactions stabilize the complex. Upon 
further increase in local concentration, Sir3p cooperative binding to DNA significantly contributes to the spreading of silencing 
along the chromatin fibers (as indicated by the diverging blue arrows). 
 
Cooperative binding and Sir3p local concentration.  
 Our results strongly suggest a cooperative binding mechanism for Sir3p to both DNA 
and NA (Figures 2.4 and 2.5). The binding mechanisms that best described the EMSA-based 
data is the nearest neighbor model (see Table 2.1). The presence in EM images of DNA entirely 
devoid of Sir3 proteins adjacent to templates with high Sir3 occupancy (Figure 2.5, D) at rSir3 
ratios as high as 16 also strongly supports our EMSA analysis. Similar gel results for Sir3p have 
recently been reported (McBryant et al., 2008). In addition to the observed cooperativity of Sir3p 
binding to DNA and NA, we observed that at identical rSir3 ratios, the formation of Sir3p-DNA or 
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Sir3p-NA complexes was highly dependent on the actual substrate molarity at which the 
experiments were performed (Figure 2.5, A-C). Increases in local Sir3p concentration appear to 
favor cooperative recruitment of Sir3 molecules to the DNA and chromatin fibers, indicative of a 
novel mode of interactions leading to silencing. The formation of higher molecular weight (seen 
close to the well during EMSA experiments, Figure 2.5, A, lanes 13 and 14, and (Georgel et al., 
2001)), referred to as supra-molecular complexes, was also shown to be highly dependent on 
molarity. The high rSir3 ratios combined with high molarity leads to the coating of DNA 
molecules, and also contributes to the formation of assemblages of Sir3p-covered DNA (see 
Figure 2.5, D, rSir3 =16, at high molarity conditions). The combination of results obtained with 
DNA and tailless NA suggests a limited role for the histone tails in Sir3p spreading. The 
cooperative nature of Sir3p binding and the importance of local concentrations lead us toward a 
model where Sir3p silencing would be described as a three-step mechanism (Figure 2.8) that 
bears some similarities to the binding and recruitment of heterochromatin proteins 1 or HP1 , , 
and , each playing a complementary role (Vershure et al., 2005; Hediger and Gasser, 2006). The 
initial recruitment of Sir3p would be dependent on interactions with nucleosomal features that 
involve binding to structurally-specific DNA conformation features of the nucleosome core 
particle (see previous section). As the local concentration of Sir3p reaches a critical value, the 
cooperative mode of binding would favor Sir3p spreading from occupied sites using DNA as a 
track. The binding of Sir3p to DNA also appears to initially promote the formation of DNA 
loops (see Figure 2.5, D, panels B and C) that are reminiscent of the MENT-induced compaction 
of chromatin (Grigoryev, 2001). This model is supported by evidence that Sir3p alone, when 
over-expressed in yeast, can account for repression observed at specific loci (Hecht et al., 1996; 
Hoppe et al., 2002; Renauld et al., 1993). As the local concentration reaches its threshold, the 
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Sir3p-coated DNA fiber would start to interact, probably through DNA-Sir3/Sir3-DNA bridges. 
The actual role of the tails of histones H3 and H4 and their post-translational modifications 
remains to be investigated. To further delineate the Sir3p domains responsible for spreading of 
silencing, we have also started a more thorough analysis of Sir-3 DNA affinity using various 
Sir3p deletion constructs.  
Sir3p binding to single-stranded DNA.  
The binding of Sir3p to ssDNA may contribute to the establishment of functional 
telomeric complexes. Telomere silencing and telomere position effect (TPE) are both associated 
with the presence of Sir3p in sub-telomeric DNA, but are also regulated by the amount of 
ssDNA available (Bourns et al., 1998). A specific class of single-stranded binding proteins, 
including Est1 (Virta-Pearlman et al., 1996), NSR1 (Lin and Zakian, 1994), GBP2 (Lin and 
Zakian, 1994), and the yeast protein Rlf6p and Chlamydomonas reinhardtii Gbp1 (Konkel et al., 
1995), has been described as binding single-stranded G-strand telomeric DNA, and it remains 
possible that Sir3p also plays a role in this process through its ssDNA binding activity. This 
mechanism may have similarities to that observed using truncated forms of Rap1 (Konkel et al., 
1995; Kyrion et al., 1992). Konkel and colleagues have shown that Rlfp6p is required for the 
appropriate location of Rap1p, a mechanism that also involves Sir3p and Sir4p (Rine and 
Herskowitz, 1987; Kyrion et al., 1992). A possible role for Sir3p, consistent with its ssDNA-
binding activity, may include the stabilization of the Rlf6p-Rap1 complex (de Bruin et al., 2000). 
Alternatively, the ss-nucleic acid binding activity of Sir3p may be functionality related to that of 
DDP1, a heterochromatin-associated in Drosophila involved in heterochromatin maintenance 
and silencing (Huertas et al., 2004). Further investigations will be necessary to precisely 
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determine the nature of the role played by ssDNA binding at the yeast mating-type loci and 
telomeres. 
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 ABSTRACT 
 
Rett Syndrome (RTT) is a debilitating neurodevelopmental disorder that has been linked 
to various mutations in the MECP2 gene in clinically diagnosed patients. The function of this 
chromatin associated protein and the biological role of these mutations remain ill-defined. Initial 
characterization described MeCP2 as a repressor of transcription that selectively binds to 
methylated CpG dinucleotides. More recently, it has been described as a strong contributor to 
chromatin condensation into higher order structures. In addition, this MeCP2-induced chromatin 
condensation was found to be independent of methyl-DNA binding. The specific molecular 
determinants for chromatin binding and compaction capability have remained mostly unknown. 
Here, we demonstrate that MeCP2 interacts with histone N-termini selectively recognizing 
histone H2A, H3 and H4 N-termini (tails). Acetylation of these tails does not significantly affect 
binding to chromatin, but decreased MeCP2 ability to fold nucleosomal arrays. In contrast to the 
wild-type MeCP2, we found that RTT-associated point mutant R133C recognizes all four histone 
N-termini, suggesting a role for the histone H2B tail in the RTT phenotype. We analyzed another 
RTT mutant, the R168X truncation, for histone tail interactions. This RTT mutant was 
previously found to retain the capability of binding to chromatin, but not supporting the 
formation of supramolecular complexes. This truncation was found to be associated with a loss 
of interactions with histone N-termini. The observed binding pattern supports the hypothesis that 
interactions with histone N-termini are required for proper MeCP2-driven chromatin 
compaction. From these results, we concluded that histone tails are required for proper MeCP2-
chromatin interactions, and contributes to the folding of chromatin into higher order structures.  
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INTRODUCTION 
 
 The field of gene regulation has been increasingly intertwined with investigations of 
epigenetic events. DNA methylation and the recruitment of specific proteins that can recognize 
methylated cytosine bases (in the context of CpGs) is probably the best-characterized epigenetic 
modification linking the transition between gene activation and repression (Cedar and Bergman, 
2009). Histone post-translational modifications (PTMs) have also generated very strong interest 
from researchers who focus on the regulation of gene expression (for recent review, see Berger, 
2007). The identification of specific histone N-termini (or tails) PTMs has led to the creation of 
an entire sub-field of research driven by the determination and characterization of the “histone 
code”. In addition to DNA and histone chemical modifications, the chromatin contribution to 
DNA-associated regulatory events can be linked with proteins that recognize either methylated 
DNA or modified histone tails. These proteins, referred to as chromatin-associated proteins 
(CAPs), can act as co-activators or co-repressors. They may also contribute to the chromatin 
compaction/de-compaction equilibrium required for the accessibility of DNA regulatory 
elements. The transition from a fully extended chromatin conformation, referred to as the 10nm-
fiber or “beads-on-the-string” to a more compacted 30nm-fiber, or even higher-order structure, 
has long been shown to strongly influence transcription efficiency. Most of the research on 
higher order chromatin structure has been performed using chromatin model systems consisting 
of defined arrays of nucleosomes (nucleosomal arrays or NA) (reviewed in Luger and Hansen, 
2005). The inherent ability of chromatin to fold under specific ionic strength conditions or 
changes in Mg concentration can be stabilized and/or enhanced by the recruitment of certain 
CAPs. These proteins can further enhance chromatin compaction and play a role in the 
maintenance of transcriptionally repressed state. Among these CAPs, the methyl CpG binding 
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protein 2 (MeCP2) has been showed to be critical for proper neural development. Specific 
MeCP2 mutations have been linked to the Rett syndrome (RTT), a progressive childhood 
neurodevelopmental disorder that is one of the most common causes of mental disabilities in 
female patients (Amir et al., 1999). MeCP2 has been initially described as a methyl DNA-
binding protein (Byrd), but can also play a significant role in chromatin compaction (Georgel et 
al., 2003). Recently, MeCP2 has been shown to not only associate with repressed chromatin 
regions, but also actively transcribed loci (Yasui et al, 2007, Chahrour et al., 2008). Regulatory 
events associated with transcription regulation and chromatin folding may require the generation 
of small domains of compacted chromatin that would affect chromatin tertiary structure that are 
still compatible with active transcription (Georgel et al., 2003). These inconsistencies in MeCP2 
behavior may indicate an additional level of signaling required to explain MeCP2s localization 
and/or function.  
The N-terminal tails of core histones serve as binding determinants for some CAPs with 
particular arrangements of PTMs serving as signaling mechanisms for their function and 
localization. The role of MeCP2 in repression has classically been described to occur through its 
binding to methylated DNA and acting as a global transcriptional repressor (Lewis et al., 1992; 
Nan et al., 1997). Previous studies using nucleosomal arrays as model chromatin demonstrate 
that MeCP2 can condense chromatin fibers and even form oligomeric structures in the absence of 
DNA methylation, suggesting that the ability of MeCP2 to silence gene expression may be 
related to large-scale chromatin organization (Georgel et al., 2003). The concept of genomic 
silencing mediated by MeCP2 is reinforced by its ability to recruit Sin3p and Histone De-
acetylase 1 (HDAC) to specific loci resulting in hypoacetylation of local histones (El-Osta et al., 
2002; Suzuki et al., 2003). The presence of HDAC suggests that histone N-termini acetylation 
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could contribute to MeCP2’s ability to bind and/or condense chromatin. Recently published data 
demonstrates that MeCP2, when complexed with mono-nucleosomes, resides on nucleosomes in 
close proximity to histone H3 by evidence of biotin transfer after protein crosslinking (Nikitina 
et al., 2007).  As a direct consequence of this observed proximity it has been assumed that H3 
tails could be a determinant for MeCP2 recruitment.   However, when MeCP2-mononucleosome 
binding was analyzed, it appeared that the H3 tail was not required for MeCP2 recruitment 
(Ishibashi et al., 2008). To date, no unequivocal information on role of other histone tails on 
MeCP2 binding or function has been gathered.  
In this study, we have investigated the importance of each individual histone N-terminal 
tail on MeCP2 binding. We also monitored MeCP2-induced chromatin compaction and found 
that the two functions of binding and compaction can be separated. Acetylation of histone tails 
was previously demonstrated to have very little effect on MeCP2 binding to mono-nucleosomes 
(Ishibashi et al., 2008). Our research confirms that MeCP2 binding to NA behaves similarly, no 
drastic change in MeCP2 binding with addition of acetylation to the N-terminal tails; however, 
we observed significant differences in MeCP2-induced compaction of NA when monitored by 
electron microscopy (EM). Investigation on the role of individual tails on MeCP2 recruitment 
indicates that the H2B tail is not a structural feature recognized by MeCP2. Histone N-termini 
from H2A, H3, and to a lesser extent, H4 participate in MeCP2 binding. Interestingly, removal of 
H3 tails affected recruitment of MeCP2 to arrays of nucleosomes in contrast to mono-
nucleosome binding studies (Ishibashi et al., 2008). Additionally, we investigated the effect of 
two MeCP2 RTT mutants on binding to nucleosomal N-termini. The MeCP2 RTT point mutant 
R133C has previously been shown to have a decreased binding affinity for methylated DNA 
when compared to the wild type protein (Ghosh et al., 2008). Our binding assays also show in 
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vitro interaction of this R133C point mutant with all histone N-termini, in contrast to the wild-
type MeCP2 protein which only complexes with tails of H2A, H3, and, less efficiently, H4. The 
RTT deletion mutant R168X which lacks the Transcription Repression Domain (TRD, see 
Figure 3.1), previously shown to retain binding capability to NA, but lacks ability to form higher 
order chromatin complexes. Our results indicate that the R168X fails to recognize histone N-
termini, possibly linking this loss of function to its inability to support formation of chromatin 
higher order complexes. The residual binding of this truncated mutant may be DNA-driven or 
could require other nucleosomal features. These in vitro binding studies directly demonstrate 
MeCP2s capability to interact with core histone N-terminal tails and signify a potential novel 
mechanism for MeCP2 localization and/or function. Furthermore, we describe differential 
chromatin binding that occurs with two known RTT mutant MeCP2 proteins, possibly 
identifying a molecular basis for RTT occurrence.  
 
Figure 3.1: MeCP2 Domains and RTT Mutants. 
MBD = Methycl CpG Binding Domain; TRD = Transcriptional Repression Domain; CTD = C-Terminal Domain 
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EXPERIMENTAL PROCEDURES 
 
Protein purification - Histone octamers were expressed and purified from bacteria, both with and 
without tails as described (Luger et al., 1997). Recombinant human full length MeCP2 (isoform 
e2, 486 amino acids) and the RTT mutants, MeCP2 (R133C) and MeCP2 (168X), were purified 
as described (Georgel et al. 2003). Purified MeCP2 proteins were dialyzed against either HEGN 
buffer (10 mM Hepes, 0.25 mM EDTA, 10% glycerol, and 2.5 mM NaCl) or H5EGN buffer (5 
mM Hepes, 0.25 mM EDTA, 10% glycerol, and 2.5 mM NaCl). Glutathione S-transferase (GST) 
fusion proteins were expressed and purified from Escherichia coli BL21 (DE3, pLys E) cells as 
has previously been described (Georgel et al. 2001). Fusion proteins were constructed to include 
one of the N-termini tails from each Drosophila melanogaster histone protein (H2A, H2B, H3, or 
H4) or Green Fluorescent Protein (GFP). 
Nucleosomal Array Reconstitution - The 208-12 DNA template was purified from the pPol-I-
208-12 plasmid (Georgel et al. 1993) as described (Hansen et al. 1989). Nucleosomal Arrays 
were reconstituted using the 208-12 DNA template with histones containing the N-termini tails 
(NAWT), without (NAtailless), and with all combinations (-H2A, -H2B, -H3, -H4) by using the salt 
dialysis method (Hansen and Lohr 1993). Nucleosomal arrays were reconstituted at a ratio of 1.1 
mol of histone octamer to mol of 208 bp of DNA. The final dialysis step was performed against 
HEGN buffer for electrophoretic mobility shift assays and H5EGN for electron microscopy 
experiments. Acetylated arrays were reconstituted using core histones treated with the histone 
acetyltransferase GCN5 as previously described (Tse et al., 1998) 
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MeCP2-Nucleosomal Array Electrophoretic Mobility Shift Assays (EMSA) - Nucleoprotein 
complexes were formed in the presence of increasing molar ratios of MeCP2 to 208 bp of DNA 
repeat (rMeCP2 = 0.25-2.0) by incubation with arrays (50 ng in 15 µl) at room temperature for 
15 min in HEGN buffer.  Nucleoprotein complexes were analyzed by electrophoretic separation 
for 1.5 hours at 10 V/cm on a 1 % agarose gel buffered with 1XTAE (40 mM Tris, 20 mM acetic 
acid, and 1 mM EDTA, pH 8.3). Gels were stained with SYBR green (Invitrogen) at 1:10,000 
dilution for 15 min. 
GST pull-down assay and immunoblotting - GST and GST-fusion proteins (GST-H2A N-
terminal tail, GST-H2B N-terminal tail, GST-H3 N-terminal tail, GST-H4 N-terminal tail, and 
GST-GFP) (2 µg) were incubated with MeCP2 (wt), MeCP2 (R133C), or  MeCP2 (168X) (1 µg) 
in the presence of BSA (10 µg) for 30 min at room temperature.  Samples were mixed with a 
50% slurry of glutathione beads (Amersham Pharmacia) incubated in TGD150 buffer  (20 mM 
Tris pH 8.0, 150 mM NaCl, 1mM DTT, 0.1% Triton X-100) with rotation at 4oC for 2 hours.  
The beads were collected by centrifugation, and washed three times with TGD150. The 
precipitated proteins were eluted in SDS-PAGE sample buffer, separated by SDS-PAGE, and 
transferred to a nitrocellulose membrane. Membranes were probed with a MeCP2 antibody and 
visualized using ECL according to the manufacturers protocol (Amersham Pharmacia).   
Linker DNA accessibility assay - Nucleosomal arrays and MeCP2-nucleoprotein complexes 
assembled as described for the EMSA analysis were incubated with 10 units of EcoRI/µg of 
DNA for 90 min at 37oC. Digestion was stopped with the addition of EDTA to a final 
concentration of 15 mM. The digested samples were treated with 10 µg of Protienase K for 60 
min at 50oC, phenol chloroform extracted, and ethanol precipitated to determine the DNA 
composition after digestion. The DNA was resuspended in 10 µl of 1X loading dye and analyzed 
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by electrophoretic separation on a 1% agarose gel at 8 V/cm for 2 h and stained with SYBR 
green.   
Electron microscopy-   Transmission electron microscopy samples were prepared as previously 
described (Nikitina et al., 2007).  NAs and MeCP2 were mixed at the desired concentrations in 
H5EGN buffer and incubated at room temperature for 30 minutes. The samples where then fixed 
with 0.1% glutaraldehyde for 4 hours at 4oC before overnight dialysis into H5EGN, and applied 
to glow-discharged carbon coated grids. The grids were positively stained with 1% aqueous 
uranyl acetate followed by a thorough washing.  These grids were subsequently examined in a 
Tecnai 12 TEM operated at 100 KV in the tilted darkfield mode. The digital images were 
captured by a TVIPS 2024x2024 CCD camera.  
RESULTS 
 
Histone N-terminal Tails Influence MeCP2-Chromatin Interaction- To understand the 
importance of the N-terminal tails of histones on MeCP2-chromatin binding and/or 
condensation, nucleosomal arrays were reconstituted using bacterially expressed histones either 
with (NAwt) or without N-terminal tails (NAtailless). The 208-12 DNA template used for these 
reconstitutions contains 12-tandem repeats of the 208 bp 5S rDNA nucleosome positioning 
sequence from Lytechinus variegates that has been extensively used for chromatin structure 
studies (for review see Hansen, 2002; Luger and Hansen, 2005). Binding of MeCP2 to 
nucleosomal arrays was initially analyzed by Electrophoretic Mobility Shift Assays (EMSA) 
(Figure 3.2, A). We have previously used this method to demonstrate MeCP2’s ability to bind 
and condense nucleosomal arrays into higher-order chromatin structures (Georgel et al., 2003). 
After incubation with wild-type recombinant MeCP2 at molar ratios rMeCP2 of 0.5-4.5, complexes 
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composed of arrays reconstituted with either wild-type histones or tailless histones were 
electrophoresed on native 1% agarose (Figure 3.2, A). We found the recruitment of MeCP2 to be 
significantly affected by the removal of all N-terminal tails of histones (Figure 3.2A: NAwt vs. 
NAtailless EMSA and Figure 3.2, B: EM images). Both an increase in free array (black arrow) and 
a decrease in NA/MeCP2 complex formation (white arrow) at ratios rMeCP2 0.5-4.5 were observed 
with the tailless arrays (Figure 3.2, B lanes 3-6) compared to the wild-type array (Figure 3.2, A 
lanes 3-6). Differences in levels of chromatin condensation between arrays with and without tails 
were viewed by Electron Microscopy (EM) (Figure 3.2, C).  Arrays comprised of full length 
histones displayed both inter- and intra- chromatin fiber interactions. Condensation within 
sections of arrays is clearly visible in some of the fields of view (yellow arrows). In addition, 
there are numerous intra-fiber interactions seen with MeCP2 and wild type arrays (yellow stars). 
The tailless arrays appear to lose some MeCP2-mediated fiber interactions. This appears to be 
the result of both a reduction in the amount of condensed arrays and in the number of intra-fiber 
interactions. 
92 
 
 
Figure 3.2, A and B: MeCP2 binding is influenced by histone N-termini. 
(a) Binding of MeCP2 to 208-12 NA. Lane 1 contains a 1 kb+ DNA ladder. Lane 2 corresponds to 208-12 NA alone. Lanes 3-8 
are MeCP2 binding to 208-12 NA at increasing rMeCP2 (ranging from 0.25 to 4.0 MeCP2 molecules per 208 bp of DNA). The 
black arrow indicates free, unbound NA. The white arrow indicates shifted complexes. (b) Binding of MeCP2 to tailless 208-12 
NA. Lane 1 contains 1 kb+ DNA ladder and lane 2 has tailless 208-12 NA alone. Lanes 3-8 correspond to tailless 208-12 NA 
with increasing rMeCP2 ranging from 0.5 to 4.5.  
 
93 
 
 
Figure 3.2, C: EM imaging of MeCP2-NA complexes with and without histone N-termini tails. 
 (Panels A-C) 208-12 NA alone. (Panels D-K) 208-12 NA with MeCP2 at rMeCP2= 0.5. MeCP2-NA complex formation is 
observed to some degree in the majority of fields (yellow arrows). Intra- chromatin fiber interactions (yellow stars) can also be 
discerned in addition to inter-fiber compaction. (Panels L-O) Tailless 208-12 NA alone. (Panels P-W) Tailless 208-12 NA with 
MeCP2 at rMeCP2= 0.5. An increase in uncomplexed arrays is observed in the absence of histone N-termini. In addition, a decrease 
in intra-fiber interactions also appears to accompany the removal of N-termini tails from NA. 
 
Individual Histone N-terminal Tails Effect on MeCP2 Binding- To evaluate the contribution of 
individual histone tails, the same experimental approach was taken using NA reconstituted with 
three wt histone and one tailless in all four combinations (NA-H2A, NA-H2B, NA-H3, NA-H4). 
EMSA using NA-H2B as a template (Figure 3.3, B) shows no significant change in the MeCP2-
NA complexes formed as indicated by mobility shift patterns similar to that of normal NA 
(Figure 3.2, A). This strongly suggests that H2B tails do not significantly contribute to MeCP2 
recruitment to the NA. Deletion of tails from histones H2A, H3, and H4 impedes the formation 
of MeCP2/NA complexes (shift delayed at similar rMECP2, compare lanes 2 to 6 in panels A, C, 
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and D) in a manner similar to what was observed with the tailless nucleosome arrays (Figure 3.2, 
B, lanes 2-6).  In addition, the increase in free NA (see black arrows Figure 3.3) confirmed a 
change in MeCP2 binding affinity for NA-H2A, NA-H3, and NA-H4.  
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Figure 3.3: MeCP2 binding efficiency to composite NAs lacking one type of histone N-termini. 
(a) Binding of MeCP2 to NAH2A-. (b) Binding of MeCP2 to NAH2B-. (c) Binding of MeCP2 to NAH3-. (d) Binding of MeCP2 to 
NAH4-. Lanes 1 contain 1 kb+ DNA ladder. Lanes 2 correspond to composite 208-12 NA alone. Lanes 3-8, composite 208-12 NA 
with an increasing rMeCP2 ranging from 0.5 – 4.5. Black arrows indicate an increase in free NA in the H2A-, H3-, and H4- 
composite arrays. The white arrow denotes the NAH2B- shifting patterns that are similar to wild type NA. 
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Direct Interaction Between MeCP2 with Histone N-Terminal Tails- To directly test the in vitro 
interactions between MeCP2 and core histone tails, we used bacterially expressed GST-histone 
N-termini fusion proteins (Hecht et al., 1995; Georgel et al., 1997) as a ligand for MeCP2 
binding assay (Figure 3.4). MeCP2 GST-fusion tail complexes were pulled down with 
glutathione-Sepharose beads, eluted, and resolved with SDS-PAGE. The separated proteins were 
subsequently transferred to a nitrocellulose membrane and visualized by immunoblotting using 
an anti-MeCP2 antibody. When compared against 10% of input protein (Figure 3.4, A, lane 1), 
MeCP2 was found to directly interact with GST-H2A and GST-H3 fusion proteins in vitro 
(Figure 3.4, lanes 3 and 5), and to a lesser extent with the GST-H4 fusion (Figure 3.4, A, lane 6). 
No interaction between MeCP2 and GST-H2B was detected in this assay (Figure 3.4, A lane 4), 
matching our EMSA results. GST alone, or fused with green fluorescent protein (GFP) were 
used as negative controls. No non-specific interaction with MeCP2 was detected (Figure 3.4, A, 
lanes 2 and 8). These in vitro IP experiments confirm the MeCP2 electrophoretic mobility results 
further demonstrating direct interactions between MeCP2 and the N-terminal tails of the core 
histones H2A, H3, and H4. 
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Figure 3.4: MeCP2 interacts with the N-termini of H2A, H3, and H4 in a GST-fusion pull-down 
assay. 
Lanes 1 and 7 indicate 10% (200 ng) of assay input MeCP2. Lane 2, MeCP2 and GST alone. Lanes 3, 4, 5, and 6 correspond to 
MeCP2 with GSTdH2A, GSTdH2B, GSTdH3, and GSTdH4 respectively. Lane 8 contains MeCP2 and GST-GFP. 
 
Effect of Histone acetylation on MeCP2 binding and chromatin compaction- MeCP2 has recently 
been described to localize not only in chromatin regions overlapping with repressed genes but 
also to active loci in the genome (Yasui et al., 2007, Chahrour et al., 2008). These actively 
transcribed regions are most often associated with hyper-acetylated H3 and H4 histone 
(Jenuwein and Allis, 2001). Individual hyper-acetylated nucleosomes did not appear to be a 
better substrate for MeCP2 binding (Ishibashi et al., 2008), but no information was reported on 
the effect of acetylation on NA folding. To determine the influence of histone N-termini 
acetylation on MeCP2 binding and chromatin condensation, acetylated nucleosomal arrays were 
assayed by EMSA and imaged by EM. These NAs were reconstituted using hyper-acetylated 
histones generated by the in vitro treatment of chicken erythrocyte histones with a histone 
acetyltransferase (GcN5) (Figure 3.5). When comparing the affinity for normal and 
hyperacetylated NA at rMeCP2 from 0.25 to 2.0, no noticeable difference in binding was observed 
(Figure 3.5, B), in agreement with the published results on mono-nucleosomes (Ishibashi et al., 
2008). This confirms that acetylation does not significantly hinder MeCP2 recruitment to 
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chromatin. However, EM images of normal NA and NAacetylated indicated a reduction in MeCP2 
ability to compact acetylated chromatin (Figure 3.5, B). 
 
Figure 3.5, A: Effects of histone acetylation on MeCP2 binding. 
Binding of MeCP2 to acetylated 208-12 NA. Lanes 1 and 7 contain a 1 kb+ DNA ladder. Lanes 2 and 8 contain 208-12 NA 
without MeCP2. Lanes 3-6, unmodified 208-12 NA with increasing rMeCP2 from 0.25 to 2.0. Lanes 9-12, acetylated 208-12 NA 
with increasing rMeCP2 from 0.25 to 2.0. 
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Figure 3.5, B: Effects of histone acetylation on MeCP2 compaction. 
EM imaging (a) acetylated 208-12 NA alone (b) MeCP2 and acetylated 208-12 NA complexes at rMeCP2 = 1. 
 
 
RTT-causing Mutant MeCP2 R133C Interactions with N-Terminal Histone Tails- The mutant 
MeCP2 R133C contains a point mutation at residue 133 converting an arginine to a cysteine 
residue which has been linked to patients suffering from RTT (Amir et al., 1999). This point 
mutation in the MBD has been shown to dramatically hinder the preference for MeCP2 to bind to 
methylated DNA (Ballestar et al., 2000). Structurally this mutation is expected to prevents proper 
interaction between the MBD and its DNA target (Ohki et al., 2001; Ballestar et al., 2000; Lee et 
al., 2001; Van den Veyver et al., 2001). We have previously demonstrated this point mutation to 
have no significant effect on binding to normal NA and to have a limited impact on the in vitro 
formation of oligomeric superstructures (Georgel et al., 2003). To complement this study, we 
decided to investigate the contribution of the individual histone tails to MeCP2 R133C 
recruitment. Similar to what was done with the wt MeCP2, we performed EMSA with the 
various combinations of composite NAs (Figure 3.6, A). Expectedly, the results indicate a 
structural role for the tails in the binding mechanism of MeCP2 R133C (NAwt vs. NAtailless). But, 
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in contrast to the differential binding observed with the wt MeCP2 (no significant H2B tail 
contact), the R133C mutant appears to be able to recognize all four histone N-termini with nearly 
equivalent affinity. When comparing the results obtained using normal NA (Figure 3.6, A, lane 
3), the removal of any individual tail (including that of H2B) resulted in a decrease in MeCP2 
R133C binding efficacy to composite NA, as indicated by the remaining uncomplexed free NA 
at rMeCP2 = 0.25 (Figure 3.6, C-F, lane 3). The lack of histone tail discrimination by the MeCP2 
R133C results were confirmed by co-IP using the GST-tail constructs previously described 
(Figure 3.6, B). The relative signal intensity for GSTdH2A, GSTdH3 and GSTdH4 were 
comparable to that observed with wtMeCP2 (Figure 3.4). The difference in function resides in 
the acquired ability for the MeCP2 R133C to recognize and bind the N-terminal region of H2B. 
This result suggests that the R133C mutation may induce a conformational change at the 
secondary or tertiary protein folding level.  
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Figure 3.6, A: RTT-linked MeCP2 R133C differential chromatin interaction. 
(Panel A) MeCP2 R133C with unmodified 208-12 NA. (Panel B) MeCP2 R133C with tailless 208-12 NA. (Panel C) MeCP2 
R133C with 208-12 NAH2A-. (Panel D) MeCP2 R133C with 208-12 NAH2B-. (Panel E) MeCP2 R133C with 208-12 NAH3-. (Panel 
F) MeCP2 R133C with 208-12 NAH4-.   Lanes 1 contain 1 kb+ DNA ladder. Lanes 2 correspond to 208-12 NA alone. Lanes 3-7, 
208-12 NAs with increasing rMeCP2-R133C from 0.25 to 2.0. 
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Figure 3.6, B: GST-fusion pull-down with MeCP2 R133C. 
Lanes 1 and 7 indicate 10% (200 ng) of assay input MeCP2 R133C. Lane 2 is MeCP2 R133C and GST alone. Lanes 3, 4, 5, and 
6 correspond to MeCP2 R133C with GSTdH2A, GSTdH2B, GSTdH3, and GSTdH4 respectively. Lane 8 contains MeCP2 
R133C and GST-GFP. 
 
The Chromatin-condensing ability of MeCP2 Is Linked to Histone Tail Binding- The RTT-linked 
R168X MeCP2 possesses a mutation that alters the arginine 168 codon to a stop codon, leading 
to a truncated protein that only contains the N-terminus and MBD domain (Lee et al., 2001; Van 
den Veyver et al., 2001).  Previously we have reported this RTT mutant to have a significantly 
decreased binding affinity for NA when assayed by native agarose gel electrophoresis (Georgel 
et al., 2003). This mutation does not prevent MeCP2-NA interaction, but leads to a loss of 
function in NA condensation and an inability to promote the formation of larger oligomeric 
suprastructures. This study suggested MeCP2s ability to condense chromatin into higher-order 
structures occurred through its transcriptional repression domain or other C-terminal domains. 
The binding pattern observed with MeCP2 R168X and NAwt (Georgel et al., 2003) is nearly 
identical to that of wtMeCP2-NAtailless binding (Figure 3.2, B), suggesting this region of 
MeCP2 is necessary for histone tail contact and is also critical for the induced chromatin 
compaction. To confirm that the EMSA patterns are the result of an inability for MeCP2 R168X 
to recognize the histone tails, we performed co-IP experiments under conditions similar to that 
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described for the wt and R133C proteins. These results showed that deletion of the residues 
outside of the N-terminus and MBD results in the complete loss of histone tail interactions 
(Figure 3.7, lanes 3, 4, 5, and 6). This confirms that histone tail interactions require the presence 
of domains other than the MBD, such as the TRD, CTDα, or CTDβ.  
 
Figure 3.7: The RTT-linked truncated MeCP2 R168X mutant loses histone N-termini interaction. 
GST-fusion pull-down assay with RTT-linked MeCP2 R168X. Lanes 1 and 7 indicate 10% (200 ng) of assay input MeCP2 
R168X. Lane 2 is MeCP2 R168X and GST alone. Lanes 3, 4, 5, and 6 correspond to MeCP2 R168X and GSTdH2A, GSTdH2B, 
GSTdH3, and GSTdH4 respectively. Lane 8 contains MeCP2 R168X and GST-GFP. 
 
 
DISCUSSION 
 
Characterization of Human MeCP2-Chromatin Binding Determinants- The experiments 
described in this study were designed to elucidate human MeCP2’s chromatin binding 
determinants and evaluate their influence on chromatin condensation. MeCP2 has long been 
described as a global repressor that is localized to methylated regions of the genome (Nan et al., 
1997). Scientific interest in this protein increased dramatically after MeCP2 mutations were 
linked to a severe neurodevelopmental disorder, the RTT (Amir et al., 1999). In addition to 
MeCP2 preferentially binding methylated DNA over unmethylated DNA, a significant role in 
chromatin compaction ability has recently been demonstrated (Georgel et al., 2003).  This in 
vitro binding study used unmethylated DNA incorporated into chromatin as a template, 
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separating MeCP2’s methylated DNA binding preference from chromatin condensing function. 
In order to further characterize MeCP2-chromatin interactions, we assembled arrays of 
nucleosomes that lacked all or one of the four N-terminal tails of the core histones H2A, H2B, 
H3, and H4. Our in vitro binding assays surprisingly displayed a significant differential MeCP2 
binding between normal chromatin and its tailless counterpart, as demonstrated by the increase in 
free NAtailess versus NAwt (Figure 3.2, lanes 4 and 5). These results indicate a clear influence of 
histone N-termini in MeCP2-chromatin interactions. This decreased affinity is also accompanied 
by a loss of efficiency in the formation of MeCP2-mediated higher order chromatin complexes. 
The cleavage of linker DNA by restriction enzymes was not sufficient to entirely destabilize the 
MeCP2-NA complexes (Georgel et al., 2003). This study in combination with previous work that 
showed MeCP2 exists as a monomer (Klose and Bird, 2004) strongly suggests a stabilizing 
effect through the formation of bivalent DNA-MeCP2-DNA “bridges” between nucleosomes. 
The reduction in MeCP2-NA complex formation in the absence of histone tails suggests these 
“bridges” may involve histone-N-termini in MeCP2 recruitment and/or complex stabilization. 
The EM images (Figure 3.2) reflect reduced interactions between MeCP2 and the NA in the 
absence of histone N-termini. The effect was observed, both in cis (intra-NA) and trans (between 
adjacent NAs), indicating that recruitment and formation of supramolecular complexes were 
affected. The absence of some specific long-range chromatin interactions (kilobases apart) in 
MeCP2-null mice suggests an in vivo role for MeCP2-mediated bridges in higher order 
chromatin loop structures (Horike et al., 2005). 
To date, there is no evidence that directly links MeCP2 function to the histone tails in the 
context of chromatin. Cross-linking experiments have previously suggested that MeCP2 binding 
occurs in the vicinity of histone H3 (Nikitina et al., 2007). Subsequent structural experiments 
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performed on mono-nucleosomes clearly showed the histone H3 tail not to be critical for MeCP2 
binding (Ishibashi et al., 2008). Here, composite nucleosomal arrays assembled using three wild 
type histones combined with one tailless histone were used to more clearly delineate the 
individual contribution of each of the N-termini region on MeCP2-NA condensation. EMSA 
results associated the reduced ability of MeCP2 to mediate complex formation with the absence 
of individual N-terminal tails of histones H2A, H3, and H4 (Figure 3.3). In contrast, the loss of 
H2B N-terminus did not affect MeCP2 binding. The difference in H3 tail interactions reported 
between single nucleosomes and NA may result from an intra-nucleosomal array effect where 
the N-terminal region contributes additively and independently to NA oligomerization (Dorigo et 
al, 2004; Zheng et al, 2005; Gordon et al, 2005; Arya and Schlick, 2006). This may indicate two 
or more adjacent N-terminal tails stabilizes MeCP2 chromatin contacts. The contribution of 
MeCP2-histone tail interaction may manifest itself in regulating compaction of larger arrays of 
nucleosomes and therefore no evident effect would be detected when using mono-nucleosome 
for binding studies (Ishibashi et al., 2008). Computer modeling analyzing the role of individual 
tails on chromatin compaction as a function of Mg2+ concentration predicts the tails of H3 and 
H4, but not H2A or H2B, play a significant role in NA condensation (Arya and Schlick, 2009). 
In order to differentiate between core histone N-termini tails involvement in promoting 
chromatin folding vs. directing histone N-termini interaction by MeCP2, GST-histone tail fusion 
Co-IPs were performed. These GST-fusion proteins have previously been used to demonstrate in 
vitro binding capabilities of Sir3, another CAP (Georgel et al., 2001). Here, these constructs 
were used to demonstrate the direct binding of MeCP2 to the histone N-terminal tails of H2A, 
H3, and H4 by this Co-IP assay (Figure 3.4). The results of these pulldown experiments were 
consistent with the EMSA conclusions which indicated a lack of interactions between the H2B 
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tail and MeCP2.  The absence of MeCP2-H2B tail interactions questions the role H2B N-termini 
may play during MeCP2 gene regulation. One possibility is by leaving the H2B tail sterically 
unhindered, it would be exposed to PTM signaling and/or other CAP interactions. Identification 
of MeCP2-histone tail interaction strongly suggests the histone code may play a role in MeCP2 
function and/or localization. These results when taken together indicate MeCP2 directly interacts 
with and is aided by the N-termini of histones to promote chromatin folding.  
Acetylation Influences MeCP2-mediated Chromatin Condensation- Based on existing literature 
describing MeCP2 as a general co-repressor, interactions with acetylated histone tails are 
expected to be limited. MeCP2 has classically been linked to histone hypoacetylation as 
evidenced by its co-purification with Sin3-histone deacetylases complexes (Jones et al., 1998; 
Nan et al., 1998). However, recent work has also linked MeCP2 to actively transcribed loci, 
leaving the potential for MeCP2 to act as a co-activator. A possible role for MeCP2 as a co-
activator came from the recent findings of MeCP2 association with promoters of active genes 
(Yasui et al., 2007, Chahrour et al., 2008).  In addition to interactions with Sin3-HDAC 
complexes, in vitro preference of MeCP2 for methylated DNA further indicates a role as a co-
repressor. However, recent studies have indicated that DNA methylation may not be required for 
MeCP2 recruitment to chromatin and induced compaction (Georgel et al., 2003). The proposed 
mechanism of preferential binding to methylated DNA and chromatin folding contrasts with the 
recent findings of MeCP2-associated transcriptionally active loci. Based on such evidence for a 
dual role as co-repressor and co-activator, MeCP2 is now considered as a transcriptional 
regulator whose recruitment to regulatory DNA elements and subsequent function is likely 
mediated by histone PTMs. Acetylation of mono-nucleosomes has been previously been 
demonstrated to not interfere with the in vitro binding of MeCP2 (Ishibashi et al., 2008). Our 
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own in vitro acetylated NA experiments confirmed these results, showing little difference in 
binding efficiency when compared to control NA (Figure 3.5, A). Interestingly, we do find 
histone acetylation to impede the condensation of chromatin as evidenced by EM images 
showing only partial MeCP2-induced condensation of the acetylated NA (Figure 3.5, B). The 
effect may simply be due to an inability for MeCP2 to overcome the electrostatic repulsion 
generated by the acetyl groups present on the histone N-termini. The apparent inability for 
MeCP2 to differentiate between normal and hyper-acetylated tails is compatible with both co-
repressor and co-activator roles. The difference in biological function may lie in MeCP2 
interactions with other co-repressors or co-activators. The interaction with the Sin3-HDAC 
complexes would definitely favor MeCP2’s ability to compact chromatin and therefore further 
repress loci that are poised for repression. The switch from co-repressor to co-activator or vice 
versa may be the result of differential post-translational modifications of MeCP2. (Zhou et al., 
2006; Tao et al., 2009). Another potential consequence of MeCP2 binding to transcriptionally 
active loci may be mediated by chromatin folding. Despite a lower ability to compact chromatin 
when histone tails are hyper-acetylated, MeCP2 can still contribute to folding. This partial 
folding may induce secondary structures that are conducive to transcription (Georgel et al., 
2003). The reduced chromatin compaction may also expose unique unidentified MeCP2 binding 
determinants critical for the recruitment of other CAPs interacting over long distances.  
Additionally, in vivo localization of MeCP2 has been demonstrated to coincide with an 
increase in H3K9 methylation on the repressor domain in the upstream regulatory region of the 
H19 gene (a MeCP2-regulated gene (Drewell, et al., 2002)) (Fuks et al., 2003). This correlation 
was suggested by the authors to be caused by the tethering of an unidentified histone 
methyltransferase to the N-terminal region of MeCP2. The presence of methylated H3K9 by 
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itself may change MeCP2’s affinity to chromatin, as well as its folding properties. The binding 
of MeCP2 to H3 tail may also enhance the methyltrasnferase activity of this unknown enzyme by 
properly orientating the histone tail. The chromatin compaction ability of MeCP2 appears to be 
influenced by the presence of histone tails and their PTM, but a further characterization of the N-
termini PTMs role in MeCP2 recruitment and/or function will have to be performed as the 
availability of specifically modified histone increases.  
Role of RTT Mutations on Chromatin Interaction - To determine the influence of RTT mutations 
on recruitment to chromatin templates, we assessed the differential chromatin binding properties 
of two RTT-linked MeCP2 mutants (R133C and R168X).  The R133C MeCP2 mutation alters 
one of the five residues that generate the hydrophobic methyl-binding pocket of the MBD (Free 
et al., 2001; Wakefield et al., 1999). This mutated form of MeCP2 displays a 100-fold less 
preference for methylated DNA compared to wild type MeCP2 (Ghosh et al., 2008). Previously 
published binding studies using MeCP2 R133C and 208-12 NA showed this mutation to have 
little effect on chromatin interactions (Georgel et al., 2003). Surprisingly, our EMSA binding 
studies identified a differential binding pattern associated with the R133C MeCP2 mutant and 
the histone H2B tailless NA-H2B (Figure 3.6, D). This gain of function was confirmed by our 
GST-fusion immunoprecipitation experiments (Figure 3.6, G, lane 4). The additional ability for 
MeCP2 R133C to recognize and bind H2B N-terminus may play a role in RTT development of 
specific cell types. This may be explained through steric hindrance preventing the recruitment of 
other specific factors that would otherwise interact with the H2B tail, resulting in deficient CAP 
binding or signaling that would impact proper regulation of specific genes leading to various 
developmental defects.  
109 
 
The additional H2B tail binding could change the MeCP2-mediated chromatin structure 
normally adopted by the wild type protein. Alterations in chromatin structure could influence 
either of MeCP2s co-repressor or co-activator activities. These point mutations gain of H2B 
binding also could affect MeCP2 recruitment to a small number of critical developmental genes, 
but not grossly change the global localization of this RTT mutant. It is also possible that the 
wtMeCP2 can bind to H2B N-termini, but only in the presence of a specific PTM, with this point 
mutation removing PTM selectivity. In order to determine the region of MeCP2 responsible for 
histone tail interaction, the RTT R168X truncated mutant was analyzed with our GST-fusion 
immunoprecipitation  assay. The MeCP2 R168X truncation has previously been used to 
demonstrate the area responsible for MeCP2-mediated higher order chromatin structure 
formation lies outside of the N-terminus and MBD domain (Georgel et al., 2003). Our GST-
histone tail fusion pull-downs with MeCP2 R168X co-localize the loss of histone tail interaction 
with the loss of higher order chromatin compaction to the TRD or other C-terminal residues 
(Figure 3.7). We suspect that these two MeCP2 functions may be interlinked, with MeCP2 
condensing chromatin into higher order structures through a DNA/histone tail-MeCP2-
DNA/histone tail “bridging” mechanism. Additional studies, possibly through additional 
truncated versions of MeCP2, will have to be performed to separate these two MeCP2 functions 
in an attempt to further elucidate their interconnection.  
Curiously, the R133C mutation of MeCP2 resides in the MDB region, well within the 
first 168 aa that we demonstrate to not interact with histone N-termini, but was found to 
influence histone H2B tail binding. MeCP2 has been described to have an abnormal tertiary 
structure compared to other identified nucleoproteins (reviewed in Hite et al., 2009). It was first 
characterized to have an anomalous molecular mass when analyzed by gel filtration (~70-80 
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kDa) yielding a different mass than calculated based on residue sequence (52.4 to 53 kDa) 
(Meehan et al., 1992; Klose and Bird, 2004). The structure of MeCP2 has subsequently reported 
to be intrinsically disordered (Adams et al., 2007).  This study demonstrated almost 60% of 
MeCP2s tertiary organization to be unstructured. The large quantity of unstructured regions has 
been hypothesized to be responsible for preventing the crystallization of full-length MeCP2. The 
arginine to cysteine point mutation of the R133C mutant adds a sulfide group that could mediate 
a possible additional disulfide bond in the mutant form but not in the wt MeCP2 protein. This 
additional disulfide bond could alter the secondary and tertiary structure of MeCP2 and/or 
change regions involved in histone N-termini interactions. Supporting this possibility, changes in 
secondary structure have been reported for the R133C, as well as T158M, R106W, and F155S 
correlating with differences in methylated DNA binding (Ballestar et al., 2000). These 
conformational changes may additionally have an effect on either chromatin binding or MeCP2-
associated chromatin compaction ability. Furthermore, the truncation of MeCP2 R168X may 
affect the overall folding in such a way that could explain the loss of histone tail interactions 
observed in our GST-fusion immunoprecipitation experiments.   
These studies on identification of differential chromatin interaction amongst RTT-linked 
MeCP2 mutants may lay the groundwork for a more in depth identification of the molecular 
basis of RTT. The next step in MeCP2 characterization will require a comprehensive analysis of 
histone N-termini tail PTMs and their effect on chromatin binding and condensation. The 
characterization of PTMs involvement in wtMeCP2s localization and function needs to be 
determined because some differences in RTT function may involve the improper reading of 
specific PTM or sequence of PTMs. The differential binding of both RTT MeCP2 mutants used 
in this study strongly indicates that other RTT-linked mutations may also be influencing MeCP2-
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chromatin interactions in a histone tail-mediated manner. The RTT linked differences in 
chromatin binding could begin to explain the dysfunctional molecular mechanism of RTT, and 
we believe will become one of the main foci of future MeCP2 studies.  
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CHAPTER 4: DISCUSSION, CONCLUSION, AND FUTURE STUDIES 
 
DISCUSSION 
 
Additional Chromatin Interactions of Eukaryotic Gene Silencing CAPs 
In recent years, documentation regarding the effect that chromatin structure may have on 
gene regulation has significantly increased. However, the specific role and mechanism of the 
individual chromatin components, their regulatory functions, and interacting partners are still 
only partially understood. This dissertation addresses the function and interacting partners of two 
well studied CAPs: Sir3 and MeCP2. The Sir3 protein in Saccharomyces cerevisiae has 
classically been described for its gene silencing activity through recruitment by the Rap1 protein 
and subsequent interactions with the de-acetylated N-terminal unstructured tails of histones H3 
and H4. In contrast, the mammalian MeCP2 protein has long been characterized to repress 
transcription through its selective binding of methyl-CpG DNA. The studies performed here 
have identified and characterized additional chromatin interactions involving Sir3 and MeCP2, 
and demonstrated that these interactions may hold significant biological implications. In 
addition, this work challenges the previous mode of action of these two CAPs, leading us to 
revisit their role in the context of chromatin interactions. While Sir3 and MeCP2 do not contain a 
classical DNA-biding domain or histone interacting domain respectively, they are proteins with a 
high intrinsic disorder, a property often associated with proteins involved in multiple protein-
protein and protein-DNA contacts (reviewed in Uversky et al., 2005). This chapter will highlight 
the biological significance of my research findings, postulate further on the molecular 
mechanism of these CAPs, and describe future experiments that could provide additional 
evidence for novel and important functions of Sir3 and MeCP2.  
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Role of Nucleic Acid Binding in Sir3-Dependent Interactions with Chromatin Fibers 
The silencing protein Sir3 has recently been characterized to bind to the DNA fiber 
within chromatin, in addition to its interaction with histone H3 and H4 N-termini (Georgel et al., 
2001). This initial work strongly suggested that Sir3 would bind in a similar manner to native 
template chromatin (208-12 NA), tailless arrays, and naked DNA. Our experiments confirmed 
these initial observations (Figure 2.1), and further characterized the role of nucleic acids binding 
by Sir3 in order to further elucidate the role of Sir3-chromatin interactions.  
In order to determine the DNA features within chromatin which may preferentially 
interact with Sir3, we examined the effect of DNA length (Figure 2.2) and structure (Figure 2.3) 
on Sir3 binding. We found that the binding ability of Sir3 was influenced more by changes in 
DNA structure than by size variation. The more “straight” fragment (HSP promoter) was a better 
substrate for Sir3 binding, followed by the “bent” (pPol I promoter), then “curved” (208-1 DNA) 
fragment (Figure 2.3). The structures of these three DNA fragments were modeled with software 
based on the Trifonov algorithm (Figure 2.3, A) designed to predict substrate curvature based on 
sequence. Structural changes were confirmed and characterized by Quantitative Agarose Gel 
Electrophoresis (Table 2.1), allowing us to calculate the radii of the three substrates to confirm 
the differential curvature. This quantifiable preference for a “straight” DNA structure initially 
indicated that linker DNA within chromatin is a more likely Sir3 binding partner, as opposed to 
“curved” nucleosomal DNA. This is due to the structure of linker DNA being expected to display 
a more straight conformation as opposed to nucleosomal DNA which possesses an induced 
curvature mediated by core histones interactions.  
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In order to test whether the short stretch of DNA at the entry/exit point of the nucleosome 
was a target for Sir3 binding, a “4-way junction” DNA template comprised of 4 oligonucleotides 
annealed in a specific order was used as a substrate for our standard binding assay. This 
construct has previously been used to mimic DNA cross-over targeted by other architectural 
CAPs such as HMGA proteins, HMGB proteins, and linker histones (Ferrari et al., 1992; 
Panyutin and Hsieh, 1993; Hill and Reeves 1997; Varga-Weisz et al., 1994). We found that the 
4-way junction DNA was the weakest DNA substrate tested in all of our Sir3 binding assays, 
indicating Sir3-DNA interactions are weak at the nucleosomal entry-exit point. This result is in 
contrast with previous studies using a DNA accessibility assay on Sir3-NA complexes which 
demonstrated no significant blockage of linker DNA digestion (Georgel et al., 2001).  Another 
possible alternative for Sir3-DNA contacts may occur at the dyad DNA section of nucleosomes. 
This area, between nucleosome base position 60 and 90, displays a straighter DNA 
conformation, as opposed to the remaining nucleosomal DNA. As such, it may provide a 
preferred DNA structure for Sir3 binding. Our length dependent binding study demonstrated that 
Sir3 could complex with DNA fragments as short as 12-bp in length, supporting the possibility 
that Sir3-DNA contacts can occur within nucleosomal DNA or short stretches of linker DNA 
(Figure 2.2). 
Throughout our nucleic acid characterization, Sir3 was found to cooperatively bind to 
nearly all fragments assayed by EMSA (Figure 2.3 and 2.4). This cooperative binding is 
demonstrated by an abrupt loss of free DNA when Sir3 reaches the critical DNA-binding 
molarity to form complexes. The mass of free DNA was measured at increasing Sir3 molar ratios 
and plotted (Figure 2.3, C and Figure 2.4). The quantification of uncomplexed DNA was 
performed as a function of fluorescence intensity by matching quantified signal against a serial 
115 
 
dilution of free DNA. These results indicated a nearest-neighbor cooperative mode of binding 
with the plotted data demonstrating a fitted curve with a distinct S-shape as opposed to a linear 
plot associated with sequential independent binding. Imaging by EM supported the cooperative 
binding model for Sir3-DNA interaction. Large Sir3-DNA complexes were observed adjacent to 
free DNA in the same field of view (Figure 2.5, panels D, E, and F). In addition to Sir3 
displaying a cooperative binding activity to naked DNA templates, a concentration dependent 
effect on binding was also observed (Figure 2.6). An increase in binding by doubling the number 
of molecules while keeping the same molar ratio between protein and DNA fragments was found 
to occur with native chromatin templates (Figure 2.6, A), the tailless array (Figure 2.6, B), as 
well as naked DNA (Figure 2.6, C). This observation matches what has been described in vivo, 
where the level of Sir3 protein in yeast was found to directly impact the spreading of silencing 
from the telomeric regions in a dosage dependent manner (Renauld et al., 1993). These 
combined observations support a model where the spreading of genetic silencing in yeast by Sir3 
would occur through cooperative binding to DNA as a nucleating event. This is then followed by 
the subsequent cooperative recruitment of other Sir3 molecules, resulting in spreading of 
heterochromatin and an increase in the position effect variegation of nearby genes. 
 Unexpectedly, we discovered that not only can Sir3 bind to double-stranded DNA, it can 
also complex with single-stranded DNA in vitro (Figure 2.7). The DNA at telomeres exists in a 
single-stranded form where in yeast the single-stranded telomeric DNA-binding protein, Rlf6, is 
known to bind and effect the localization of Rap1 (Konkel et al., 1995). Sir3 has been known to 
localize to silent areas in the yeast genome, including telomeric regions (Aparicio et al., 1991), 
and interact with Rap1 and Sir4 in vivo to maintain silencing at these loci (Rine and Herskowitz, 
1987; Kyrion et al., 1992; Gotta et al., 1996).  Our data suggests that the Sir3 protein through this 
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single-stranded DNA binding capability may be involved in a mechanism for stabilizing the 
Rlf6-Rap1 complex at single-stranded telomeric DNA regions. 
Role of Histone N-termini in MeCP2-Chromatin Interactions 
 MeCP2 has classically been defined as a methyl-DNA binding silencing protein, but has 
recently been shown to display additional activities linking it to both activation of gene 
expression and RNA splicing (Young et al., 2005; Yasui et al., 2007; Chahrour et al., 2008). In 
vitro MeCP2-chromatin condensation studies have also demonstrated MeCP2-mediated 
chromatin compaction to be independent of DNA methylation specific binding (Georgel et al., 
2003). In light of these findings, we set out to determine if the N-termini tails of core histones 
influence MeCP2-chromatin interactions. Bacterially-expressed tailless histones were purified 
and used for chromatin reconstitution into 208-12 NA. These NA were then incubated with 
MeCP2 at differing molar ratios and complex formation was assayed by EMSA (Figure 3.1, B) 
and EM (Figure 3.1, C). The EMSA studies revealed that the removal of histone N-termini had a 
significant effect on MeCP2 recruitment. Higher molar ratios of MeCP2 were required to achieve 
tailless NA complex formation similar to their normal NA counterparts (Figure 3.1, A vs. B).  
EM imaging revealed a corresponding decrease in MeCP2-mediated chromatin interactions and a 
decrease in the level of condensation associated with the removal of histone N-terminal tails 
(Figure 3.1, C). This is the first evidence which suggests that MeCP2 interacts with histone N-
termini, and it opens the possibility of another level of MeCP2 recruitment through specific 
histone modifications. There is some supporting in vivo data linking the localization of MeCP2 
with H3K9 methylation at observed loci in mouse fibroblast cells (Fuks et al., 2003), perhaps 
indicating a preference for this modification in the process of MeCP2 binding.  
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To determine if individual tails have an influence on MeCP2-chromatin interactions, 
composite arrays comprised of three wild type and one tailless histone were reconstituted and 
incubated with increasing amounts of wt MeCP2 (Figure 3.2). While removal of individual tails 
did not affect binding to the same degree observed with the tailless arrays, MeCP2-complex 
formation was reduced in arrays lacking individual H3, H4, and H2A histone N-termini (Figure 
3.2, A, C, and D). MeCP2 complex formation was essentially unaffected by the lack of H2B 
tails, as shown by the EMSA profiles (Figure 3.2, B). Our EMSA results indicate a histone tail 
effect on MeCP2-mediated chromatin condensation. From these results, we cannot unequivocally 
conclude whether the MeCP2-mediated chromatin compaction follows the same rules as the 
standard histone H3 and H4 tail-mediated compaction described in other chromatin structural 
studies (Zheng et al., 2005; Kan et al., 2007; Kan et al., 2009). GST-fusion histone N-termini 
were used to assess MeCP2-histone N-termini interactions providing additional information on 
this CAPs chromatin condensation ability. These GST constructs have previously been used to 
investigate other CAP-histone N-terminal interactions (Georgel et al., 2001). Our GST-pulldown 
experiments revealed a direct interaction between MeCP2 and histone H2A, H3, and H4 N-
termini (Figure 3.3). These results confirm that direct MeCP2-histone tail interactions occur in 
vitro, and may be influencing MeCP2-mediated chromatin condensation.  
Direct contact between histone tails and MeCP2 within chromatin signifies a possible 
role for histone post-translational modifications in MeCP2 binding, localization, and/or function. 
Since MeCP2’s recently described association with promoters of active genes (Yasui et al., 2007; 
Chahrour et al., 2008), where CpG methylation may be at a minimum, a novel mechanism of 
MeCP2 recruitment should be envisioned. Since histone tails appear to play an important role, 
their post-translational modifications may further modulate MeCP2 recruitment. To test for the 
118 
 
effect of acetylation, one of the most common PTMs, we examined the influence of 
hyperacetylated histone tails on MeCP2-mediated chromatin condensation (Figure 3.4). While 
we found histone acetylation to not have an effect on MeCP2 complex formation compared to 
un-modified NA (Figure 3.4, A), EM imaging revealed a reduction in induced chromatin 
condensation (Figure 3.4, B). This result matches the predicted function of MeCP2 as it is known 
to interact with Sin3/HDAC1 at specific target loci (Nan et al., 1998; Suzuki et al., 2003). These 
findings suggest MeCP2 recruitment to chromatin is not completely hindered by acetylated N-
termini tails, which support the previous finding that MeCP2 can function not only as a 
transcriptional repressor, but is also capable of associating with active genes marked by histone 
acetylation (Yasui et al., 2007; Chahrour et al., 2008). The role of MeCP2 at the promoters of 
these active genes is currently unknown, but may be linked to the modulation of local histone 
arrangement into distinct chromatin structures (Georgel et al., 2003). The role of MeCP2 on 
active genes may also be the result of long-distance genetic interactions. As MeCP2 induces 
chromatin folding, it may bring distant regulatory elements into close proximity through a 
potential looping mechanism, as has been postulated for its silencing function (Horike et al., 
2005).  
The role of MeCP2 and how mutations impact its function in the underlying molecular 
mechanism of RTT development remains poorly characterized. Here, we examined two common 
RTT mutations, one with a single-point mutation in the MBD, MeCP2 R133C, and one with a 
point mutation resulting in an early stop codon, generating a truncated mutant, MeCP2 R168X 
(Amir et al., 1999). The MeCP2 R133C mutation has previously been described to have lost its 
selectivity for methyl DNA (Usufzai and Wolffe 2000), yet retains its ability to condense 
chromatin (Georgel et al., 2003). Our GST-fusion study demonstrates MeCP2 R133C point 
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mutant to be a gain of function mutation. As the wt MeCP2 can only interact with histones H2A, 
H3, and H4 (Figure 3.5, B), the R133C mutant can recognize all four histone tails. This 
additional tail interaction may signify an unnatural point of contact interfering with proper 
MeCP2-mediated chromatin condensation. It also may indicate that wt MeCP2 can only 
recognize H2B N-termini when it is adequately post-translationally modified. The point mutation 
may simply abolish this selective binding. Additionally, EMSA experiments determined the 
R133C point mutation had a reduced binding with composite arrays comprised of H2B tailless 
histones (Figure 3.5, A) as opposed to the wt MeCP2 being affected by the loss of only H2A, H3, 
and H4 tails. However, this difference in mobility with removal of the individual tails was 
observed at a lesser degree than that in the wt MeCP2 composite arrays EMSA (Figure 3.3). To 
begin to delineate the region of the MeCP2 protein responsible for the histone tail interactions, 
the truncated mutant, MeCP2 R168X, was assayed using our GST-fusion histone N-termini pull-
down assay (Figure 3.6). This experiment revealed that the mutant lacking the TRD and CTDs 
did not bind to any of the four histone tails. Since the MeCP2 R168X mutant was previously 
demonstrated to retain partial binding to 208-12 template chromatin, it appears that MeCP2 can 
contact nucleosomes through determinants other than the N-terminal tails. However, the R168X 
mutant was not capable of generating higher order structures of the type observed with wt 
MeCP2 (Georgel et al., 2003). In conclusion, our pull-down experiments suggest that some of 
the previously characterized effects of MeCP2 on generating chromatin higher order structures 
could be mediated by histone N-termini contacts. The changes in MeCP2’s ability to condense 
chromatin in a histone acetylation-dependent manner indicate a role for post-translational 
modifications. These potential regulatory events will require further research to clearly identify 
the critical histone tail modifications involved in MeCP2-chromatin interactions. Because these 
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two RTT mutants differentially bind to core histone tails, it appears that the histone code, or 
maybe more accurately the lack of proper recognition by mutant MeCP2, may play a crucial role 
in the molecular mechanism of RTT development. 
Possible Role of Intrinsic Disorder in Sir3/MeCP2 Chromatin Interactions 
In addition to structured domains defining protein’s function and partners, a large number 
of them contain a significant amount of unordered segments, as demonstrated by comparison of 
the eukaryotic proteome (Oldfield et al., 2005; Liu et al., 2006). These “unorganized” segments 
are known to be unable to adopt standard three-dimensional secondary structures and are referred 
to as being intrinsically disordered (reviewed in Uversky et al., 2005). Protein intrinsic disorder 
(ID) has been explored for many years, and has been referred to by many terms such as “proteins 
being partially unfolded” (Linderstrøm-Lang and Schellman, 1959), flexible (Pullen et al., 1975), 
or mobile (Cary et al., 1978). The higher amounts of intrinsic disorder found in eukaryotic 
proteins have been theorized to correspond to the increased complexity required for additional 
protein-protein interactions important in gene regulation and cell signaling. These multimeric 
complexes may not be necessary in less complex organisms. In support of this theory, a 
comprehensive analysis of eukaryotic transcription factors has identified that a large majority of 
them contain extended intrinsically disordered regions (Liu et al., 2006). These long stretches of 
ID regions have been proposed to participate in the formation of a flexible scaffold required for 
multiple biological interactions. To support this theory, multiple studies have linked these 
disordered regions of proteins with a large number of functions, including DNA interactions 
(Spolar and Record 1994; Weiss et al., 1990; Paull et al., 2001), RNA-binding (Allain et al., 
1996; Markus et al., 1997; Nanduri et al., 1998), and protein-protein associations (Muro-Pastor et 
al., 2003; Scully et al., 1997; Zhong et al., 1999; Zhang et al., 1998). Although these intrinsically 
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disordered regions lack a detectible structure, some areas have been described to undergo 
conformational changes that lead to the adoption of ordered structures upon binding to their 
physiological partner (Li et al., 2000; Bothner et al., 2001; Bourhis et al., 2004). The lack of a 
characterized, ordered domain responsible for Sir3’s DNA binding ability could point to the 
large disordered regions within this CAP as responsible for this interaction. Similarly, MeCP2’s 
ability to recognize histone N-termini may be related to its high levels of intrinsic disorder. 
The Sir3 protein has recently been described to bind to DNA in vitro, despite the lack of 
an identifiable DNA binding domain. Throughout previous studies and during our Sir3-nucleic 
acid characterization, no sequence dependent binding has been observed for this CAP. Primary 
amino acid sequence analysis of Sir3 reveals some basic charge patches (Green highlight, Figure 
4.1) that may indicate potential DNA contacts. Analyzing the primary sequence by predictor of 
natural disorder regions (PONDR) VL-XT, one of the algorithms used to identify IDs,  also 
reveals a high number of intrinsically disordered stretches of residues defining a large region 
spanning between residues 190 and 409 (Figure 4.2) (Romero et al., 2001). Although Sir3 does 
not contain a structured DNA binding domain, it may undergo an induced structural change upon 
binding/interacting with its cognate partner, similarly to what has been described for other 
intrinsically disordered DNA binding proteins (Schulz, 1979; Weis et al., 1990; Spolar and 
Record, 1994; Huth et al., 1997). The high mobility group box domain of HMG proteins 
(described in Chapter 1) mediates its DNA binding through either a sequence-dependent manner 
(one HMG box) or with little to no sequence specificity (requiring two or more HMG-boxes) 
(Wen et al., 1989). Biophysical measurements have indicated that HMGA proteins undergo 
conformational changes upon binding to their DNA targets (Huth et al., 1997). Another example 
of a DNA-binding protein unstructured in the absence of DNA is the GCN4 protein, a eukaryotic 
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transcriptional activator (Hope and Struhl, 1987). This protein has also been characterized to 
undergo induced local folding that generates a stable helical structure upon binding to its cognate 
DNA binding site (Weis et al., 1990). Based on this work, we believe that without a defined, 
structured DNA-binding domain, the intrinsic disordered segment (residues 190-409) of Sir3 is a 
likely candidate to mediate its DNA-binding function. 
 
Figure 4.1: Sir3’s Protein Primary Amino Acid Sequence. 
Green highlights signify amino acids with basic charges that could interact with the negatively charged backbone of nucleic 
acids. 
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Figure 4.2: Degree of Intrinsic Disorder in Sir3’s Primary Structure. 
PONDR Score = Degree of Disorder (> 0.5 indicates disordered sequence) (Romero et al., 2001); VL-XT= Integrated predictor 
of order/disorder domains; Black bars indicate large segments of intrinsic disorder 
 
Similar to Sir3’s lack of an identified structured DNA binding domain, MeCP2 lacks a 
defined structure capable of mediating histone tail binding ability. The only structured domain 
described for MeCP2 is the MBD, which has classically been characterized to impart a 
preference for methylated DNA (Lewis et al., 1992; Ballestar et al., 2000). Analysis of the 
primary sequence of MeCP2 reveals acidic residues interspersed throughout its length. These 
acidic patches could generate possible sites of interactions with the basic residues prevalent in 
core histone N-termini. In addition, the MeCP2 protein contains several regions of high intrinsic 
disorder (Figure 4.4) that may account for its ability to interact with the N-termini of core 
histones H2A, H3, and H4 (Figure 3.3). Within these ID regions may reside the key residues that 
interact with specific charges on the unstructured N-termini of H2A, H3, and H4. The inability 
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for wild type MeCP2 to bind to the H2B N-terminus (and the GST-GFP peptide) suggests that 
MeCP2 is capable of recognizing specific amino acid sequences (possibly including modified 
residues), and is not binding indiscriminately to short peptides. These studies do not indicate 
whether this binding can induce formation of a secondary structure within MeCP2, but the 
potential remains for this mechanism based on other examples of protein folding upon binding to 
the biological relevant target (Bothner et al., 2001; Li et al., 2000). One such example of 
binding-induced folding of disordered protein segments involves the Hdm2 (human double 
minute 2) and the Arf (ADP Ribosylation Factor) proteins, known to be unstructured as 
individual monomers in aqueous solutions (DiGiammariono et al., 2001). When these two 
proteins form a heterodimer, they transition from a state of intrinsic disorder to a β-sheet 
structure (Bothner et al., 2001). The IA3 protein, an inhibitor of yeast proteinase A (YprA), is 
another example of an intrinsically disordered protein folding upon binding to its recognition site 
(Dreyer et al., 1985; Green et al., 2004). This 68 aa protein was found to be unstructured when 
uncomplexed, but adopts a near perfect α-helix between residues 2-32 when interacting with the 
YprA’s active site cleft (Li et al., 2000). The remaining residues were accounted for as random 
coil in the X-ray structure, which may indicate a persistent state of disorder in the unbound 
sections of IA3 protein. As MeCP2 displays structural similarities with the above-described 
proteins, it is expected to follow similar “induced folding” rules. The large amount of disorder in 
the MeCP2 protein could be responsible for its ability to interact with multiple partners and play 
a significant role in its multiple biological functions.  
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Figure 4.3: MeCP2’s Protein Primary Amino Acid Sequence. 
Red highlights signify amino acids with acidc charges that could interact with the positively charged residues of core histone N-
termini. 
 
 
Figure 4.4: Degree of Intrinsic Disorder in MeCP2’s Primary Structure. 
PONDR Score = Degree of Disorder (> 0.5 indicates disordered sequence) (Romero et al., 2001); VL-XT= Integrated predictor 
of order/disorder domains  
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CONCLUSIONS 
 
The experiments described within this dissertation have demonstrated that the CAPs Sir3 
and MeCP2 have novel chromatin interactions outside of what had originally been described. 
These expanded roles may contribute to explaining their roles in multiple complex cellular 
mechanisms. Each of the CAPs interacting partners may contribute to their varying cellular 
functions, but the exact role and biological significance of each partner remains only partially 
defined. The findings presented in this dissertation contribute to the characterization of the newly 
discovered Sir3-DNA binding ability, and the identification of additional chromatin determinants 
for MeCP2. Biochemical evidence also connect the binding versatility of both Sir3 and MeCP2 
with their intrinsically disorder structure.  
The differential binding displayed by the two RTT mutants tested in this work, supports 
the theory that MeCP2’s chromatin contacts play an important biological role during 
development. The loss of N-termini interaction exhibited in MeCP2 R168X truncation mutants 
indicates that the TRD or CTD domains play a role in histone interaction.  In addition, all three 
domains correspond to regions of high intrinsic disorder (Figure 4.5) that are possible regions 
linked to core histone N-termini binding. MeCP2’s interaction with histone tails also opens the 
possibility for direct connections with the “histone code”. Histone PTMs could play a role in the 
discriminating behavior of this CAP. MeCP2 itself can be post-translationally modified, creating 
an additional level of regulation. Consequently, the PTM status both of the CAP and the histone 
N-termini and the corresponding levels of local DNA methylation could all contribute to this 
CAP’s proper localization and/or function (Zhou et al., 2006; Tao et al., 2009). Interestingly, 
hyper-acetylation of histone N-termini did not influence MeCP2-chromatin interactions as 
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demonstrated by EMSA. It did, however impact the level of compaction (Figure 3.5, B). This 
may indicate that MeCP2 can bind to chromatin before histone tail deacetylation. This is 
consistent with MeCP2’s ability to associate with Sin3 and HDAC1 as it would modify the local 
chromatin landscape. The newly discovered neuronal-specific hydroxymethyl-DNA may also be 
involved in MeCP2 distribution and/or function, and deserves attention in the future as it may 
prove to be a target for preferential binding in further studies with implications for proper 
neuronal gene expression (Kriaucionis and Heintz 2009). These hydroxymethyl-DNA studies 
and additional MeCP2 mutational studies will be needed to fully characterize the role of MeCP2 
and chromatin interactions in neuronal gene regulation; a topic more fully explored in the Future 
Studies section at the end of this dissertation. 
 
Figure 4-5: Alignment between Sir3’s known Domains and Calculated Intrinsic Disorder Regions. 
PONDR Score = Degree of Disorder (> 0.5 indicates disordered sequence) (Romero et al., 2001); VL-XT= Integrated predictor 
of order/disorder domains 
 
Sir3 cooperative DNA binding is another example of how multiple chromatin 
determinants may be important for proper CAP functioning. Our results demonstrate that Sir3 
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binding and its spreading over associated genomic silenced regions may occur in multiple 
sequential steps (Figure 2.8). Recruitment of Sir3 would proceed through previously described 
interactions with the Rap1 protein, with the level of histone-tail acetylation being an important 
factor for initial chromatin interactions. Upon binding to chromatin via histone tails, subsequent 
DNA-binding promotes cooperative Sir3-DNA binding possibly through local folding of Sir3’s 
intrinsic disordered regions. As Sir3 does not possess a defined DNA binding motif, the 
intrinsically disordered regions appear to be good candidates for mediation of Sir3-DNA 
interactions. The location of Sir3 DNA binding regions was proposed to reside between residues 
214 and 380 by Dr. Connelly and colleagues (Connelly et al., 2006). This area corresponds to a 
highly un-structured region residing between the BAH domain and AAA domain of Sir3 (Figure 
4.6). Within this large region of intrinsic disorder lies a patch of basic charges. Eight out of the 
sixteen amino acids, located between residues 232-247, are either lysine (6) or arginine (2), and 
this is the area most likely to mediate DNA contacts. Intrinsic disorder is commonly associated 
with eukaryotic transcription factors, but Sir3 may be an example of a silencing factor using its 
ID region as an additional targeting mechanism for chromatin interaction. Further in vitro and 
more importantly in vivo studies will be required to determine the biological importance of Sir3’s 
cooperative DNA-binding function and will be described in the following Future Studies section. 
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Figure 4.6: Alignment between Sir3’s known Domains and Calculated Intrinsic Disorder Regions. 
PONDR Score = Degree of Disorder (> 0.5 indicates disordered sequence) (Romero et al., 2001); VL-XT= Integrated predictor 
of order/disorder domains 
 
 
Link between Architectural Proteins, Histone PTM, and ATP-dependent Remodelers. 
The two CAPs studied in this project, Sir3 and MeCP2, have already been the topic of 
thorough investigation to characterize their interactions with chromatin. Our findings describing 
and defining multiple chromatin determinants for CAP-chromatin interactions suggests that other 
CAPs, in particular other architectural proteins, might benefit from similar treatment. Due to 
their structural similarities, the other members of the MBD family of proteins, in particular, 
should be assessed for any interactions with core histone N-termini. As with other CAPs that 
interact with histone tails (ex. Sir3, HP1), the PTM status of the unstructured histone N-termini 
may play a role in CAPs affinity and selectivity (Strahl and Allis 2000; Georgel et al., 2001; 
Bannister et al., 2001; Lachner et al., 2001). Additional experiments will be needed to determine 
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which, if any, PTMs influence the localization and function of MeCP2 and possibly other MBD 
proteins. With MeCP2 being shown to be able to condense chromatin, and two other MBD 
family members, MBD2 and MBD3, found to associate with chromatin remodelers, the 
possibility of a link between histone N-termini PTM signaling, MBD proteins localization, and 
chromatin structure alterations is reasonably high (Georgel et al., 2003; Feng and Zhang, 2001; 
Wade et al., 1999; Denslow and Wade 2007), although not described in the current accepted 
mechanism. The addition of histone N-termini PTM as an active component for MeCP2 
recognition would result in an increased versatility. As multiple CAPs share similar recognition 
domains and mode of action, this is likely to influence their contribution to multiple cellular 
processes. Identifying and characterizing the influence and function of each CAP-chromatin 
interaction is critically important for the understanding of the dynamics in higher order 
chromatin structure. With chromatin structure now recognized to play an essential role in 
eukaryotic cell development, differentiation, and propagation, understanding these structural 
interactions and their potential role in combination with any mutational errors is the first step 
towards the design of corrective measures or treatments. 
FUTURE STUDIES 
 
 The studies described above indicate novel chromatin interactions for Sir3 and MeCP2 
which may contribute to their biological activity; in addition to the functions they have 
previously been assigned. Further in vitro studies on both Sir3 and MeCP2 will be needed to 
identify the region(s) responsible for these additional chromatin-associated interactions. 
Subsequent in vivo experiments using these results will be required to confirm the biological 
significance of these CAPs-chromatin interactions.      
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To determine the in vivo role for Sir3’s DNA binding ability, the residues necessary for 
interaction must first be identified. Sir3 truncation mutants followed by subsequent point 
mutations over identified areas could be used to assess DNA binding with in vitro EMSAs as 
described in Chapter 2. The area spanning residues 214 and 380 and specifically the positive 
residues between aa 232-247 are prime targets for this study. Once the key residues have been 
identified, the effect of DNA-binding loss on Sir3 silencing could be analyzed. The contribution 
of Sir3’s DNA-binding on chromatin condensation could be identified in vitro through EMSAs 
with DNA-binding deficient mutants and 208-12 NA. The in vivo effect of loss of Sir3 DNA 
binding can be assessed by inserting an expression vector (eg. Yep13) with the DNA-binding 
deficient mutated Sir3 gene identified through EMSA into Sir3 null yeast strains (Shore et al., 
1984; Renauld et al., 1993). By increasing or decreasing the dosage of mutant Sir3 and assessing 
the telomeric position effect attributed previously to Sir3 dosage (Renauld et al., 1993), the 
importance of Sir3’s cooperative DNA-binding on the spread of genomic silencing could be 
addressed.  
Additional Sir3-chromatin interactions and the role of other potential co-regulators that 
influence binding could be assessed with similar EMSA studies used in this dissertation. The O-
Acetyl-ADP-ribose, a byproduct of Sir2’s enzymatic activity, has recently been described to 
influence Sir3’s chromatin binding in vitro (Liou et al., 2005; Martino et al., 2009). This 
influence on binding is proposed to occur through a conformational change in Sir3’s structure 
upon binding of O-Acetyl-ADP-ribose to the AAA domain. To assess if this effect is mediated 
by Sir3’s DNA binding, O-Acetyl-ADP-ribose can be added at increasing concentration to the 
Sir3-DNA binding reaction mix and assayed for alterations in electrophoretic mobility. 
Additionally, the effect of specific histone variants could be investigated. For example, H2A.Z 
132 
 
has been characterized to reside in boundary regions of silenced chromatin (Meneghini et al., 
2003) and may influence Sir3 recruitment. This histone variant could be incorporated in place of 
H2A during nucleosomal array reconstitutions, and assayed similarly by EMSA, as described 
above. This would reveal whether the incorporation of the H2A.Z variant is sufficient to 
influence Sir3-silencing by assessing if any change in Sir3-chromatin binding/spreading occurs. 
To ascertain the effect of histone N-termini binding on MeCP2 biological function, the 
regions and residues responsible for tail interactions must first be delineated. Similar to what was 
described for Sir3 mutations, additional truncated mutants of MeCP2 will need to be created, 
spanning the region between aa 168 and the C-terminal end. This area has been identified as 
critical for MeCP2-histone N-termini interaction/s to occur (Figure 3.6). By using the GST-
histone N-termini fusion pull-down assay in combination with these generated mutants, we 
would expect to identify sequences responsible for interaction. Subsequent point mutations over 
these regions could then be tested to identify the key residues required for histone tail interaction. 
These point mutants could then be used to generate transgenic mice and monitored for detectable 
phenotypic behavior in a manner similar to what was described by Pelka and co-workers (2006). 
To characterize the molecular mechanism of action, ChIP-chip and/or ChIP-seq in combination 
with microarray or Q-PCR strategies could be used to monitor changes in MeCP2 localization 
and corresponding effects on gene expression (Yasui et al., 2007; John, et al., 2008).   
Additionally, long-distance interactions and global chromatin effects may be revealed through 
analysis of MeCP2-histone binding deficient mutants in the context of formation of silent-
chromatin loop. This mechanism has been recently proposed to explain how a gene regulating 
mechanism of wt MeCP2 could affect the Dlx5-Dlx6 locus in mouse (Horike et al., 2005). This 
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MeCP2-induced chromatin looping was lost in MeCP2 null mice, but the role of histone N-
termini in this silencing mechanism has not been addressed.  
Other RTT mutants should also be assessed for differences in core histone N-termini 
interactions. This would allow for the determination of the differential binding amongst the 
common RTT mutations. The GST-histone N-termini fusion pull-down assay described above 
could be employed for this purpose. Further MeCP2 studies will be needed to determine the 
influence of the histone code on MeCP2 recruitment and function. A specific system has recently 
been developed making use of short modified peptides to assess the effect of individual and 
combinatorial PTMs on protein binding efficiency (personal communication: Denu and Garske). 
This system is based on a modified Western Blot method combined with an array of various 
modified peptides deposited on a nitrocellulose membrane. After incubation with appropriate 
templates, the membrane is probed, analyzed by classical immunofluorescence methods and the 
specificity for certain PTMs are assessed. This system would be ideally suited to analyze the 
effects that histone PTMs have on wild type MeCP2 binding. Known RTT mutants could also be 
tested in this manner to investigate differential binding. The biological function of subsequently 
identified PTM preferences could then be confirmed in vivo by ChIP, or even ChIP-seq for 
localization comparisons (John et al., 2008). 
5-hydroxymethyl-DNA, a recently discovered neuronal DNA modification, could also 
play a role as a key target for MeCP2-dependent gene regulation during development, as was 
suggested by Kriaucionis and Heintz (2009). An in vitro competition South-Western assay of 
various combinations of unmodified DNA, methylated DNA, and hydroxymethyl-DNA could be 
performed with MeCP2 to analyze the preference between these various types of DNA 
modifications (Ballestar et al., 2000). The enthropy of binding could also be assessed to measure 
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the strength of MeCP2 interaction with these three DNA substrates (Ghosh et al., 2008). To 
determine if a correlation exists between localization of this modification and MeCP2 
recruitment, ChIP-sequencing comparing pull-downs could be used to reveal if they overlap in 
the genome (John et al., 2008). Additionally, the RTT mutations can be tested in a similar 
manner to ascertain if a link exists between RTT and MeCP2-hydroxymethyl-DNA interaction. 
Identifying the components of chromatin and how individual chromatin associated 
proteins contribute to the alteration of chromatin higher order structure is essential in 
understanding gene regulation. Developmental disorders such as Rett Syndrome are incredibly 
difficult to treat until the complete mechanism of gene regulation and genome maintenance is 
defined. Ascertaining the individual components that contribute to the formation of chromatin 
higher order structure will lead to therapies to inhibit or correct deficiencies found in some 
patient’s genomes and/or transcriptomes. These proposed studies will advance the understanding 
of the mechanism of chromatin condensation by these two CAPs.  
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